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List of Abbreviations 
Ac   acetyl 
Ad   adamantyl 
Alk   alkyl 
AMLA  ambiphilic metal-ligand activation 
ATR   Attenuated total reflectance 
BA   benzoic acid 
BIES   base assisted internal electrophilic substitution 
Bn   benzyl 
Bphen   4,7-diphenyl-1,10-phenanthroline 
Bu   butyl 
cat   catalytic 
CMD   concerted metalation-deprotonation 
cod   1,5-cyclooctadiene 
Cp*   1,2,3,4,5-pentamethylcyclopentadiene 
Cy   cyclohexyl 
DCE   1,2-dichloroethane 
DCM   dichloromethane 
DMF   N,N-dimethylformamide 
DMAP  4-(diemethylamino)pyridine 
DMSO  dimethylsulfoxide 




EDG   electron donating group 
EI   electron ionization 
Et   ethyl 
EWG   electron withdrawing group 
FG   functional group 
FTICR   fourier transform ion cyclotron resonance 
GC-MS  gas chromatography-mass spectrometry 
GVL   γ-valerolactone 
Hept   heptyl 
HMF   5-hydroxymethylfurfural 
HRMS   high resolution mass spectrometry 
Int   intermediate 
IES   internal electrophilic substitution 
IR   infrared 
J   coupling constant (NMR) 
KIE   kinetic isotope effect 
L   ligand 
M   metal 
Mes   2,4,6-trimethylphenyl 
Me   methyl 
Ms   mesyl, methylsulfonyl 




M. p.   melting point 
NBS   N-bromosuccinimide 
NMP   N-methyl-2-pyrrolidinone 
NMR   nuclear magnetic resonance 
ORTEP  Oak Ridge Thermal Ellipsoid Plot 
PEG   polyethylene glycole 
Ph   phenyl 
phen   1,10-phenanthroline 
PIDA   (bisacetoxyiodo)benzene 
PIFA   [bis(trifluoracetoxy)iodo]benzene 
ppm   parts per milion 
ppb   parts per bilion 
py   pyridine 
SPO   secondary phosphine oxide 
THF   tetrahydrofurane 
TLC   thin layer chromatography 
TOF   time of flight 
TON   turnover number 
TS   transition state 







1.1 Transition Metal-Catalyzed C–H Functionalizations 
Substituted arenes are key building blocks in living organisms, pharmaceutical compounds and 
functional materials, such as optoelectronic devices. Traditionally, there have been several ways to 
functionalize arenes with alkyl groups and heteroatoms, while the synthesis of arene–arene bonds was 
challenging and conjuncted to several limitations. The discovery and development of nickel- and 
palladium-catalyzed cross-coupling reactions opened new possibilies for the formation of C–C and   
C–heteroatom bonds.[1] This class of broadly applicable reactions offered the possibility for the 
selective formation of a bond between electron-deficient and electron-rich arenes, alkenes or alkynes. 
As electrophilic arenes halogen-, triflate- or tosylate-substituted arenes are suitable, while as 
nukleophilic coupling partner several organometallic reagents are applicable. The most important are 
boronic acids and esters (Suzuki-Miyaura coupling),[2] organozinc compounds (Negishi coupling),[3] 
Grignard reagents (Kumada-Corriu coupling)[4] and organostannanes (Stille coupling).[5] In addition 
to these biaryl forming reactions, alkenylation (Mizoroki-Heck reaction)[6] and alkynylation reactions 
(Sonogashira-Hagihara coupling)[7] are well established. The general reaction structure and the most 
common organometallic reagents are depicted in Scheme 1. 
 




In 2010, the Nobel prize in chemistry was awarded to Richard F. Heck, Ei-Ichi Negishi and Akira 
Suzuki, for the development of palladium-catalyzed cross-coupling reactions.[8] Recent publications 
showed these reactions to work at incredibly low catalyst loadings in the range of parts per billion (ppb) 
and turn over numbers (TON) of higher than 106.[9] Despite this groundbreaking improvement of the 
organic chemist’s toolbox, cross-coupling reactions have the general drawback that 
prefunctionalization of the subtrates is needed.[10] Considering the overall process from the bulk 
chemical to the fine chemical product, these prefunctionalizations are accompanied by the use of 
stoichiometric reagents, byproducts and solvents, diminishing the overall step and atom economy. 
Therefore it would be highly attractive to substitute the prefunctionalization of one or both coupling 
partners by the direct functionalization of C–H bonds (Scheme 2). 
 
Scheme 2: Cross-coupling and C–H activation approaches. 
 
An early example of a catalytic C–H functionalization reaction that does not rely on prefunctionalized 
arenes was already reported in 1969, before the discovery of cross-coupling reactions.[11] In their 
pioneering work, Yuzo Fujiwara and Ychiro Moritani were able to perform an oxidative alkenylation 
reaction of benzene with syrene to generate stilbene (5aa) in a formal dehydrogenative coupling 
(Scheme 3).  
 






The former prefunctionalization and oxidative addition process was replaced by a catalytic C–H 
metalation keystep. Based on the metal catalyst and oxidation state, several mechanisms for the 
activation of C–H bonds have been widely accepted (Scheme 4):[10, 12] a) oxidative addition for low 
valent, electron-rich late transition metals; b) σ-bond metathesis for early transition metals and 
lanthanoids; c) 1,2-addition to unsaturated M=X bonds; d) electrophilic substitution with late transition 
metals in higher oxidation states; and e) base assisted deprotonation, using internal carboxylate or 
secondary phosphine oxide (SPO) ligands.  
 





The redoxneutral base-assisted metalation is a common process for the majority of C–H activation 
reactions.[10] Depending on the transition state geometry several mechanisms for the metalation step 
have been proposed (Scheme 5). The independently disclosed concerted metalation deprotonation 
(CMD)[13] and the ambiphilic metal ligand activation (AMLA)[14] pathways are characteristic for a six 
membered transition states, which can be stabilized by agostic metal hydrogen interactions. Electron-
rich arenes preferentially react in a base-assisted internal electrophilic substitution (BIES) type 
mechanism, which is distinguished by a precoordination of the catalyst by the unsaturated ipso-carbon 
atom prior to the deprotonation step.[15] Moreover, alkoxylate-and hydroxylate-assisted metalations 
occur via a four membered transition state in an internal electrophilic susbstitution (IES) mechanism.[16]  
 
Scheme 5: Transition states for the base assisted deprotonation of benzene. 
 
One major challenge of direct C–H activation strategies is to distinguish between several C–H bonds 
to achieve a selective functionalization at the desired position.[17] Three main strategies have been 
identified to achieve site-selectivity. Substituents at the arene, especially when they are bulky, could 
be used to block adjacent positions (Scheme 6, a). Besides sterical control, site-selectivity could be 
achieved making use of the electronic structure of the substrate. This approach functionalizes the most 
acidic position, as depicted at the pka values of purine (b).
[18] Lewis-basic groups at the substrates could 










1.2 C–H Activation by Chelation Assistance 
The C–H bond is an unbiquitous structural motif in organic molecules. Therefore, strategies to achieve 
site-selectivity are important, when C–H bonds should be activated and functionalized directly by 
transition metal catalysis. One option is the use of Lewis-basic groups that lead the catalyst to a certain 
position, thereby multiplying the effective concentration of the catalyst at that position. In 1986, Larry 
N. Lewis and Joanne F. Smith demonstrated this concept on the deuteration and alkylation of phenol, 
using a transient phosphite directing group and catalytic amounts of complex 11 (Table 1),[19] which 
was previously described by Parshall et al.[20] In 1993, Murai and Chatani used this directing group 
approach for the hydroarylation of alkenes by ruthenium-catalysis (b). In their report, they were able 
to control between the mono- and the dialkylated products (13 and 14) by simply changing the substrate 
ratios.[21]  
 
Entry Equiv (12a) Equiv (4c) Yield (13) [%] Yield (14) [%] 
1 1.0 1.0 75 8 
2 1.0 3.0 < 1 94 
Table 1: Pioneering hydroarylation reactions by a) Lewis & Smith and b) Murai & Chatani. 
 
A plenty of Lewis-basic groups are known to act as a directing group. They can be grouped according 
to their coordination behaviour in strongly and weakly coordinating directing groups.[22] While 




phosphorous or nitrogen atoms, the term weakly coordinating directing group is used for a directing 
group, that coordinates by weak σ-donating oxygen atoms. Strongly coordinating directing groups can 
be differentiated in bidentate, such as 8-aminoquinoline[23] or the triazole-based directing group 
TAM[24] (Scheme 7, a) and mondentate directing groups,[25] like 2-pyridin, 1-pyrazole, 2-oxazolin or 
ketimines (b). Commonly used weakly coordinating directing groups are carboxylic acids, esters, 
ketones, aldehydes, ethers or hydroxyl groups (c).[22a] 
 
Scheme 7: Representative examples of directing groups. 
 
Since the employed directing group is usually not part of the target molecule the post-synthetic 
transformation of these groups is an important issue. Scheme 8 shows selected examples for 
post-synthethic modifications: (a) conversion of the triazole based directing group TAM to a 
carboxylic acid by oxidation with NOBF4;
[26] (b) traceless removal of the carboxylic acid directing 
group by copper(I)-catalyzed protodecarboxylation;[27] (c) annulative introduction of the carboxylic 





Scheme 8: post-Functionalization of directing groups by (a) removal, (b) traceless removal (c) direct 
incorporation to the target molecule. 
 
In contrast to the advanced development of C–H functionalization methods for strongly coordinating 
directing groups, weakly coordinating directing groups are priviledged subtrates for the majortity of 
transformations. A plethora of structural motifs are commercially available at reasonable prices and 
often accessible from natural feedstocks. In addition, methods for post-synthethic modifications are 





1.3 Ruthenium Catalyzed C–H Functionalization 
Since Lewis and Smith reported the catalytic addition of ethylene to phenol in 1986,[19a] ruthenium 
complexes have emerged as a general class of catalysts for the functionalization of arenes. For the 
activation of C–H bonds, complexes of the type (arene)RuCl2-dimers as versatile precursors or well-
defined arene ruthenium biscarboxylates have shown to be a powerful class of catalysts. [29] Compared 
to other 4d and 5d transition metals associated to C–H activation, the price of ruthenium is constantly 
low, making it economically attractive. Table 2 shows commonly used second and third row transition 
metals for the activation of C–H bonds together with their prices and typical catalysts or precursors. It 
is noteworthy, that complexes of the 3d transition metals cobalt,[30] iron[31] and manganese[32] have 
recently shown to be powerful tools for C–H functionalization, but especially the use of weakly 
coordinating directing groups remains challenging for 3d metals.  
Metal USD per fine ounce USD per mol Typical catalysts and precursors 
Iridium 1375 8488 
 
Palladium 1009 3439 Pd(OAc)2, PdCl2, Pd(acac)2 
Rhodium 2240 7418 
 
Ruthenium 250 812 
 






The active arene ruthenium biscarboxylate 31 or cationic arene ruthenium carboxylate catalyst 32 can 
be used in isolated form or generated in-situ from the commercial available ruthenium(II) dimer 30 
and carboxylic acid salts (and non coordinating anion salts) (Scheme 9).[34] 
 
Scheme 9: Synthesis of the active ruthenium(II) carboxylate catalysts. 
 
The catalytic cycle is commenced by the coordination of the active complex by the directing group, 
subsequently followed by the activation of the otherwise unreactive C–H bond via a six membered 
transition state that generates 33. Ruthenacycle 33 can react with various reactants under the formation 
of C–C or C–heteroatom bonds (Scheme 10).[35] The reaction with halogenated arenes,[36] primary 
halogenated alkanes[37] or alkynyl bromides[38] resulted in the C–C bond formation in the 
ortho-position, while secondary or tertiary alkyl halides reacted para to the ruthenium–carbon bond.[39]      
C–C multiple bonds were known to react in redox neutral hydroarylation reactions[39b, 40] or oxidative 
couplings[28, 41] in the ortho-position, that can be followed by annulation reactions. The reaction with 










1.4 Ruthenium-Catalyzed Twofold C–H Activation Between Benzoic Acids and Acrylic 
Esters 
Since the pioneering work of Fujiwara and Moritani in the late 1960s,[11b-d] tremendous progress has 
been made in the twofold C–H activation between arenes and and alkenes with various transition 
metals, such as palladium, rhodium and ruthenium.[41e, 44] There are two major challenges to be 
addressed for this type of transformations. Achieving site-selectivity and finding a suitable reagent for 
the oxidation. The site-selectivity could be achieved by applying the directing group strategy that leads 
the catalyst directly to a certain C–H bond, thereby multiplying the effective catalyst concentration 
next to the target bond.[44] Traditionally, the second challenge was addressed by the use of oxidation 
agents, which is accompanied by the formation of by-products.  
In an early report by Miura et al. in 1998, this problem was solved by the use of Cu(OAc)2·H2O as 
oxidant in the palladium-catalyzed alkenylation of 2-phenylsulfonanilides 44 with acrylates 45 
(Scheme 11, a).[45] Here, the authors showed the versatility of their C–H activation approach by 
demonstrating different substrates, inter alia benzoic acids 21 to be viable in their transformation (b). 
 





In 2007, Satoh, Miura and co-workers showed that the alkenylation of benzoic acids (21) with various 
activated alkenes could be performed by rhodium catalysis.[46] Here, the C7-alkenylated phthalide 
48laa was formed as the major product when acrylates were used as coupling partners, while 
acrylonitrile (4e) and acrylamides 4d gave the ordinary phthalides 49 (Scheme 12).[47] The rhodium-
catalyzed alkenylation was further extended by the use of acrylic acids,[48] vinyl ketones and vinyl 
sulfones.[49]  
 
Scheme 12: Rhodium-catalyzed twofold C–H alkenylation of benzoic acid (21l). 
 
In 2011, Ackermann et al. demonstrated that benzoic acids (21) could be alkenylated by ruthenium 
catalysis with Cu(OAc)2·H2O as oxidant.
[41g] Notably, acrylonitrile (4e) and acrylic esters 45 could be 
used as substrates and in water as naturally-benign reaction medium (Scheme 13). Cai et al. were able 
to apply a phase-separation based catalyst recycling procedure[50] in a mixture of polyethylene glycole 





Scheme 13: Ruthenium(II)-catalyzed alkenylation ortho-toluic acid (21a). 
 
Major improvements were presented by Ackermann and co-workers, by showing 
ruthenium(II)-biscarboxylate catalysis could perform this reaction with oxygen as the sole oxidant 
(Scheme 14, a).[41d] Later, Su and co-workers demonstrated this oxidase-type reactivity for 
rhodium(III)-catalysis.[52] Recently, Ackermann and co-workers developed an electrochemical 
approach for the rhodium(III)-catalyzed alkenylation/annulation sequence for the synthesis of 
phthalides. Here, the oxidant could be replaced by applying electric current, notably in the absence of 
any chemical oxidant (b).[53] 
 





1.5 Carboxylic Acid as a Traceless Directing Group 
Carboxylic acids are among the most versatile functional groups in organic chemistry. They are cheap 
and commercially available in a large variety and they could be functionalized by a plethora of well 
established synthetic methods.[54] Due to their natural occurrence, they display an attractive target for 
modern catalytic approaches.[54] Gooßen and co-workers elegantly merged the copper-mediated 
decarboxylation of benzoic acids and cross-coupling methods to a decarboxylative C–C bond 
formation in the ipso-position (Scheme 15).[55] 
 
Scheme 15: Decarboxylative cross-coupling of 2-nitrobenzoic acids (50) with 
1-bromo-4-chlorobenzene (51a). 
 
In 2007, an alternative approach was presented by the Daugulis group. There, the authors combined a 
palladium(II)-catalyzed ortho-C–H arylation of benzoic acids 21 with a copper(II)-catalyzed 
protodecarboxylation of the directing group in a second step (Scheme 16).[27] This two metal, two step 
approach gave access to a great variety of meta- and para-substituted arenes, which was largely 
expanded by contributions of several other groups.[56] 
 





In 2008, the Miura group improved this concept by the development of an ortho-C–H 
alkenylation/decarboxylation one-pot tandem process.[57] The authors showed their system to operate 
with 2- and 3-carboxylic acids of pyrrole, indole, (2,3-benzo)furane, (benzo)thiophenes (55 or 57) with 
catalytic amounts of palladium(II) or rhodium(III) for the C–H activation reaction and stoichiometric 
amounts of copper(II) or silver(I) salts for the decarboxylation (Scheme 17).  
 
Scheme 17: Two metal, one pot decarboxylative arylation by Miura et al. 
 
Furthermore, Larrosa and co-workers expanded the scope of this transformation to ortho-substituted 
benzoic acids[58] and salicylic acids[59] using palladium(II) and silver(I) salts to afford meta-substituted 
arenes. It is noteworthy that the authors applied their method in a consecutive sequence of a Kolbe-
Schmidt carboxylation, followed by the alkenylation/decarboxylation tandem reaction, generating 





Scheme 18: Kolbe-Schmitt-carboxylation, C–H arylation, decarboxylation sequence by Larrosa. 
 
Methods using one metal that facilitates both, the C–H functionalization and the decarboxylation were 
rare. Lee and co-workers showed their NHC supported palladium(0) complex 62 to enable the 
decarboxylative alkenylation of heteroarenes.[61] Lee et al. indicated the versatility of ruthenium(II) 
catalysis by the development of an ortho-amidation/decarboxylation tandem reaction using benzoic 
acids 21 and isocyanates (63)[62] and expanded the scope of C–H amidation reactions.[63] 
 





1.6 Hydrogen Isotope Exchange Reactions (HIE) for Isotopic Labeling 
Isotopologues of chemical compounds containing the heavier isotopes of hydrogen, namely deuterium 
(D, 2H) and trithium (T, 3H), have a wealth of important applications in the clarification of reaction 
mechanisms and biological pathways.[64] Furthermore, deuterated compounds are commonly used as 
indiscernible solvents in NMR spectroscopy and as mass tagged reference materials in mass 
spectrometry. Thereby, these labeled analogues are tagged in specific positions, without changing the 
global chemical, physical and biological properties.[65] 
In comparison to C–H bonds, the C–D bond has a lower zero-point energy, which is a result of a lower 
vibrational frequency and a slightly shorter bond distance between carbon and deuterium. This energy 
gap can be observed as kinetic isotope effect (KIE) (Figure 1).[66] 
 
Figure 1: Graphical representation of the zero-point energy, bond-distance and the activation 
energies for the homolysis of a C–H and C–D bonds.[67] 
 
KIE’s are differentiated between primary KIE’s, that could be observed when the labeled bond is 
broken and secondary KIE’s as a result of steric interactions or hybridization changes, while the bond 
stays intact. Garg et al. demonstrated the power of the KIE in their total synthesis of 
(–)-N-methylwelwitindoline C isonitrile. Specific deuterium labeling in the C10-position nearly 
doubled the yield of the desired nitrene insertion reaction, while the formation of by-products was 




Table 3: Kinetic isotope effect of the nitrene insertion in the total synthesis 
(–)-N-methylwelwitindoline C isonitrile. 
 
Isotope Yield of 66 [%] Yield of 67 [%] 
R = H 33 25 
R = D 60 8 
 
In order to synthesize isotopologues there are two major approaches. The de novo synthesis using 
labeled precursors and the late-stage hydrogen isotope introduction in the desired position.[69] Here, 
especially C–H functionalization methods are quiet attractive, because they give easy access to 
otherwise unreactive positions, without the need of prefunctionalization.[70] In 2002, Bergman and co-
workers demonstrated iridium(III) complexes to be active in the exchange of C(sp3)–H and C(sp2)–H 
bonds of Ibuprofen (Scheme 20, a),[71] whereas Chen et al. showed the deuteration of the anthelmic 





Scheme 20: Iridium-catalyzed deuteration of Ibuprofen (68) and Niclosamide (70). 
 
While the hydrogen isotope exchange of aromatic C–H bonds is well explored,[64c, 70a] methods for the 
selective functionalization of alkenes are rare. In 2008, Hartwig and co-workers reported an iridium(III) 
pincer complex 71 that exchanges alkenyl C–H bonds with C6D6 as the deuterium source (Scheme 21, 
a).[74] Grotjahn et al. used ruthenium(II) for the (per)deuteration alkenes by isomerization of the double 
bond with D2O as deuterium source.
[75] Jia and Lin used commercial available RuHCl(CO)(PPh3)3 (73, 
b) and Yorimitsu used catalytic amounts of [Ir(OH)(cod)]2 and N-mesylbenzamides to deuterate the 
double bond of stilbene and methylidene groups.[76] Oro and co-workers showed, that NHC-supported 











1.7 Renewable Hydrocarbons in Organic Synthesis 
Fossil oils and gases are finite ressources and going to be limited in the future.[78] However, the 
majority of chemical products are based on fossil ressources.[79] In 1998, Anastas and Warner 
formulated the twelve principles of green chemistry, which demonstrate the major challenges on the 
way to a green and sustainable production of chemical products.[80] One of these major challenges is 
to discover ways to aquire bulk chemicals from sustainable sources or to find sustainable alternatives 
for those chemicals. Especially the conversion of biomass into bulk chemicals is an attractive 
approach.[81] Thereby, it is important that the substrates do not compete to food production and are, 
ideally, waste products from other industries.[82] Renewable feedstocks with the biggest potential are 
mono-, di- and polysaccharides, lignin, proteins and extractives. Since the majority of those feedstocks 
are highly functionalized polymers, effective methods for hydrolysis, defunctionalization and 
separation have been developed to reduce their complexity and make biomass available for the 
chemical supply chain.[83] Herein, several compounds have been proposed to be future plaform 
molecules. These biomass-derived platform molecules need to be accessible in high quantities at 
reasonable costs and should be convertible to a plethora of chemicals by basic reactions.[84]  
γ-Valerolactone and levulinic acid are supposed to be biomass-derived future platform molecules. 
They could be synthesized from sugars, cellulosic and hemicellulosic biomass, that could be either 
directly converted to levulinic acid (76)[85] and γ-valerolactone (GVL, 77)[86] or via the isolation of 
5-(hydroxymethyl) furfural (HMF, 75)[87] as the intermediate.[86a, 88] 
 






Biomass derived GVL (77) is a versatile precursor to various chemicals, especially for the production 
of fuels and polymers.[89] Scheme 23 gives an overview of bulk chemicals and their applications, that 
could be synthesized from GVL (77) using simple and low cost standard manipulations. 
 
Scheme 23: Synthesis of bulk chemicals from biomass-derived γ-valerolactone (77).[89] 
 
Besides the production of fuel and bulk chemicals, especially the substitution of traditional solvents 
has a big influence to the overall ratio between traditional and renewable reagents.[90] Scheme 24 shows 
a selection of alternative solvents. In general, these solvents have higher molecular weights and higher 
boiling and flammability points, thereby increasing the safety compared to their traditional pendants.[91] 




properties. Therefore, it is highly important to evaluate these properties and show the applicability of 
these solvents in a broad set of reactions in order to install them as viable alternatives.[92] 
 








C–H Activation has emerged as a powerful and sustainable approach for the functionalization of arenes. 
Thereby it extended the methodological repertoire of organic chemists and changed the way organic 
synthesis is planned and perfomed.[93] Several transition metal complexes have turned out to be broadly 
applicable and have been extensively developed within the last two decades. Although there is a current 
trend in substituting 4d and 5d metals by cheaper 3d transition metals, especially the use of weakly 
coordinating directing groups is unique for the heavier 4d and 5d metals.[22] Within this context 
ruthenium based catalysts are particularly attractive, because of their lower price compared to the other 
metals in combination with a cheap and well developed synthesis of the catalytically active complexes.  
Ruthenium based catalysts are applicable to a large number of oxidative and redox neutral reactions. 
For oxidative tranformations S. Warratz and C. Kornhaaß recently showed that costly stoichiometric 
copper(II) and silver(I) oxidants can be substituted by simple oxygen as the sole oxidant in the 
annulative synthesis of iso-coumarines.[41d] To extend this economic and highly sustainable approach 
a catalytic system for the annullative synthesis of phthalides 47 from benzoic acids 21 and alkenes 45 
with oxygen as sole oxidant was investigated (Scheme 25). In addition to the development of a 
synthethic method extensive mechanistic studies were conducted to develop a deeper understanding 
of the catalytic mode of action. 
 
Scheme 25: Ruthenium-catalyzed oxidative alkenylation of benzoic acids 21. 
 
The removal or post-modification of the directing groups is an ongoing topic in directed C–H 
functionalization. In case of the phthalide synthesis the directing group is incorporated in the desired 
product, displaying perfect atom economy. As observed in the previous project, small amounts of a 
decarboxylated side product were formed during the annulation. For palladium chemistry, limited 




for ruthenium catalysis only a single example was known.[94] In order to explore this new area in 
ruthenium catalysis, this unprecedented reactivity was investigated, in order to develop a domino 
functionalization decarboxylation process (Scheme 26). 
 
Scheme 26: Ruthenium-catalyzed decarboxylative alkylation/alkenylation. 
 
Compounds labeled with higher isotopes of hydrogen are highly important for the study of reaction 
mechanisms, NMR-experiments or as specifically tagged reference materials. While arene labeling is 
a common and well-developed process, reports for the hydrogen isotope exchange (HIE) reaction at 
alkenes were limited to few examples.[70a] Based on observations of hydrogen scrambling at the alkene 
during general alkenylation studies this reactivity was investigated (Scheme 27). 
 
Scheme 27: Ruthenium-catalyzed deuteration of acrylic esters. 
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3 Results and Discussion 
3.1 Ruthenium(II)-Oxidase Catalyzed Twofold C–H Alkenylation with Oxygen as the 
Sole Oxidant 
Ruthenium(II)-biscarboxylate catalysis has emerged as a powerful tool for the introduction of alkene 
moieties into organic molecules. Among other catalytically active complexes based on various metals, 
ruthenium catalysis offers the possibility of performing the alkenylation of C–H bonds in a twofold 
fashion, formally abstracting two protons in an oxidative process. Copper(II) and silver(I) salts have 
been shown to be the oxidants of choice in these transformation, but their use is accompanied by 
stoichiometric metal waste formation. In 2015, Ackermann et al. demonstrated that 
ruthenium(II)-biscarboxlates are able to use molecular oxygen as a sole oxidant, forming 
iso-coumarines from benzoic acids and alkynes (Scheme 28).[41d] 
 
Scheme 28: Ruthenium(II)-oxidase catalyzed synthesis of iso-coumarines. 
 
The following studies extended these first observations of the ruthenium(II)-oxidase reactivity by the 
development of a catalytic system and extensive studies on the reactions mechanism of the twofold    
C–H activation between benzoic acids and alkenes. 
3.1.1 Optimization Studies for Ruthenium(II)-Oxidase in Traditional Solvents 
The study was commenced by the optimization of the reaction of 2-methylbenzoic acid (21a) with 
n-butyl acrylate (45a) in a catalytic system consisting of an in situ formed ruthenium(II)-biscarboxylate 
catalyst, acetate base/ligand and an alcoholic solvent under an ambient atmosphere of molecular 
oxygen (Table 4). The acetate salt was varied in methanol as the solvent (entries 1-3), showing 
potassium to be the optimal counterion. The use of n-butanol as the solvent (entry 5) resulted in a slight 
improvement, while ethanol and tert-butanol (entries 4 and 6) showed less efficacy. The ratio between 
the benzoic acid and the acrylate component showed a strong dependency, which favors an excess of 
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the benzoic acid (entries 7, 8 and 9). The use of p.A-grade methanol and dried and purified methanol 
as the reaction medium gave comparable yields, highlighting the robustness of this catalytic system 
(entries 9 and 10). Entries 11 and 12 demonstrated the crucialty of the ruthenium(II) catalyst as well 
as of the acetate source. Changing the solvent to n-butanol improved the yield to 66%, when 21a was 
used as limiting reagent (entry 13). 
Table 4: Optimization of the substrate ratios, solvent and acetate source.
 
Entry 21a/45a [mmol] Solvent MOAc Yield [%][a] 
1 2.0/1.0 MeOH NaOAc 74 
2 2.0/1.0 MeOH KOAc 88 
3 2.0/1.0 MeOH CsOAc 82 
4 2.0/1.0 EtOH KOAc 78 
5 2.0/1.0 n-BuOH KOAc 90 
6 2.0/1.0 t-AmylOH KOAc 67 
7 1.0/1.2 MeOH KOAc 50 
8 1.0/2.0 MeOH KOAc 51 
9 1.0/1.5 MeOH  KOAc 57 
10 1.0/1.5 MeOH (p.A) KOAc 58 
11 2.0/1.0 MeOH --- --- 
12[b] 2.0/1.0 MeOH KOAc --- 
13 1.0/1.5 n-BuOH KOAc 66 
[a] Reaction conditions: 21a, 45b, [RuCl2(p-cymene)]2 (30) (5.0 mol %), MOAc (1.0 mmol), solvent 
(3.0 mL), O2 (1.0 atm), 60 °C, 18 h. Yield of isolated product.
 [b] Without [RuCl2(p-cymene)]2. 
 
Using higher boiling n-butanol as the solvent the temperature was elevated to 80 °C, which improved 
the efficacy (Table 5). The yield of this transformation still depended on the ratio between benzoic 
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acid and acrylic ester (entries 1-4). Increasing the oxygen volume showed minor effects (entry 5), 
whereas entries six and seven demonstrated, that simple air could be used as the oxidant. Slightly better 
yields were observed, when the acrylate was used as reagent and solvent at 120 °C (entry 9). The 
ruthenium(II)-oxidase system was further found to be active even at remarkable low temperatures of 
37 °C or 25 °C giving good or moderate yields at prolonged reaction times (entries 10-13). 
Table 5: Opimization of the ruthenium oxidase catalysis. 
 
Entry 21a/45a [mmol] Solvent (3 mL) T [°C] Yield [%][a] 
1 1.0/1.5 n-BuOH 80 74 
2[b] 1.0/1.5 n-BuOH 80 76 
3 1.5/1.0 n-BuOH 80 84 
4 2.0/1.0 n-BuOH 80 90 
5[c] 1.5/1.0 n-BuOH 80 86 
6[d] 1.5/1.0 n-BuOH 80 77 
7[e] 1.0/1.5 n-BuOH 80 72 
8 1.0/1.5 n-BuOH 120 69 
9 1.0/5.0 --- 120 80 
10 2.0/1.0 MeOH 37 37 
11[f] 2.0/1.0 MeOH 37 82 
12 2.0/1.0 MeOH 25 11 
13[f] 2.0/1.0 MeOH 25 53 
[a] Reaction conditions: 21a, 45b, [RuCl2(p-cymene)]2 (30) (5.0 mol %), KOAc (1.1 mmol), solvent 
(3.0 mL), O2 (1.0 atm), T, 18 h. Yield of isolated product.
 [b] CsOAc instead of KOAc. [c] Under 140 
mL of O2.
 [d] Under air. [e] Reaction performed in an autoclave under air (10 bar). [f] 2.5 days. 
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The optimized catalytic system consists of 5 mol % of [RuCl2(p-cymene)]2 (30), 1.1 equivalents of 
potassium acetate and n-butanol as the solvent under an ambient pressure of oxygen. Depending on the 
price gap between the usually more valuable benzoic acid component and the acrylic reaction partner 
the ratio between 21 and 45 can be customized, giving higher yields for higher benzoic acid loadings 
(entries 1, 3 and 4). 
 
3.1.2 Scope of Ruthenium(II)-Oxidase Catalyzed Formation of Phthalides  
With these optimized conditions in hand, the scope for differently substituted benzoic acids was tested. 
The reaction smoothly proceeded with alkyl, aryl and ether substituents in the ortho-position (entries 
1-4, 7 and 8), selectively forming the phthalides (47) in moderate to good yields. Reactive iodo, bromo 
and hydroxyl substitutents (entries 5, 6 and 8) were tolerated under the reaction conditions, 
demonstrating the selectivity of the ruthenium catalyst for the activation of C–H bonds and giving 
access to post-syntethic modifications.  
Table 6: Scope of the ruthenium(II)-oxidase alkenylation of benzoic acis (21) with 
ortho-substituents. 
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Entry Benzoic acid Product Yield [%][a] 
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[a] Reaction conditions: 21 (1.0 mmol), 45a (1.5 mmol), [RuCl2(p-cymene)]2 (30) (5.0 mol %), 
KOAc (1.0 mmol), n-BuOH (3.0 mL), O2 (1.0 atm), 80 °C, 18 h. Yield of isolated product. 
  
When benzoic acids without 2-substituent were subjected to the reaction conditions, regioisomers and 
double alkenylations were observed. A methyl substituent in the meta-position of the benzoic acid 
selectively guides the catalyst to the sterically less crowded 6-position, without the formation of  any 
double alkenylated species (Table 7, entry 1). When a Lewis basic methoxy group is installed in the 
3-position of the benzoic acid three products were oberserved, with the alkenylated 5-methoxy 
phthalide 48jaa being the major product (entry 2). For the mono-functionalized products the 2-position 
is preferentially alkenylated, indicating that the coordinative effect of the methoxy substituent had a 
stronger influence than its repulsive effects. Symmetrical 4-substituted and unsubstituted benzoic acid 
gave mixtures of mono- and di-functionalization with the singly functionalized phthalide as the major 
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Table 7: Scope of the ruthenium(II)-catalyzed alkenylation of benzoic acids 21 without 
ortho-substituents. 
 







47ia: 47 48iaa: 0 
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47ka: 33 48kaa: 28 
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47la: 43 48laa: 23 
[a] Reaction conditions: 21 (1.0 mmol), 45a (1.5 mmol), [RuCl2(p-cymene)]2 (30) (5.0 mol %), 
KOAc (1.0 mmol), n-BuOH (3.0 mL), O2 (1.0 atm), 80 °C, 18 h. Yield of isolated product.  
 
Other electron-withdrawing susbstituents, like chloride, fluoride, trifluoromethyl, thioether, keto, nitro 
or amino groups, at the benzoic acid component gave yields below two turnovers under the reaction 
conditions. When the acrylic ester component is varied, several alkyl substituted acrylic esters gave 
the desired products (entries 1 and 2). Benzyl acrylate showed good reactivity, but was accompanied 
by a transesterification side-reaction with the solvent (entry 3). Aromatic acrylates, acrylonitrile, 
methyl vinyl ketone and simple alkenes did not lead to the desired products.  
Table 8: Scope of the acrylic ester component 45. 
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[a] Reaction conditions: 21a (1.0 mmol), 45 (1.5 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), KOAc 
(1.0 mmol), n-BuOH (3.0 mL), O2 (1.0 atm), 80 °C, 18 h. Yield of isolated product.
 [b] Isolated 
as a mixture with the transesterification product 47aa. 
 
In summary, a method for the alkenylation of benzoic acids with acrylates that uses oxygen as the sole 
oxidant was developed. The reaction conditions tolerated various substitution patterns at the arene 
moiety, including synthetically useful functional groups like halogens. Nevertheless, there are two 
major drawbacks concerning the solvent that leave room for improvement. First, the oxidation of the 
solvent to butanoic acid, that was observed as a side reaction. Second, n-butanol has a very low flash 
point point of 35 °C. In combination with the oxygen atmosphere and a temperature of 80 °C this is a 
potential safety hazard, that should be avoided, when possible.  
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3.1.3 Optimization Studies for Ruthenium(II)-Oxidase in Renewable Solvents 
Given the findings of the previous study, we tried to overcome these drawbacks by optimizing the 
ruthenium(II)-oxidase system for the synthesis of phthalides in green and renewable solvents. 
Replacing the alcoholic solvent with environmentally benign γ-valerolactone (77) already improved 
the yields compared to the former study (Table 9, entry 1). Mesityl carboxylate as the ligand and base 
or reduced acetate loadings resulted in decreased product formation (entries 2-4). In analogy to the 
previous study, the ratio between substrates 21a and 45a showed a strong effect, favoring an excess of 
the benzoic acid (entry 5). This concentration effect was compensated by the addition of equivalent 
amounts of acetic acid, which led to better yields (entry 6), that were further improved by raising the 
concentration of the reagents to 1.0 M (entries 6, 8 and 9). Entry 7 confirmed potassium acetate to be 
crucial for the reactivity.  
Table 9: Optimization of the additives for ruthenium(II)-oxidase in γ-valerolactone (77). 
 
Entry 21a/45a [mmol] M Additive 1 [mmol] Additive 2 [mmol] Yield [%][a] 
1 1.0/1.5 0.3 KOAc (1.0) --- 75 
2 1.0/1.5 0.3 KO2CMes (1.0) --- 47 
3[b] 1.0/1.5 0.3 --- --- 37 
4 1.0/1.5 0.3 KOAc (0.5) --- 65 
5 2.0/1.0 0.3 KOAc (1.0) --- 83 
6 1.0/1.5 0.3 KOAc (1.0) HOAc (1.0) 81 
7 1.0/1.5 0.3 --- --- --- 
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Entry 21a/45a [mmol] M Additive 1 [mmol] Additive 2 [mmol] Yield [%][a] 
9 1.0/1.5 1.0 KOAc (1.0) HOAc (1.0) 90 
[a] Reaction conditions: 21a, 45a, [RuCl2(p-cymene)]2 (30) (5.0 mol %), additives, GVL (77) (M), 
O2 (1.0 atm), 80 °C, 18 h. Yield of isolated product.
 [b][Ru(O2CMes)2(p-cymene)] (99) (10 mol %) 
as the catalyst. 
 
Reduced loadings of the precatalyst resulted in lower yields and incomplete conversion of the starting 
materials (Table 10, entry 1), while no reaction was observed in its absence (entry 2). Other 
ruthenium(II) and ruthenium(III) sources were shown to be inactive under the reaction conditions 
(entries 3 and 4). 
Table 10: Optimization of the catalysts the ruthenium(II)-oxidase in γ-valerolactone (77). 
 
Entry 21a/45a [mmol] M Catalyst [mol %] Additive [mmol] Yield [%][a] 
1 1.0/1.5 1.0 
[RuCl2(p-cymene)]2 (30) 
(2.5) 
HOAc (1.0) 30 
2 1.0/1.5 0.3 --- --- --- 
3 1.0/1.5 1.0 [RuCl2(cod)]n (10) --- --- 
4 1.0/1.5 1.0 RuCl3∙xH2O (10) --- traces 
[a] Reaction conditions: 21a, 45a, catalyst (5.0 mol %), KOAc (1.0 mmol), additive, GVL (77)  
(M), O2 (1.0 atm), 80 °C, 18 h. Yield of isolated product. 
 
The reaction proved to be tolerant to water (Table 11, entry 1) and other green and renewable reaction 
media, such as L-ethyl lactate, 2-methyl THF and tetrahydrofuryl alcohol were shown to be suitable 
solvents for the ruthenium(II)-oxidase catalysis (entries 2-4). 




Table 11: Ruthenium(II)-oxidase in green solvents. 
 
Entry 21a/45a [mmol] M Solvent Additive [mmol] Yield [%][a] 
1 1.0/1.5 0.3 GVL (77)/H2O (2:1) --- 49 
2 1.0/1.5 1.0 L-ethyl lactate (94) HOAc (1.0) 59 
3 1.0/1.5 1.0 2-methyl THF (88) HOAc (1.0) 81 
4 1.0/1.5 1.0 
tetrahydrofuryl 
alcohol 
HOAc (1.0) 82 
[a] Reaction conditions: 21a, 45a, [RuCl2(p-cymene)]2 (30) (5.0 mol %), KOAc (1.0 mmol), 
additive, solvent (M), O2 (1.0 atm), 80 °C, 18 h. Yield of isolated product. 
 
The optimized reaction conditions consisted of 5.0 mol % of the [RuCl2(p-cymene)]2 (30) catalyst and 
equimolar amounts of acetic acid and potassium acetate as a 1.0 M solution in γ-valerolactone (77) 
under an ambient atmosphere of oxygen. The use of this green and environmentally benign solvent 
was the solution for both of the major drawbacks of the reaction in n-butanol. The higher flash point 
of 96 °C dramatically increased the safety profile of the reaction. In addition, γ-valerolactone (77) was 
stable against oxidation. 
  
Results and Discussion 
39 
 
3.1.4 Scope of Ruthenium(II)-Oxidase in Biomass Derived γ-Valerolactone (77) 
With these optimized conditions in hand, the scope for the ruthenium(II) oxidase in γ-valerolactone 
(77) was investigated. In general, the improved catalytic system gave higher yields with the benzoic 
acid 21 as the limiting component and several functional groups were tolerated under the reaction 
conditions. This scope was largely performed by Marcel Emir Baumert during his bachelor thesis.[95] 
The benchmark system, consisting of 2-methylbenzoic acid (21a) and n-butyl acrylate (45a), 
performed effectively giving 47aa in excellent quantities of 90% (cf. 74% in n-butanol) and scaling 
the reaction up to 5 mmol provided the product in almost quantitative 97% yield (Table 12, entry 1). 
As in the former study, alkyl-, aryl- and ether-groups, same as bromine and iodine (entries 2-5, 10, 11, 
13, 16) were well tolerated. Hydroxyl-, mesyl- and tosyl-substituents delivered the products in 
moderate yields, thereby expanding the opportunities for post-synthetic modifications (entries 6-8). 
Aromatic and enolizable aliphatic ketones worked smoothly, delivering the products in very good 
yields (entries 9 and 15). Challenging dimethylamino groups and natural occurring vanilic acid were 
tolerated under the reaction conditions (entries 14 and 17). Steric effects dominated the 
stereoselectivity of meta-functionalized benzoic acids (entries 13-15). Even potentially coordinating 
methoxy groups or ketones showed the exclusive functionalization at the 6-position. Simple benzoic 
acid and symmetrical 4-dimethylaminobenzoic acid gave good yields as mixture of mono- and 
di-functionalized products, while the electron-rich 3,4,5-trimethoxy substituted benzoic gave the single 
functionalization product in almost quantitative yield (entries 16, 17 and 18).  
Table 12: Ruthenium(II) oxidase scope of benzoic acids (21). 
 




(5 mmol scale: 
97) 
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[a] Reaction conditions: 21 (1.0 mmol), 45a (1.5 mmol), [RuCl2(p-cymene)]2 (30) (5.0 mol %), 
KOAc (1.0 mmol), HOAc (1.0 mmol), GVL (77) (1.0 mL), O2 (1.0 atm), 80 °C, 18 h. Yield of 
isolated product. 
 
The variation of the acrylic ester component 45 showed an ample and expanded scope (Table 13). 
Several linear and branched alkyl substituted acrylates smoothly formed the desired products in 
moderate to very good yields (entries 1-4), while linear and cyclic ethers gave very good yields (entries 
6 and 7). In contrast to the former conditions, benzyl substituted ethers could be isolated in pure form 
and excellent yields. A chiral, menthol derived acrylate showed good reactivity, but here the 
stereoinformation showed almost no effects on the diastereomeric ratio of the product (entry 9). The 
outstanding selectivity of the ruthenium(II)-oxidase for acrylic alkenes is highlighted by entry 10, that 
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Table 13: Ruthenium(II) oxidase scope of acrylic esters (45). 
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[a] Reaction conditions: 21a (1.0 mmol), 45 (1.5 mmol), [RuCl2(p-cymene)]2 (30) (5.0 mol %), 
KOAc (1.0 mmol), HOAc (1.0 mmol), GVL (77) (1.0 mL), O2 (1.0 atm), 80 °C, 18 h. Yield of 
isolated product. 
 
The structure of 47ad was unambigously confirmed by x-ray crystallographic analysis of single 
crystals obtained by slow solvent evaporation of a diethylether solution. 47ad crystalized in a 
monoclinic space group, with both enantiomers in the assymetric unit. 
 
Figure 2: ORTEP plot of the crystal structure of 47rb. Ellypsoids were drawn at a 50% probabillity 
level. Selected hydrogens were omitted for clarity. 
 
With γ-valerolactone (77), a highly effective, green and renewable solvent was introduced to the field 
of ruthenium-catalyzed C–H activations. With the benzoic acid component 21 as the limiting reagent, 
the yields were generally higher compared to n-butanol and the scope of the ruthenium(II)-oxidase was 
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largely broadened, inter alia by valuable functional groups, such as amines and hydroxyl based 
mesyl- and tosyl-groups.   
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3.1.5 Evaluation of Ruthenium(II)-Oxidase Reactivity in Flow 
Organic reactions have traditionally been performed in batch reactors. Recently, continuos flow 
reactions and reactors have gained a lot of attention, because they inherently increase the safety profile 
of a reaction.[96] From the point of the synthethic organic chemist flow chemistry offers great 
possibilities for effective mixing of different phases, like the highly effective release of reaction gases 
at specific points and over long distances is possible, as well as the use of heterogenous catalysts that 
react with the reagents of the solution that flows by.[97] 
Since the ruthenium(II)-oxidase is using oxygen as the sole oxidant, the chances of applying 
continuous flow techniques for ruthenium-catalyzed oxidative transformations were evaluated, using 
the alkenylation of benzoic acids as the model system. A Vapourtec easy-MedChem flow system 
equipped with a tube-in-tube gas-liquid reactor, which releases the gas via a semi-permeable inner 
membrane tube was used. Following the flow setup (Figure 3) the reaction solution is pumped into the 
heated tube-in-tube reactor, where pure oxygen is released to the solution. Behind the reactor a back 
pressure regulator, which allows to adjust the reactor pressure, was installed, followed by a automated 
product collector. 
 
Figure 3: Tube-in-tube gas-liquid reactor flow setup.[98]  
 
In the second reactor setup (Figure 4), the substrate solution was pumped through the unheated gas-
liquid reactor, where the reaction solution is saturated with oxygen at room temperature. Downstream 
a second reactor, equipped with filling material that creates a turbulent flow inside the reactor, was 
connected. Behind the second reactor the back pressure regulator and the automated product collector 
were installed. 




Figure 4: Turbulent flow reactor setup. [98] 
 
The study was commenced by the use of an in situ formed catalytic system consisting of 5.0 mol % of 
[RuCl2(p-cymene)]2 and an equivalent amount of potassium actetate in methanol as the solvent (Table 
14). A reactor pressure of ~1.4 bar was proven to be inefficient (entries 1 and 2). Raising the pressure 
to ~8.0 bar resulted in increased yields of around 40%, that were not affected by the addition of 
additional acid (entries 3 and 4). Lowering the oxygen pressure resulted in a drop in reactivity (entry 5). 
Higher concentrations gave a slightly better yields, but were accompanied by solubility issues (entry 
6), while faster flow rates resulted in a drop in yield (entry 7). Rising the temperature to 120 °C 
positively affected the reactivity (entry 8). To ensure the effectivity of the gas supply of the gas-liquid 
reactor, the solvent was prepurged with O2 and the reaction was carried out without additional oxygen 
supply, resulting in lower yields (entry 9). 
Table 14: Optimization of the ruthenium(II)-oxidase catalyzed alkenylation in flow Ⅰ. 
 
Entry Additive (equiv) M T [°C] Pressure Yield [%][a] 
1 --- 0.3 80 ~1.4 12 
2 --- 0.3 100 ~1.4 14 
3 --- 0.3 100 ~8.0 41 
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Entry Additive (equiv) M T [°C] Pressure Yield [%][a] 
4 HOAc (1.0) 0.3 100 ~8.0 39 
5[b] --- 0.3 100 ~8.0 35 
6 --- 1.0 100 ~8.0 43 
7[c] --- 1.0 100 ~8.0 23 
8 --- 0.3 120 ~8.0 55 (48) 
9[d] --- 0.3 120 ~8.0 23 
[a] Reaction conditions: 21a (1.0 mmol), 45a (1.5 mmol), [RuCl2(p-cymene)]2 (30) (5.0 mol %), 
KOAc (1.0 mmol), additive, n-BuOH (M), O2 (10 bar), T, 0.2 mL/min. Yield were determined by 
GC analysis vs. n-dodecane as internal standard. Isolated yields are given in parentheses. 
[b] O2 (5.0  bar). 
[c] Flow rate: 0.5 mL/min. [d] No O2 pressure, O2 purged methanol used. 
 
When n-butanol was applied as solvent reactivity comparable to methanol was observed (Table 15, 
entry 1). The use of the well-defined ruthenium mesitylate catalyst instead of the in-situ formed acetate 
complex gave lower yields, that could be raised by the addition of acetic acid (entries 2 and 3). 
Performing the reaction in the turbulent reactor setup gave diminished yields (entries 4 and 5). Since 
the use of pure n-butanol as solvents showed poor solubility especially for the acetate component, the 
solvent was changed to a n-butanol:methanol:water mixture, resulting in a homogenous solution of all 
components (entries 5-12). The use of the turbulent reaction setup showed low reactivity (entry 5), 
while the standard setup provided good yields, that were hardly affected by the addition of acetic acid 
(entries 6 and 7). Simple ruthenium(III) chloride as the catalyst did not result in the formation of 
product 47aa (entry 9). Raising the temperature, lowering the flow rate to 0.1 mL/min or increasing 
the acrylate concentration showed somehow diminished yields (entries 8, 10 and 11). A 
γ-valerolactone (77):water mixture as solvent gave low yield, while pure GVL (77) could not be used 
due to unsatisfactory solubility properties.  
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Table 15: Optimization of the ruthenium(II)-oxidase catalyzed alkenylation in flow Ⅱ. 
 
entry Additive (equiv) Solvent M Yield [%] [a] 
1 --- n-BuOH 0.3 54 (53) 
2[b] --- n-BuOH 0.3 28 
3[b] HOAc (1.0) n-BuOH 0.3 41 
4[c] --- n-BuOH 0.3 35 
5[c] --- n-BuOH:MeOH:H2O (5:1:1) 0.3 29 
6 --- n-BuOH:MeOH:H2O (5:1:1) 0.3 74 (71) 
7 HOAc (1.0) n-BuOH:MeOH:H2O (5:1:1) 0.3 76 (71) 
8[d] --- n-BuOH:MeOH:H2O (5:1:1) 0.3 59 
9[e] --- n-BuOH:MeOH:H2O (5:1:1) 0.3 traces 
10[f] --- n-BuOH:MeOH:H2O (5:1:1) 0.3 32 
11[g] --- n-BuOH:MeOH:H2O (5:1:1) 0.3 62 
12 --- n-BuOH:MeOH:H2O (2:1:1) 0.5 48 
13 --- GVL (77): H2O (3:1) 0.5 28 
[a] Reaction conditions: 21a (1.0 mmol), 45a (1.5 mmol), [RuCl2(p-cymene)]2 (30) (5.0 mol %), 
KOAc (1.0 mmol), additive, n-BuOH (M), O2 (10 bar), 120 °C, 0.2 mL/min. Yield were determined 
by GC analysis vs. n-dodecane as internal standard. Isolated yields are given in parentheses. 
[b] [Ru(O2CMes)2(p-cymene)] (99) (10 mol %), without [RuCl2(p-cymene)]2 and KOAc. 
[c] Turbulent reactor setup used. [d] 140 °C. [e] RuCl3∙nH2O (10 mol %) instead of 
[RuCl2(p-cymene)]2.
 [f] 45a (3.0 mmol). [g] Flow rate 0.1 mL/min. 
  
This optimization showed, the ruthenium(II)-oxidase to be compatible with the flow setup, although 
there were several limiting factors. The short reaction time of 75 minutes, is in challenge for the kinetic 
profile (see 3.1.6.1) of the ruthenium(II)-oxidase, that begins fast and goes slowly to completion. 
Generally the small reaction scale (1.0 mmol in 3.0 mL of solvent) for the optimization were somewhat 
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less than perfect for the flow process. For the technical reasons, the reactor needs to be pre- and post-
rinsed with pure solvent resulting in high dilution of the reactants at the beginning and the end. On a 
larger scale or in continuous flow this dilution effect would be minimized or vanished. 
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3.1.6 Kinetic and Mechanistic Studies 
3.1.6.1 Oxygen Uptake Study and Investigation of the Oxidation Mode 
As the next step, the kinetic profile of the reaction was investigated. Given the oxidative nature of the 
reaction the oxygen consumption was measured. The reaction immediately started after the acrylic 
ester was added and after 35 minutes a conversion of 60% was observed and of 80% after 110 minutes. 
Analogous studies in n-butanol and without solvent were performed by Dr. Svenja Warratz, showing 
similar reaction profiles.[99] 
 




















Figure 5: Oxygen uptake of the ruthenium(II)-oxidase alkenylation. 
 
After 18 hours reaction time phthalide 47aa was isolated in 87% (0.87 mmol), while 0.54 mmol of 
oxygen were consumed, indicating that oxygen is acting as a four-electron acceptor. Thereby several 
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scenarios of multinuclear oxygen activations or, more likely, a multistep oxygen activation with a 
(su)peroxo intermediate are conceivable. In order to test this hypothesis, the reaction was performed 
under an atmosphere of argon and several representative oxidants were added (Table 16). While tert-
butyl hydroperoxide and di-tert-butyl-peroxide (entries 1 and 2) did not result in the formation of the 
phthalide 47, the addition of aqueous hydrogen peroxide solution gave an exothermic reaction 
accompanied by product formation in moderate yields (entries 3, 4, 5 and 7). Dr. Svenja Warratz 
further tested potassium superoxide as an oxidant, which resulted in low product formation.[99] 
Table 16: Oxidant suitability study for ruthenium(II)-catalyzed alkenylation. 
 
Entry R Solvent Oxidant Yield [%][a] 
1 Et MeOH t-BuOOH --- 
2 Et MeOH (t-BuO)2 --- 
3 Et MeOH H2O2 (30%, aq.) 46 
4[b] n-Bu n-BuOH H2O2 (30%, aq.) 47 
5[b,c] n-Bu n-BuOH KO2 13 
6[b,d] n-Bu GVL (77) H2O2 (30%, aq.) 52 
7[b] n-Bu H2O H2O2 (30%, aq.) 61 
[a] Reaction conditions: 21a (2.0 mmol), 45 (1.0 mmol), [RuCl2(p-cymene)]2 (30) (5.0 mol %), 
KOAc (1.0 mmol), solvent (M), oxidant (2.0 equiv), Ar or N2, 60 °C, 18 h. Yield of isolated 
product. [b] 80 °C. [c] Reaction performed by Dr. Svenja Warratz. [d] HOAc (1.0 equiv) added. 
 
In summary, the experimental data indicated that oxygen is acting as a four-electron oxidant, 
transferring the electrons in two consecutive two-electron steps. As an intermediate organic peroxides 
and hydroperoxides could be excluded, while hydrogen peroxide is a potent oxidant. The exothermic 
profile of the hydrogen peroxide addition makes it likely to be a quasistationary intermediate in the 
oxidation process that reacts faster than oxygen.  
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3.1.6.2 Labeled Oxygen Study 
Even though the formation of water as the only byproduct is logical and likely to occur, an 
experimental proof was missing. Therefore, a study using 18O2 as the oxidant was conducted in order 
to verify the formation H2
18O. Since the direct detection of water is difficult by mass spectrometric 
methods, a recently developed method was applied in cooperation with Prof. Dr. Konrad 
Koszinowski.[100] Here defined amounts of phosphorylchloride were added to the reaction mixture to 
be hydrolyzed by the formed water. Analysis of the hydrolization products (PO2Cl2)
- and 
[(PO2Cl2)2H/Na]
- by ESI-MS allowed to conclude isotope ratios. The reaction was carried out using 
the standard condition under an ambient atmosphere of normal or labeled oxygen. After the reaction 
was finished phosphoryl chloride was added to the crude mixture, analyzed by ESI-MS and the 
products were isolated. As expected the test reaction did not show unnatural amounts of 18O (entry 1). 
The incorporation of 18O in the hydrolysis product in entry two was 28% and thus lower than expected. 
This low value is reproduced in entry 3 and is probably due to to exchange reations between acetate, 
acetic acid and formed H2
18O. The products of the entries two and three did not show any unnatural 
incorporation of 18O. 




[a] 18O in 47aa [%] Yield [%] [b] 
1 16O2 0 0 Not isolated 
2 18O2 28 0 81 
3 18O2 31 0 72 
[a] Percentage of [P16O18OCl2]
- in [PO2Cl2]
- ([P]-). [b] Reaction conditions: 21a (1.0 mmol), 45a 
(1.5 mmol), [RuCl2(p-cymene)]2 (30) (5.0 mol %), KOAc (1.0 mmol), HOAc (1.0 mmol), GVL 
(77) (1.0 mL), O2 (1.0 atm), 80 °C, 18 h. Yield of isolated product. 
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3.1.6.3 Kinetic Isotope Effect (KIE) Studies 
In order to gain more information about the mode of the C–H activation, the effect of isotopically 
labeled substrates on the reaction kinetics were evaluated. Previous studies, performed by Dr. Svenja 
Warratz, showed a kinetically relevant C–H ruthenation process with a KIE of ~3.0 in n-butanol by 
comparing the reaction rates of [D5]-benzoic acid ([D5]-21l) and non-deuterated benzoic acid (21l) in 
independent reactions (Scheme 29).[99]  
 
Scheme 29: Kinetic isotope effect in n-butanol. 
 
To minimize side reactions, exempli gracia double alkenylations, 2-methylbenzoic acid with 
deuterium in the 6-position ([D1]-21a) was prepared by ruthenium(II)-catalyzed hydrogen isotope 
exchange (HIE) reaction, followed careful purification (Scheme 30). 
 
Scheme 30: Ruthenium-catalyzed hydrogen isotope exchange (HIE) at the 6-position of 
2-methylbenzoic acid. 
 
Using GVL (77) as the solvent, substrates [D1]-21a and 21a were subjected to the reaction conditions 
and the KIE was determined by comparison of the reaction rates of independent reactions. In contrast 
to former observations the reaction rates were almost identical with a calculated KIE of ~1.0 (Figure 
6).  
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Figure 6: Conversion vs. time plot for the KIE measurement in γ-valerolacton. 
 
To find out, if this change of the KIE results of solvent or the equimolar addition of acetic acid, the 
study was reperformed under identical conditions, using n-butanol instead of γ-valerolactone (77) as 
the solvent (Figure 7). This study showed a strong dependence of the ortho-position being a hydrogen 
or deuterium atom, with a calculated KIE of ~2.6. Comparing both studies, the initial TOF of the 
reaction of unlabeled 21a is higher in n-butanol (3.3∙h-1) compared to γ-valerolacton (2.0∙h-1), while 
the initial rate of the labeled [D1]-21a is faster in GVL (77) (2.0∙h
-1) as compared to the reaction in 
n-butanol (3.3∙h-1).  
 
 







































 = 2.59 ± 0.5 
m
D
 = 0.21 ± 0.02 
 
Figure 7: Conversion vs. time plot for the KIE measurement in n-butanol. 
 
Within the proposed catalytic cycle (see chapter 3.1.6.5) the coordination of the acrylate is followed 
by the migration of one of the acrylic protons from the α- to the β-position. To test if this hydrogen 
migration step is a kinetically relevant event, we studied the kinetic isotope effect of the unlabeled vs. 
the deuterium labeled acrylic ester. Using the methodology described in chapter 3.3 α,β-labeled benzyl 
acrylate was synthesized by ruthenium-catalyzed hydrogen isotope exchange between acrylic esters 
and deuterated water (Scheme 31).  




Scheme 31: Synthesis of deuterium labeled acrylic esters. BA = Benzoic acid. 
 
When the labeled and unlabeled acrylates were submitted to the reaction conditions, almost similar 
inital rates were observed (Figure 8). With a calculated KIE of ~1.1, these measurements excluded a 
primary KIE. 
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Figure 8: Conversion vs. time plot for the acrylate dependent KIE measurement. 
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In summary, the kinetic isotope effect measurements showed a solvent dependend kinetically relevant 
C–H ruthenation event. In n-butanol as the reaction medium the C–H activation was the turnover 
limiting step, while in γ-valerolactone (77) no KIE was observed. The insertion and isomerisation step 
was investigated in γ-valerolactone (77), again the measurement did not show a kinetically relevant 
C–H breaking or forming event. 
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3.1.6.4 Synthesis of Reaction Intermediates 
To gain deeper insights into the ruthenium oxidase reactivity intermediates were synthesized by 
selectively stopping the reaction at different stages. These intermediates were used to comprehend the 
elementary steps of this transformation. The general synthesis of this classes of compounds was 
inspired by studies performed by Dr. Svenja Warratz.[41d, 99] 
The investigations were commenced by the synthesis of the cycloruthenated complexes 100. Since 
these complexes have a vacant coordination site, pyridine or DMAP were used as donor ligand in order 
to obtain a stable structure. While the synthesis was already described using aprotic, apolar CH2Cl2 as 
reaction medium, the isolation of 100-Py was also possible from methanol and γ-valerolactone (77) as 
the reaction solvents, albeit in somewhat lower yields (Table 18).[41d, 99] 
Table 18: Synthesis of donor stabilized intermediates 100. 
 
Entry Solvent 100-Py [%] [a] 100-DMAP [%] [a] 
1 CH2Cl2 71 72 
2 MeOH 51 --- 
3 GVL (77) 38 --- 
[a] Reaction conditions: [RuCl2(p-cymene)]2 (0.16 mmol), pyridine/DMAP (0.32 mmol), 
21r-Na(0.82 mmol), NEt3 (0.40 mL), solvent (5.00 mL), Ar, 25-35 °C, 36 h. Yield of isolated 
product. 
 
Crystalisation from CH2Cl2 overlayered with n-hexane at -30 °C delivered crystals of 100-DMAP 
suitable for x-ray diffraction christallography (Figure 9). Complex 100 crystallized with two molecules, 
stabilized by π-stacking of the DMAP units, in the elementary cell together with one CH2Cl2 molecule 
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and four H2O units, stabilizing the structure by additional hydrogen bonding. The Ru1 and O1 distance 
is 2.078 Å and 2.058 Å between Ru1 and C12.  
 
Figure 9: ORTEP plot of the crystal structure of 100-DMAP. Ellypsoids were drawn at a 50% 
probabillity level. H2O, CH2Cl2 and hydrogen atoms were omitted for clarity. 
 
A second intermediate 101 was accessible by performing the reaction with stoichiometric amounts of 
[RuCl2(p-cymene)]2 (30) in the absence of an oxidant. The yields of this reaction were in the excellent 
range for different solvents, already indicating the stability of this species (Table 19). In addition, 
complex 101 has shown to be bench-stable for at least four months. 
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Table 19: Synthesis of complex 101 in different solvents. 
 
Entry Solvent Isolated yield of 101 [%][a] 
1 MeOH 96 
2 GVL (77) 85 
3 PhMe 87 (>99[b]) 
[a] Reaction conditions: [RuCl2(p-cymene)]2 (30) (0.1 mmol), 21r (0.2 mmol), 45b (0.2 mmol), 
potassium acetate (0.4 mmol), MeOH (5.0 mL), Ar, 60 °C, 36 h. Yield of isolated product. [b] 0.6 
mmol scale. 
 
Crystallization from CH2Cl2 overlayered with n-hexane at -30 °C delivered crystals of 101 suitable for 
x-ray christallography (Figure 10). In contrast to the expectation the ruthenium–carbon bond was not 
localized at one carbon atom, but C11, C12 and C22 forming an allyl anion type interaction to the 
ruthenium center allowing complex 101 to reach 18 valence electrons. The bond distances are 2.232 Å 
for Ru1–C11, 2.189 Å for Ru1–C12 and 2.163 Å for Ru1–C22. The Ru1–O2 bond distance is 2.093 Å, 
and thus slightly elongated than in the previous ruthenapentacycle 100. 




Figure 10: ORTEP plot of the crystal structure of 101. Ellypsoids were drawn at a 50% probabillity 
level. Hydrogen atoms were omitted for clarity. 
 
To obtain further insights to the cycloruthenation, complex 100-Py was reacted with methylacrylate, 
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Table 20: Reaction of 100-Py with methyl acrylate (45b). 
 
Entry Solvent Yield of 100 [%] 
1 MeOH 90 
2 GVL (77) 93 
[a] Reaction conditions: 100-Py (20.6 μmol), 45b (22.0 μmol), solvent (1.00 mL), Ar, 60 °C, 18 h. 
Yield of isolated product.  
 
In-situ nuclear magnetic resonance (NMR) studies, performed by Dr. Svenja Warratz, showed this 
process to proceed via an intermediate, that is presumably the seven-membered ruthenacycle resulting 
from the insertion of the double bond into the ruthenium carbon bond, before it is isomerizing to 
ruthenacycle 101.[99] In order to support this assumption, 101 was synthesized with deuterated acrylic 
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Table 21: Synthesis of 100 with deuterated acrylic esters. 
 
Entry Isotope Yield of [Dn]-101 [%] 
1 R = H 85 
2 R = D 93 
[a] Reaction conditions: [RuCl2(p-cymene)]2 (30) (0.1 mmol), 21r (0.2 mmol), [D2]-45b or [D3]-45b 
(0.2 mmol), potassium acetate (0.4 mmol), solvent (5.0 mL), Ar, 60 °C, 36 h. Yield of isolated 
product. 
 
NMR and mass spectrometry (MS) analysis of the products showed almost quantitative exchange of 
the migrated proton with the methanol solution, which could be a result of de- and reprotonation or an 
exchange by dihydrogen bonding (DHB)[101] of a hydridic intermediate. Figure 11 zooms into the 
1H-NMR spectra of complexes 101, [D1]-101 and of [D2]-101 showing the resonances of the methylene 
protons. 




Figure 11: Expansion of the methylene region of the 1H-NMR spectra of complexes 101, D1-101 and 
D2-101. 
 
To test whether the isomerization process is reversible or not, complex 101 was subjected to the 
reaction conditions using perdeuterated reagents (Scheme 32). NMR-Spectroscopic and MS analysis 
of the reaction mixture showed no incorporaton of deuterium into complex 101, indicating the 
isomerization process to be irreversible.  
 
Scheme 32: Isomerization test of complex 101. 
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Finally, the product formation step was simulated by reacting a solution of complex 101 with acetic 
acid under an ambient oxygen atmosphere (Table 22). The reaction in methanol at 60 °C did not show 
any measurable conversion of 101, while γ-valerolactone (77) at 80 °C gave 30% isolated yield of 
47rb. Due to several extraction steps on small scale it is assumed, that the product formation is higher 
than the isolated yield. 
Table 22: Product release from complex 101. 
 
Entry Solvent (mL) AcOH (equiv) T [°C] Yield of 47rb [%] 
1 MeOH (1.0) 10 60 traces 
2 GVL (77) (0.5) 50 80 30 
[a] Reaction conditions: 101 (0.1 mmol), AcOH, solvent, O2, T, 18 h. Yield of isolated product. 
 
The release of 47rb was repeated with [D1]-n-butanol as the solvent and deuterated acetic acid giving 
87% yield (Scheme 33). NMR and ESI-MS analysis showed 60% deuterium incorporation selectively 
at one of the methylene protons. 
 
Scheme 33: Product release from complex 101 with deuterated solvents. 
 
This selective partial deuterium incorporation provides further insights into the product formation step, 
because two possible product formation scenarios could be ruled out. A direct reductive O–C 
Results and Discussion 
69 
 
elimination providing phthalide 47rb would not incorporate deuterium in the methylene position. 
Futhermore, the release of the ortho-acrylated naphthoic acid followed by a ruthenium independent 
base catalyzed oxa-Michael reaction is implausible, because the deprotonation, addition, reprotonation 
sequence would lead to quantitative incorporation of deuterium from the reaction medium. The 
assumed formation of the product is likely to occur via an irreversible β-H-elimination, forming an 
alkenylated ruthenium–hydride intermediate, which is releasing product 47rb. This transition state is 
related with the assumed transition state for the isomerisation process from 100 to 101. Therefore it is 
likely, that complex 101 is an off cycle intermediate, only formed in absence of a suitable oxidant.  
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3.1.6.5 Proposed catalytic cycle  
Computational studies, performed by Torben Rogge supported the experimental results and provided  
further details of a BIES-type C–H activation, which is stabilized by a weak agostic interaction 
between the ruthenium center and the activated hydrogen atom.[102] Based on the experimental and 
computational findings, the following catalytic cycle is proposed (Scheme 34): One of the acetate 
ligands of the in-situ formed cymene ruthenium bisacetate complex [A] undergoes ligand exchange 
with benzoic acid (21) to form complex [B]. This complex reacts in an reversible BIES type                     
C–H ruthenation process with the proposed transition state [B-C]# to form the well characterized 
intermediat [C], resp. complex 100. In γ-valerolactone (77) this process showed no kinetic isotope 
effect, while in n-butanol as the solvent the activation of the C–H bond is the turnover limiting step. 
The coordinated carboxylic acid is exchanged with the acrylate (45) to form [D]. The coordinated 
acrylic ester reacts in an 1,2-insertion into the ruthenium–carbon bond, to form ruthenaheptacycle [E], 
which reacts in a β-H-elimination to form the ruthenium hydride species [F], that exchanges the 
hydridic hydrogen with the solution[101] and further reacts to the isolated off-cycle intermediate [G], 
resp. complex 101 in the absence of a suitable oxidant. In the presence of an oxidant complexes [F] 
and [G] form the phthalide 47 under formation of the catalytically active species [B]. While the 
oxidation step is not fully understood as of yet, oxygen is assumed to act as an four electron oxidant 
in two separated two electron oxidation processes forming hydrogen peroxide as a potent oxidant 
intermediate.  
 




Scheme 34: Proposed catalytic cycle of the ruthenium(II)-oxidase catalyzed alkenylation of benzoic 
acids. 
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3.2 Ruthenium(II)-Catalyzed Decarboxylative Alkenylation/Alkylation of Benzoic Acids 
When 2-methoxybenzoic acid (21c) was reacted with n-butyl acrylate (45a) under ruthenium oxidase 
reaction conditions in n-butanol, the formation of the targeted phthalide in moderate yield was 
accompanied by small amounts of two byproducts differing by two mass units. These byproducts were 
identified as meta-alkenylated and alkylated anisoles 97ca and 98ca. 
 
Scheme 35: Observation of decarboxylated C–H functionalization products. 
 
Similar observations using internal alkynes as coupling partners for benzoic acids were made by Dr. 
N. Y. Phani Kumar.[103] Being curious about this reactivity, the reaction was optimized in order to 
discover a new access to meta-substituted arenes by C–H functionalization. 
3.2.1 Optimization Studies 
The study was commenced by reacting 2-methoxybenzoic acid (21c) with n-butyl acrylate (45a) or 
benzyl acrylate (45d) in a 3:1 ratio and catalytic amounts of the well-defined ruthenium mesitylate 
complex 99 in various solvents under inert atmosphere. PhMe as the reaction medium provided a good 
starting point, while 1,4-dioxane and NMP gave only small quantities of 97ca, (Table 23, entries 1-4). 
Careful analysis of the reaction mixture of entries 1 and 4 showed the saturated acrylates 102 as a side 
product, indicating the acrylic esters to be suitable oxidants in this chemistry. Using the benzoic acid 
21c as the limiting reagent delivered less 97ca as minor byproduct, whereas phthalide 47ca was 
obtained as the major product (entry 5). 
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Table 23: Optimization of the ruthenium(II)-catalyzed alkenylative decarboxlyation. 
 
Entry R Solvent Yield [%][a] 
1 n-Bu PhMe 33 
2 n-Bu 1,4-dioxane <10[b] 
3 n-Bu NMP traces[b] 
4 Bn PhMe 28 
5 n-Bu PhMe <20[b][c] 
[a] Reaction conditions: 21c (3.0 mmol), 45 (1.0 mmol), [Ru(O2CMes)2(p-cymene)] (99) 
(10 mol %), solvent (3.0 mL), Ar, 120 °C, 18 h. Yield of isolated product. [b] Determined by GC-
analysis. [c] 21c (1.0 mmol), 45a (2.2 mmol). 
 
In order to prevent the reduction of the acrylic substrate, several oxidants were tested (Table 24). MnO2 
gave a slight improvement (entries 1 and 2), while silica and iron oxide were not suitable (entries 3 
and 4). The best results were obtained by using vanadium(V) oxide (entries 5 and 6). Persulfate and 
organic oxidants did not affect the yields (entries 7-9), while the hypervalent iodine reagent PIDA shut 
the reaction down (entry 10). 
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Table 24: Optimization of additives for the ruthenium(II)-catalyzed alkenylative decarboxlyation. 
 
Entry R Additive (1.0 equiv) Yield [%][a] 
1 n-Bu MnO2 37 
2 Bn MnO2 39 
3 n-Bu SiO2 27 
4 n-Bu Fe2O3 15 
5 n-Bu V2O5 55 
6 Bn V2O5 60 
7 Bn t-BuC(O)Me 31 
8 Bn Na2S2O7 32 
9 Bn Benzoquinone 35 
10 Bn PhI(OAc)2 --- 
[a] Reaction conditions: 21c (3.0 mmol), 45 (1.0 mmol), [Ru(O2CMes)2(p-cymene)] (99) 
(10 mol %), oxidant (1.0 equiv), PhMe (3.0 mL), Ar, 120 °C, 18 h. Yield of isolated product. 
 
After vanadium(V) oxide had been identified as the oxidant of choice, its loading was optimized (Table 
25). While overstoichiometric amounts did not induce the desired improvement, substoichiometric 
amounts resulted in lower yields (entries 1-4). 
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Table 25: Optimization of the vanadium(V) oxide concentration for the ruthenium(II)-catalyzed 
alkenylative decarboxlyation. 
 
entry V2O5 (equiv) Yield [%] 
1 1.0 60 
2 2.0 62 
3 0.5 46 
4 0.2 28 
[a] Reaction conditions: 21c (3.0 mmol), 45d (1.0 mmol), [Ru(O2CMes)2(p-cymene)] (99) 
(10 mol %), V2O5, PhMe (3.0 mL), Ar, 120 °C, 18 h. Yield of isolated product. 
 
After the optimal amount of vanadium(V) oxide was identified, several solvents were tested under 
these optimized conditions (Table 26). Water, DCE or n-hexane as the solvents showed low reactivity, 
while acetonitrile gave 55% of the desired product (entries 1-4). The temperature was raised to 150 °C 
and several higher boiling solvents were evaluated. DMF delivered the product in moderate yield, 
while DMSO shut down the reaction (entries 5 and 6). o-Xylene and m-xylene showed comparable 
reactivity to PhMe at 120 °C (entries 7 and 8). 
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Table 26: Optimization of the solvent for the ruthenium(II)-catalyzed alkenylative decarboxlyation. 
 
Entry Solvent T [°C] Yield [%] 
1 H2O 120 15 
2 DCE 120 22 
3 n-hexane 120 27 
4 MeCN 120 55 
5 DMF 150 48 
6 DMSO 150 --- 
7 o-xylene 150 60 
8 m-xylene 150 60 
[a] Reaction conditions: 21c (3.0 mmol), 45d (1.0 mmol), [Ru(O2CMes)2(p-cymene)] (99) 
(10 mol %), V2O5 (1.0 mmol), solvent (3.0 mL), Ar, T, 18 h. Yield of isolated product. 
 
Lowering the loading of catalyst 99 to 5.0 mol % decreased the yield to 50% (Table 27, entry 1), while 
running the reaction without the catalyst demonstrated its crucialty for the reaction (entries 1 and 2). 
An independent decarboxylation event followed by a meta-alkenylation of anisole was also ruled out 
(entry 3).  
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Table 27: Further experiments for the optimization of the ruthenium(II)-catalyzed alkenylative 
decarboxlyation. 
 
Entry Difference Yield [%] 
1 [Ru(O2CMes)2 (p-cymene)] (5.0 mol %) 50 
2 Without [Ru] --- 
3 Anisole (3.0 mmol) instead of 21c --- 
[a] Reaction conditions: 21c (3.0 mmol), 45d (1.0 mmol), [Ru(O2CMes)2(p-cymene)] (99) 
(10 mol %), V2O5 (1.0 mmol), PhMe (3.0 mL), Ar, 120 °C, 18 h. Yield of isolated product. 
 
The ruthenium(II)-catalyzed alkenylation decarboxylation tandem process was successfully optimized 
to give good yields of 60% in the benchmark reaction of benzoic acid 21c with alkene 45d. The 
optimized reaction conditions consisted of 10 mol % of the well-defined ruthenium(II) bismesitylate 
catalyst 99 and vanadium(V) oxide as the oxidant as a 0.3 M solution in PhMe as the solvent. 
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3.2.2 Scope of the Decarboxylative Alkenylation 
With the optimized reaction conditions in hand, the substrate scope of the decarboxylative alkenylation 
was tested (Table 28). The benchmark reaction between 2-methoxybenzoic acid (21c) and benzyl 
acrylate (45d) was performed on a 5.0 mmol scale giving an improved yield of 75% (cf. 60% on a 
1.0 mmol scale), indicating that scaling up this process is possible and even beneficial (entry 1). 
Ethoxy- and phenoxy substituents (entries 2 and 3) in the 2-position of the benzoic acid were as well 
tolerated as a second or third methoxy group at different positions of the aromatic motif (entries 4-7). 
The installation of a methoxy group, chloride or bromide substituents in the 5-position improved the 
yields, which could be explained by a weak coordinative interaction synergizing with the directing 
group effect (entries 6-9). Naphthoic acid 21ae was shown to be a viable substrate in this 
transformation (entry 10). 
Table 28: Scope of benzoic acids 21 in the ruthenium(II)-catalyzed decarboxylative alkenylation. 
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[a] Reaction conditions: 21 (3.0 mmol), 45d (1.0 mmol), [Ru(O2CMes)2(p-cymene)] (109) 
(10 mol %), V2O5 (1.0 mmol), PhMe (3.0 mL), Ar, 120 °C, 18 h. Yield of isolated product. 
 
The scope of the decarboxylative alkenylation was further evaluated for the acrylic ester component 
(45, Table 29). Aliphatic esters gave moderate yields (entries 1 and 2), that were slightly improved by 
the installation of a 2-methoxyethyl group (entry 3). While tetrahydrofurfuryl acrylate gave a good 
yield of 70% (entry 4), the best result was obtained by the use of an acrylic ester bearing the bulky 
cholesteryl skeleton as the side-chain (entry 5). Since the yields in this transformation were in the 
moderate to good region, the optimal reagents 21ae and cholesteryl acrylate (45l) were combined, 
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Table 29: Scope of acrylic esters 45 in the ruthenium(II)-catalyzed decarboxylative alkenylation. 
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[a] Reaction conditions: 21c (3.0 mmol), 45 (1.0 mmol), [Ru(O2CMes)2(p-cymene)] 99 (10 mol %), 
V2O5 (1.0 mmol), PhMe (3.0 mL), Ar, 120 °C, 18 h. Yield of isolated product.
[b] 21aa (3.0 mmol) 
instead of 21c. 
 
The ruthenium(II)-catalyzed decarboxylative C–H alkenylation reaction showed moderate to almost 
quantitative isolated yields. The scope was however compromised by the requirement of an ether 
functionality in the ortho-position of the benzoic acid (21). Yet, several ethers, bromine, chlorine and 
benzannullated arenes were well tolerated at the benzoic acid (21). Several substituents at the acrylic 
moiety (45), bearing ether groups or a bulky cholesteryl unit were accepted in this transformation.  
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3.2.3 KIE and CO2 Evolution Studies 
The kinetic isotopic effect for the the reaction of benzyl acrylate 45d with 21c and [D1]-21c was 
measured by comparing the initial rates in two parrallel reactions (Figure 12). The kinetic data clearly 
indicated a turnover limiting C–H ruthenation event, with a kinetic isotope effect of 2.5. The results 
were supported by independent DFT calculations, subsequently performed by Hong and co-
workers.[104]  













 = 2.50 ± 0.5
m
D
























 = 0.50 ± 0.03 
 





Results and Discussion 
84 
 
Optical observation of a significant amount of gas bubbles that were formed during the course of the 
reaction gave a first hint of the expected CO2 evolution. To prove this, a fermentation tube filled with 
limewater was connected to the atmosphere of the reaction. Clouding, especially in the region next to 
the reaction atmosphere confirmed the formation CO2 (Scheme 36).  
 
Scheme 36: Lime-water test for the decarboxylative alkenylation. 
 
The kinetics of the decarboxylative C–H alkenylation were studied by performing the reaction with 
the atmosphere connected to a gas measurement construction and (Figure 13). In order to avoid 
inaccuracies by boiling solvent, the reaction temperature was lowered to 100 °C, with the catalytic 
system performing at the same efficacy level. 



























Figure 13: CO2 release study for the ruthenium(II)-catalyzed decarboxylative alkenylation. 
 
The reaction immediately started after adding the acrylate, reaching two turnovers already after 19 
minutes. In the following the curve flattened, showing 60% conversion in four hours, before the 
reaction slowly went to completion. After 18 hours the gas volume indicated roughly 77% of product 
to be formed, correlating with 82% of 97aad that were isolated after workup and purification. 
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3.2.4 Mechanistic and Kinetic Studies of Ruthenium(II)-Catalyzed Decarboxylative Alkylation 
In addition to the decarboxylative alkenylation of benzoic acids, Dr. N. Y. Phani Kumar developed a 
protocol for the decarboxylative hydroarylation of maleimides.[105] The reaction showed a broad 
substrate scope and worked even at a remarkable low temperature of 50 °C, when necessary. Scheme 
37 shows the general reaction equation of this transformation together with selected examples 
representing the broad substrate scope.[105] 
 
Scheme 37: Ruthenium(II)-catalyzed decarboxylative alkylation.[105] 
 
Based on the experience gained in the ruthenium(II)-catalyzed decarboxylative alkenylation, 
mechanistic studies of this system were conducted to compare these two transformations. The KIE was 
determined to be 1.14 by 19F-NMR (Figure 14), 1.16 by GC measurement and 1.05 by in operando 
infrared measurement, that closely correlates with a value of 1.08 estimated by DFT calculations.[106] 
In contrast to the decarboxylative alkenylation reaction, the C–H activation process is not the turnover-
limiting step. This result could be explained by additional steric bulk of the maleimide, which increases 
the energetic barrier of the coordination step and makes it turnover-limiting.[105]  
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 = 1.14 ± 0.002
 
Figure 14: Kinetic isotope effect measurement of the decarboxylative alkylation. 
 
Differently deuterium labelled benzoic acids 21 were subjected to the reaction conditions in order to 
retrace the labels in the products (Scheme 38). Deuteration at the acid moiety led to unspecific 
incorporation of deuterium in the product, with three major incorporation sites at the ipso-position, the 
5-position and the syn-position of the succinimide. An equal incorporation motif with a slightly lower 
deuterium incorporation was observed when the 6-position of the benzoic acid was isotopically labeled. 
The results indicated that both, the acidic proton as well as the proton in the 6-position were cleaved 
and both positions were reprotonated by the solvent. The position of the deuterium at the succinimide 
revealed the syn-insertion of the maleimide to be favored, while the deuteration in the original 
5-position of substrate 21af indictated the succinimide moiety to act as a directing group. 




Scheme 38: Isotope labeling study for the ruthenium(II)-catalyzed decarboxylative alkylation. 
 
The kinetics of the reaction were followed by measuring the carbon dioxide formation (Figure 15). 
The speed and the kinetic of this transformation are comparable to the related decarboxylative C–H 
alkenylation. Again, the isolated yield of 79% is in good accordance with the 81%, estimated by the 
CO2 quantity. 
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Figure 15: CO2 release study for the ruthenium(II)-catalzed decarboxylative alkylation. 
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3.3 Ruthenium(II)-Catalyzed Hydrogen Isotope Exchange on Acrylic Esters 
Deuterated compounds are commonly used in NMR spectropscopy, as tagged references in mass 
spectrometry und for the clarification of reaction mechanisms and biological processes.[64a, 64c] While 
the exchange of arene C(sp2)–H bonds is a well known process, examples for the direct labeling of 
olefinic C(sp2)–H bonds continue to be limited.[70a] Within general studies on the 
ruthenium(II)-catalyzed C–H alkenylation of various substrates, the incorporation of deuterium to 
acrylic C–H bonds was observed (Scheme 39). Further investigation of this reactivity led to a powerful 
method for the selective preparation of deuterated acrylic esters (45).  
 
Scheme 39: Observation of deuterium incorporation at acrylic C–H bonds during mechanistic 
studies. 
 
3.3.1 Optimization of the Hydrogen Isotope Exchange on Acrlyic Esters 
The optimization of the reaction conditions was commenced by changing various reaction parameters 
for the deuteration of benzyl acrylate (45d) in a biphasic reaction system with D2O as the isotope 
source. The experiments showed similar deuteration values of the β-hydrogens, while the α-position 
seemed to be slightly less reactive. Potassium acetate as additive at 80 °C led to minor deuteration at 
the acrylic positions, which was increased at elevated temperatures (entries 1 and 2). Cationic 
ruthenium(II) species or potassium methoxide as ligand showed no exchange of the hydrogen atoms 
(entries 3 and 4). Potassium tert-butanoxide gave very good incorporation in the β- and moderate 
incorporation in the α-position, indicating that steric effects might play a role (entry 5). The well 
defined ruthenium(II) mesitylate complex 99 showed moderate activity, which was slightly increased 
using the related bulkier adamantyl complex 105 (entries 6 and 7). Additional co-catalytic amounts of 
the corresponding adamantyl carboxylic acid to the well defined complex 105 led to major 
improvements (entry 8, cf. entry 7). 
 
Results and Discussion 
91 
 
Table 30: Optimization of the ruthenium(II)-catalyzed deuteration of acrylic ester 45d. 
 
Entry Additive (mol %) T [°C] Recovered [%][a] D1 [%] D2 [%] D3 [%] 
1 KOAc (10) 80 82 <10 <10 <10 
2 KOAc (10) 100 64 63 63 16 
3[b] KOAc (10) 80 56 0 0 0 
4 KOMe (10) 80 55 0 0 0 
5 KOt-Bu (10) 80 52 90 90 68 
6[c] --- 80 80 44 44 27 
7[d] --- 80 70 53 53 30 
8[d] AdCO2H (10) 80 68 90 90 74 
[a] Reaction conditions: 45d (1.0 mmol), [RuCl2(p-cymene)] (30) (2.0 mol %), additive, D2O (1.0 
mL), Ar, 80 °C, 18 h. Yield of isolated product, deuterium incorporation was determined by 
1H-NMR. [b] [Ru2Cl3(p-cymene)2][PF6] (2.0 mol %) instead of [RuCl2(p-cymene)]2.
 
[c] [Ru(O2CMes)2(p-cymene)2] (99) (4.0 mol %) instead of [RuCl2(p-cymene)]2.
 
[d] [Ru(O2CAd)2(p-cymene)2] (105) (4.0 mol %) instead of [RuCl2(p-cymene)]2. 
 
The in-situ generated adamantyl carboxylate and 2,4,6-tri-iso-propylbenzoate based catalyst systems 
showed less efficacy than the mixtures of well defined adamantylate complex and acid (Table 31, 
entries 1 and 2). A trifluoromethyl group attached to any position of the ligand gave complete 
incorporation of deuterium in the range of the stochastic D to H ratio of the reaction solution, with the 
meta-trifluoromethylbenzoic acid (m-CF3-BA, 106) being optimal (entries 3-6). The power of this 
ligand system was further highlighted by perfect incorporation, even at a reduced catalyst loading of 
only 1.0 mol %. Double trifluoromethylated benzoic acid ligands showed a lower deuterium 
incorporation accompanied by a switch in selectivity between the α- and the β-positions (entries 7 and 
8). 
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D1 [%] D3 [%] D3 [%] 






83 76 76 71 
3 m-CF3-BAK (10) m-CF3-BA (10) 74 >95 >95 >95 
4[b] m-CF3-BAK (5.0) m-CF3-BA (5.0) 68 >95 >95 >95 
5[b] o-CF3-BAK (5.0) o-CF3-BA (5.0) 46 >95 >95 >95 












83 38 38 55 
[a] Reaction conditions: 45d (1.0 mmol), [RuCl2(p-cymene)] (30) (2.0 mol %), additive 1, 
additive 2, D2O (1.0 mL), Ar, 80 °C, 18 h. Yield of isolated product, deuterium incorporation was 
determined by 1H-NMR spectroscopy. [b] [RuCl2(p-cymene)]2 (1.0 mol %).  
 
The ruthenium(II) catalyst was proven to be crucial for the reactivity (Table 32, entry 1) and further 
shown to be active in polar aprotic γ-valerolactone (77) as the solvent (entry 2). In addition, benzene 
and PhMe proved to be suitable solvents for the hydrogen isotope exchange reaction. RuCl3·(H2O)n 
and [Cp*CoI2]2 did not show any reactivity (entries 3 and 4), while [Cp*RhCl2]2 and [Mn(CO)5Br] led 
to the decomposition of 45d (entries 5 and 6). 
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Table 32: Catalyst test for the deuterium labeling of acrylic ester 45d. 
 
Entry Catalyst (mol %) Recovered [%] [a] D1 [%] D2 [%] D3 [%] 




55 >95 >95 >95 
3[b,d] RuCl3∙xH2O (1.0) >95 0 0 0 
4[b] [Cp*RhCl2]2 (1.0) 8 <10 <10 <10 
5[b] [Cp*CoI2]2 (1.0) >96 0 0 0 
6[b] [Mn(CO)5Br] (2.0) <5 <10 <10 <10 
[a] Reaction conditions: 45d (1.0 mmol), catalyst, m-CF3-BA (106) (5.0 mol %), m-CF3-BAK 
(106-K) (5.0 mol %), D2O (1.0 mL), Ar, 80 °C, 18 h. Yield of isolated product, deuterium 
incorporation was determined by 1H-NMR. [b] NMR conversion vs. internal standard. [c] GVL (77) 
(1.0 mL) added. [d] m-CF3-BAK (106) (15 mol %), m-CF3-BAK (106-K) (15 mol %). 
 
The optimized catalytic system consisted of 1.0 mol % of [RuCl2(p-cymene)]2 and 5.0 mol % of 
meta-trifluormethylbenzoic acid (106) and the corresponding benzoate ligand (106-K) without further 
solvent other than on D2O as a simple and user-friendly isotope source.  
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3.3.2 Scope for Hydrogen Isotope Exchange Labeling on Acrylic Esters 
Next, the scope of this hydrogen isotope exchange reaction was tested. Due to the volatility of this 
class of reagents, yields and deuterium incorporations werde determined by 1H- and 2H-NMR of 
reaction solution extracts, referenced by internal standards and confirmed by mass spectrometry. 
Among the tested substrates, benzyl or pimary and secondary alkyl substituted acrylic esters 45 
generally showed excellent deuterium incorporations in the range of the stochastic D to H ratio of the 
reaction mixture (Table 33). Highly volatile methyl and ethyl acrylate (45b and 45c) needed the 
addition of C6D6 (or ususal benzene or PhMe) as a solvent in order to prevent evaporation or 
condensation, when the reaction was performed on a 1.0 mmol scale (entries 2 and 3). Higher boiling 
liquid acrylic esters with a trifluorethyl substituent, linear and cyclic ethers or natural occurring chiral 
alcohols smoothly reacted on the water surface (entries 3-8). Acrylates with high melting point, as 
cholesteryl acrylate needed the addition of C6D6 as the co-solvent (entry 9). The outstanding selectivity 
of this labeling reaction is highlighted by excellent deuteration rates in the acrylic positions, while the 
distal terminal alkene remained almost untouched (<<5%) (entry 10). 
Table 33: Scope of aliphatic acrylic esters for the ruthenium(II)-catalyzed deuteration. 
 
Entry Product Yield [%] [a] D1 [%] D2 [%] D3 [%] 
1 
 
90 96 96 96 
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Entry Product Yield [%] [a] D1 [%] D2 [%] D3 [%] 
2[b] 
 
>95 95 95 95 
      
3[b] 
 
>95 96 96 96 
      
4 
 
>95 95 95 94 
      
5 
 
75 95 95 95 
      
6 
 
91 95 95 94 
      
7 
 
>95 98 98 98 
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Entry Product Yield [%] [a] D1 [%] D2 [%] D3 [%] 
8 
 
>95 97 97 97 
 
 
     
9[b] 
 
>95 99 99 98 
      
10[b] 
 
>95 96 96 96 
      
[a] Reaction conditions: 45 (1.0 mmol), [RuCl2(p-cymene)]2 (30) (1.0 mol %), m-CF3-BA (106) 
(5.0 mol %), m-CF3-BAK (106-K) (5.0 mol %), D2O (1.0 mL), Ar, 80 °C, 18 h. Conversion and 
deuterium incorporation was determined by 1H-NMR vs. internal standards. [b] C6D6 (1.0 mL) 
added.  
 
The labeling reaction was not limited to aliphatic and benzylic acrylates, also aromatic acrylic esters 
45 smoothly reacted under the optimized recation conditions, showing an unexpected broad functional 
group tolerance. Trifluoromethyl groups were accepted as well as chlorine, bromine, iodine and ethers 
on the arene (entries 1-6). An acetyl group para to the acrylic ester showed minor incorporation at the 
enolizable methyl group as a side reaction (entry 7). Even coordinating or oxidizing substituents, such 
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as cyano- und nitro-groups smoothly reacted, with slightly diminished incorporation in the α-position 
(entries 8 and 9). 
 
Table 34: Scope of aromatic acrylic esters for the ruthenium(II)-catalyzed deuteration. 
 
Entry Product Yield [%] D1 [%] D2 [%] D3 [%] 
1 
 
>95 96 96 84 
      
2 
 
80 96 96 96 
      
3 
 
>95 95 95 95 
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Entry Product Yield [%] D1 [%] D2 [%] D3 [%] 
4 
 
84 92 92 92 
      
5 
 
>95 97 97 97 
      
6 
 
>95 94 94 94 
      
7[b] 
 
>95 96 96 70 
      
8[b] 
 
89 85 85 52 
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Entry Product Yield [%] D1 [%] D2 [%] D3 [%] 
9[b] 
 
>95 95 95 36 
[a] Reaction conditions: 45d (1.0 mmol), [RuCl2(p-cymene)]2 (30) (1.0 mol %), m-CF3-BA (106) 
(5.0 mol %), m-CF3-BAK (106-K) (5.0 mol %), D2O (1.0 mL), Ar, 80 °C, 18 h. Conversion and 
deuterium incorporation was determined by 1H-NMR vs. internal standards. [b] C6D6 (1.0 mL) added. 
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3.3.3 Kinetic Studies and Catalyst Investigations 
Next to deuterium oxide, deuterated methanol was identified as a second possible deuterium atom 
source, which offered the possibility of performing the reaction in a homogenous fashion and studying 
the kinetics of the hydrogen isotope exchange reaction by in operando NMR studies.The deuterium 
incorporation in both β-positions showed identical values, while the exchange in the α-position was 
slightly slower.  
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In order to explain the highly beneficial effect of trifluoromethylated benzoic acids as ligands, the in 
situ formed catalyst was synthesized and crystallized it from CH2Cl2/n-hexane at -30°C. Complex 107 
crystallized with two diametrically opposed molecules in the assymetric unit. The ruthenium–oxygen 
distances are with 2.068 Å, 2.150 Å and 2.147 Å inconspicious and comparable with those reported 
by Milstein and co-workers for the related acetate complex.[107]  
 
Scheme 41: Synthesis and crystal structure of the catalyst 107. 
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3.3.4 Scale-Up and Synthethic Applications of Deuterated Acrylates 
In order to synthesize synthetically useful amounts of the deuterated acrylates, the reaction was scaled 
up. Volatile methyl acrylate (45b) was chosen to be the ideal substrate, since it could be directly 
condensed from the reaction solution. Successively the catalyst loading was lowered to 0.5 mol %, 
0.2 mol % and even down to 1.0 mol ‰, still giving excellent deuteration rates in the range of the D 
to H ratio of the reaction solution and remarkable turnover numbers (TON) up to 1070 per ruthenium 
center (entries 1-3). Further reduction of the catalyst loading to 0.1 mol ‰ showed the limits of 
effectivity (entry 6). Since the deuteration rate of the products represented the stochastic ratio of D to 
H of the reaction solution, high deuterium incorporation needed a huge excess of the deuterium source. 
In order to reduce this excess, the labeling reaction was performed in two consecutive steps. First 
predeuteration to 75% with a low D to H ratio of 3.0 was performed. In a second step, the deuteration 
was increased to 93% with a D to H ratio of 10, yielding [D3]-45b in 68% over both steps using an 
overall D to H excess of ~5 (entries 4 and 5). 
Table 35: Scale up of the ruthenium(II)-catalyzed deuteration of acrylic esters. 
 
Entry 45b [mmol] A/B D/H Yield [%][a] % D TON[b] 
1 22 0.5/2.5 9.7 74 90 200 
2 55 0.2/1.0 3.0 88 75 495 
3 22 0.1/0.5 9.9 82 87 1070 
4 55 0.1/0.5 3.0 82 72 890 
5[c] 40 0.1/0.5 10 83 93 --- 
6 55 0.01/0.05 3.0 not isolated 12 --- 
[a] Yield of isolated product. deuterium incorporation was determined by 1H-NMR. [b] Based on 
isolated product and turnovers per ruthenium center. [c] Product of entry 4 as the substrate. 
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With multigram amounts of the deuterated methyl acrylate ([D3]-45b) in hand, the labeled alkene was 
applied in  ruthenium(II)-catalyzed annulative alkenylation and decarboxylative alkenylation reactions. 
D2-21a smoothly reacted with [D3]-45b under ruthenium(II)-oxidase conditions, forming the phthalide 
[D3]-47ab in 79% yield and 93% deuteration in the labeled positions (Scheme 42).  
 
Scheme 42: Selective synthesis of deuterium labeled phthalides. 
Under decarboxylative reaction conditions [D3]-45b reacted with [D2]-21c to the alkenylated arene in 
54% yield and 84% deuteration the ipso-position, while the olephinic hydrogen atoms were deuterated 
in 89% (Scheme 43). 
 
Scheme 43: Selective synthesis of deuterium labeled meta-alkenylated arenes. 
In addition the deuterium labeled methyl acrylate was successfully applied in the synthesis of a labeled 
cyclobutene alcohol 110 (Scheme 44). Cyclobutene 110 is a common precursor to various 
2-alkylcyclobutenones and 2-alkenylcyclobutanones 111 which are important markers for the analysis 
of irradiated foodstuffs.[108] The synthesis started by in situ formation of methylene dioxolan, from 108. 
A 2+2 cycloaddtition with the deuterated methyl acrylate formed methyl ester [D3]-109 in 64% yield. 
Subsequent reduction delivered alcohol [D3]-110 in 79% and 90% deuterium at both C
3 positions and 
62% in the C2 position. Various labeled cyclobutanone foodstuff markers 110 could be accessed from 
this key intermediate by an oxidation, Wittig reaction, deprotection sequence. 





Scheme 44: Synthesis of the labeled key intermediate [D3]-121 of alkyl- and       
alkenylcuclobutenones 122. 
 
In conclusion, the synthesis of isotopically labeled methyl acrylate was successfully scaled up to 
multigram scale. The catalytic system proved to be highly efficient, working at remarkably low 
loadings of 1.0 mol‰ and TON’s up to 1070. The labeled acrylic esters were applied in the synthesis 
of labeled phthalide [D3]-47ab, meta- substituted alkenylarene [D3]-97cd and [D3]-110, which could 
be used as a key intermediate for the synthesis of labeled irradiated foodstuffs markers. 
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4 Summary and Outlook 
Within the last two decades C–H activation processes have evolved from a promising concept to a 
powerful class of reactions for the construction of organic molecules, especially pharmaceutically 
active compounds.[22a, 30a, 31a, 32b, 32c, 41e, 109] Compared to commonly employed cross-coupling reactions, 
the need for prefunctionalization of the reactants is reduced to a minimum. Thereby the production 
process of the target molecule is optimized from the economic point of view by reducing the number 
of steps, as well as from the ecologic point of view by preventing undesired waste formation.  
Ruthenium(II) complexes have been shown to act as potent catalysts in a variety of C–H 
functionalizations, inter alia enabling the twofold oxidative C–H alkenylation between arenes and 
alkenes.[41e, 44] Thus far, these oxidative transformations were restricted to the use of stoichiometric 
amounts of costly and ecologically problematic copper(II) and silver(I) salts as oxidant. In 2015, 
Ackermann et al. showed, that these salts could be substituted by simple and environmentally benign 
oxygen as the oxidant.[41d] Based on these findings, the synthesis of phthalides (47) from benzoic acids 
(21) and acrylic esters (45) was proven viable (Scheme 45).  
 
Scheme 45: Ruthenium(II) oxidase catalyzed twofold C–H alkenylation for the synthesis of 
phthalides (47). 
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Thereby, a robust catalytic system based on n-butanol as the solvent was developed.[110] Subsenquently, 
the sustainability and applicability of this system was largely increased by the use of the 
environmentally benign, renewable γ-valerolactone (77) as the solvent.[111] This method for the 
synthesis of phthalides (47) was characterized by a broad substrate scope, yields of up to 98% and 
environmentally benign water as the only byproduct. The isolation and characterization of two reaction 
intermediates in combination with extensive mechanistic studies gave major insights into the catalytic 
mode of action. The ruthenium(II)-oxidase system has been shown to perform in batch, as well as in 
flow and for large scale applications the security profile of the reaction could be further improved by 
the substitution of oxygen by less hazardous hydrogen peroxide.  
Throughout the reaction a racemic mixture of isomers is formed, which is just minorly affected by the 
use of chiral acrylic esters. The mechanistic studies indicated, that the stereoinformation of the product 
is set by the benzoic acid orientation in the cycloruthenation step. Therefore the development of 
ruthenium(II)-biscarboxylate catalysts, bearing chiral information would be highly interesting, in order 
to form the products in an enantioselective fashion. 
A different reactivity was observed, when the reaction was performed with salicylic ethers under inert 
conditions. Instead of the formal oxa-Michael addition, these conditions led to the extrusion of carbon 
dioxide providing a new route to meta-substituted arenes (Scheme 46).[112] Optimization of the reaction 
conditions led to a stable catalytic system for the decarboxylative C–H alkenylation, which provided 
the targeted meta-alkenylated arenes in up to 97% yield. Our studies demonstrated this unique reaction 
is occurring via a domino process, with the C–H alkenylation occuring prior to the decarboxylation 
event. It is noteworthy, that transformations of this type were formerly unknown for ruthenium 
catalysis. 
 
Scheme 46: Ruthenium(II)biscarboxylate-catalyzed decarboxylative C–H alkenylation of benzoic 
acids. 
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In contrast to the related redox neutral decarboxylative alkenylation with alkynes, this unique 
transformation is restricted to salicylic ethers as the substrates, while other substituents provide 
mixtures of products. Therefore, efforts to broaden the substrate scope of this transformation would be 
highly interesting. In addition, the substitution of vanadium(V) oxide by less harmful and greener 
oxidants or electric current and the reduction of the benzoic acid excess would improve the economical 
applicability of this reaction. 
Methods for hydrogen isotope exchange (HIE) of arene C–H bonds are well established,[64c, 70a] while 
studies on the isotopic labeling of olefinic C–H bonds are limited to few reports. During general 
labeling studies, ruthenium(II)-biscarboxylates were found to exchange hydrogen atoms at the acrylic 
moiety with the solvent. Optimization led to a highly effective method for deuterium labeling, which 
selectively takes place at the alkene positions (Scheme 47). The labeling reaction effectively worked 
with D2O or in deuterated methanol as deuterium source with an ample substrate scope and very low 
catalyst loadings down to 1‰. 
 
Scheme 47: Ruthenium(II)-catalyzed hydrogen isotope exchange of olefinic C–H bonds. 
 
Since the tritiation of bioactive compounds is an important diagnostic tool for pharmaceutical 





5 Experimental Section 
5.1 General Remarks 
Unless otherwise noted, all reactions were performed under an Ar or N2 atmosphere using pre-dried 
glassware and standard Schlenk-techniques.  
Solvents  
All solvents for reactions involving moisture-sensitive reagents were dried, distilled and stored under 
an inert atmosphere (Ar or N2) according to the following standard procedures.  
Water (H2O) was degassed before its use, applying repeated freeze-pump-thaw degassing procedure.  
Methanol (MeOH) was distilled from magnesium methanolate.  
n-Butanol (n-BuOH) was distilled and stored over 4Å molecular sieve. 
tert-Amyl alcohol (t-AmOH) was stirred over Na chips for 5 h at 120 °C and then distilled at ambient 
pressure.  
Dichloromethane (CH2Cl2) and tetrahydrofuran (THF) were purified using a solvent purification 
system (SPS) from MBraun.  
1,2-Dichloroethane (DCE) was dried over CaH2 for 8 h, degassed and distilled.  
N-Methyl-2-pyrrolidone (NMP) was dried over NaH and subsequently distilled under reduced 
pressure. 
N,N-Dimethylformamide (DMF) and dimethylsulfoxide (DMSO) were dried over CaH2 for 4 h at 
150 °C and subsequently distilled under reduced pressure.  
Benzene, toluene, m-xylene, p-xylene, n-hexane and 1,4-dioxane were dried by distillation from Na 
using benzophenone as indicator.  
γ-Valerolactone (77), L-ethyl lactate, 2-methyl THF and tetrahydrofufuryl alcohol were distilled 
and stored over 4 Å molecular sieves.  
Deuterium oxide was purchased from Deutero and used as received. 
Benzene-d6 was purchased from Deutero and stored over 4 Å molecular sieves. 
 
Flow Reactions 
Flow reactions were performed on a Vapourtech® easy-MedChem E-Series flow reactor equipped 
with V-3 pumps, collection valve and back pressure regulator, gas-liquid reactor and CFC-tube 





A Vacuubrand® RD4 rotary vane vaccum pump was used. Measured vacuum: 0.1 mbar (uncorrected 
value). 
 
Melting Points (M. p.) 
Melting points were measured, using a Stuart® Melting Point Apparatus SMP3 from Barloworld 
scientific. Reported values are uncorrected.  
 
Chromatography  
Analytical thin layer chromatography (TLC) was performed on 0.25 mm silica gel 60F-plates with 254 
nm fluorescent indicator from Merck®. Plates were visualized under UV-light or developed by 
treatment with a potassium permanganate solution followed by carefully heating. Chromatographic 
purification of products was accomplished by flash column chromatography on MERCK Geduran® 
silica gel, grade 60 (40–63 μm, 70–230 mesh ASTM).  
 
Gas Chromatography (GC) 
The conversion of the reactions was monitored via gas chromatography or coupled gas 
chromatography-mass spectrometry using a 7890 GC-system with/without mass detector 5975 (Triple-
Axis-Detector) or a 7890B GC-system coupled with a 5977A mass detector, both from Agilent 
Technologies®. 
 
Single crystal X-ray diffraction analysis 
Data collection was done on a Bruker® D8 Venture four-circle-diffractometer or Bruker® D8 three-
circle-diffractometer from Bruker AXS GmbH; used detector: Photon II from Bruker AXS GmbH; 
used X-ray sources: microfocus IµS Cu/Mo or Mo Mircosource from Incoatec GmbH with mirror 
optics HELIOS and single-hole collimator from Bruker AXS GmbH.  
Used programs: APEX3 Suite (v2017.3-0) and therein integrated programs SAINT (Integration) und 
SADABS (Absorption correction) from Bruker AXS GmbH;[113] structure solution was done with 
SHELXT, refinement with SHELXS[114] or SHELXL[115] in the graphical user interface SHELXLE;[116] 




Special Utilities: SMZ1270 stereomicroscope from Nikon Metrology GmbH was used for sample 
preparation; crystals were mounted on MicroMounts or MicroLoops from MiTeGen; for sensitive 
samples the X-TEMP 2 System was used for picking of crystals;[118] crystals were cooled to given 
temperature with Cryostream 800 from Oxford Cryosystems. 
 
Recycling Preparative HPLC 
Recycling preparative HPLC (GPC) was performed on a system from JAI® (LC-92XX II Series, 
injection-and control-valve, UV and RI detector) connected to JAIGEL HH series columns. 
Chloroform of HPLC grade was employed. 
 
Nuclear Magnetic Resonance Spectroscopy (NMR) 
Nuclear magnetic resonance (NMR) spectroscopy was performed at 300, 400, 500 or 600 MHz 
(1H-NMR), 61 or 77 MHz (2H-NMR), 75, 100 or 126 MHz (13C-NMR, APT) and 283 MHz or 471 
MHz (19F-NMR) at BRUKER (Avance Ⅲ 300, Avance Ⅲ HD 300, Avance Ⅲ 400, Avance Ⅲ HD 400, 
Avance Ⅲ HD 500) and VARIAN (Mercury VX300, Mercury Plus 300, VNMRS 300, Inova 500 and 
Inova 600) instruments. Chemical shifts were reported as δ-values in ppm relative to the residual proton 
peak or carbon peak of the deuterated.  
Solvent 1H-NMR 13C-NMR 
CDCl3 7.26 77.16 
C6D6 7.16 128.06 
Methanol-d4 4.87, 3.31 49.00 
Toluene-d8 2.09 137.86 
DMSO-d6 2.50, 3.30 39.52 
 
For characterization of the observed resonance multiplicities the following abbreviations were applied: 
s (singlet), d (doublet), t (triplet), q (quartet), p (pentet), hept (heptet), m (multiplet), dd (doublet of 
doublet), dt (doublet of triplet), or analogue representations. The coupling constants J are reported in 







Infrared Spectroscopy (IR) 
Infrared spectra were recorded on a Bruker Alpha-P ATR-spectrometer. Analysis of the spectral data 
has been done by using the OPUS 3.1 software from Bruker, respectively OPUS 6. Absorption (ṽ) was 
given in wave numbers (cm–1). Spectra were recorded in the range of 4000 to 400 cm–1.  
 
Mass Spectrometry (MS) 
Electron ionization (EI) and EI high resolution mass spectra (HR-MS) were measured on a time-of-
flight (TOF) mass spectrometer AccuTOF from JOEL. Electrospray ionization (ESI) mass spectra 
were recorded on an Ion-Trap mass spectrometer LCQ from Finnigan®, a quadrupole time-of-flight 
maXis from Bruker Daltonic® or on a time-of-flight mass spectrometer microTOF from Bruker 
Daltonic®. ESI-HR-MS spectra were recorded on a Bruker® Apex Ⅳ or a Bruker Daltonic® 7T, fourier 
transform ion cyclotron resonance (FTICR) mass spectrometer. The ratios of mass to charge (m/z) 
were indicated, intensities relative to the base peak (I = 100) were written in parentheses. 
 
Reagents  
Chemicals obtained from commercial sources with purity above 95% were used without further 
purification. The following compounds were synthesized according to previously described methods: 
2-tosylbenzoic acid (21n),[119] 2-mesylbenzoic acid (21o),[119] 5-chloro-2-methoxybenzoic acid 
(21γ),[120] 5-bromo-2-methoxybenzoic acid (21δ),[121] 2-methoxy-2-naphthoic acid(21ε),[120] 
[D2] methyl acrylate ([D2]-45b),
[122] benzyl acrylate (45d),[123] 4-fluorobenzyl acrylate (45i),[123] 
menthyl acrylate (45j),[123] pent-4-enyl acrylate (45k),[123] cholesteryl acrylate (45l),[123] 2-
trifluoromethylphenyl acrylate (45o),[123] 4-chlorophenylacrylate (45p),[123] 4-bromophenyl acrylate 
(45q),[123] 4-iodophenyl acrylate (45r),[123] 4-acetylphenyl acrylate (45u),[123] 4-cyanophenylacrylate 
(45v),[123] 4-nitrophenylacrylate (45w)[123]. 
 
The following compounds were obtained by the generous courtesy of the persons named below: 
Karsten Rauch: [Ru(O2CMes)2(p-cymene)] (99), [RuCl2(p-cymene)]2 (30), [Cp*RhCl2]2. 
Dr. Svenja Warratz: [Ru(O2CAd)2(p-cymene)] (105), [Ru2Cl3(p-cymene)2][PF6]. 
Dr. Ruhuai Mei: [Cp*CoI2]2. 
M. Sc. Torben Rogge: [Ru(O2CAd)2(p-cymene)] (105). 





5.2 Representative Procedures 
5.2.1 Representative Procedure A: Ruthenium(II)-Catalyzed Oxidative Alkenylation of 
Benzoic Acids in n-Butanol  
Benzoic acid 21 (1.00 mmol, 1.0 equiv), [RuCl2(p-cymene)]2 (30) (30.6 mg, 0.05 mmol, 5.0 mol %) 
and KOAc (108 mg, 1.10 mmol, 1.1 equiv) were placed in a pre-dried 25 mL Schlenk-tube. The flask 
was evacuated and refilled with O2 three times. n-BuOH (3.0 mL) and acrylate 45 (1.50 mmol, 1.5 
equiv) were added and the reaction mixture was stirred at 80 °C for 18 h. At ambient temperature, all 
volatiles were removed in vacuo. The residue was purified by column chromatography on silica gel 
(n-hexane/EtOAc). 
5.2.2 Representative Procedure B: Ruthenium(II)-Catalyzed Oxidative Alkenylation of 
Benzoic Acids in γ-Valerolactone (77) 
Benzoic acid 21 (1.00 mmol, 1.0 equiv), [RuCl2(p-cymene)]2 (30) (30.6 mg, 0.05 mmol, 5.0 mol %) 
and KOAc (98.0 mg, 1.00 mmol, 1.0 equiv) were placed in a pre-dried 25 mL Schlenk-tube. The flask 
was evacuated and refilled with O2 three times. γ-Valerolactone (77) (1.0 mL), HOAc (60 mg, 1.00 
mmol, 1.0 equiv) and acrylate 45 (1.50 mmol, 1.5 equiv) were added and the reaction mixture was 
stirred at 80 °C for 18 h. At ambient temperature, the mixture was diluted with H2O (10 mL), extracted 
with n-hexane/MTBE (1/1, 3×10 mL) and washed with H2O (5∙10 mL). All volatiles were removed in 
vacuo and the residue was purified by column chromatography on silica gel (n-hexane/EtOAc). 
5.2.3 Representative Procedure C: Ruthenium(II)-Catalyzed Decarboxylative Alkenylation of 
Benzoic Acids 
Benzoic acid (21) (3.00 mmol, 3.0 equiv), [Ru(O2CMes)2(p-cymene)] (99) (56.2 mg, 0.10 mmol, 
10.0 mol %) and V2O5 (182 mg, 1.00 mmol) were placed in a pre-dried pressure tube equipped with a 
rubber septum. The tube was evacuated and refilled with N2 or Ar three times. Dry PhMe (3.0 mL) 
and acrylate 45 (1.00 mmol, 1.0 equiv) were added. The tube was closed and the reaction mixture was 
stirred at 120 °C for 18 h. At ambient temperature, all volatiles were removed in vacuo and the residue 




5.2.4 Representative Procedure D: Ruthenium(II)-Catalyzed Deuteration of Acrylic Esters 
[RuCl2(p-cymene)]2 (30) (6.1 mg, 0.01 mmol, 1.0 mol %), m-CF3-benzoic acid (106) (9.5 mg, 
0.05 mmol, 5.0 mol %) and potassium m-CF3-benzoate (106-K) (12 mg, 0.05 mmol, 5.0 mol %) were 
placed in a pre-dried 25 mL Schlenk-tube equipped with a rubber septum. The tube was evacuated and 
refilled with Ar three times. Acrylic ester (45) (1.00 mmol, 1.0 equiv) and D2O (1.0 mL, 55 mmol, 
55.0 equiv) were added and the mixture was heated to 80 °C for 18 h. At ambient temperature, the 
internal standard was added and the mixture was extracted with CDCl3 (1.0 mL). An aliquote (0.1 mL) 
of the organic phase was removed, filtered and rinsed with CDCl3 through a small plug of silica and 
analyzed by NMR spectroscopy.  
5.2.5 Representative Procedure E: Ruthenium(II)-Catalyzed Deuteration of Acrylic Esters in 
C6D6 
[RuCl2(p-cymene)]2 (30) (6.1 mg, 0.01 mmol, 1.0 mol %), m-CF3-benzoic acid (106) (9.5 mg, 
0.05 mmol, 5.0 mol %) and potassium m-CF3-benzoate (106-K) (11.5 mg, 0.05 mmol, 5.0 mol %) 
were placed in a pre-dried 25 mL Schlenk-tube equipped with a rubber septum. The tube was evacuated 
and refilled with Ar three times. Acrylic ester (45) (1.00 mmol, 1.0 equiv), C6D6 (1.0 mL) and D2O 
(1.0 mL, 55 mmol, 55.0 equiv) were added and the mixture was heated to 80 °C for 18 h. At ambient 
temperature, the internal standard was added. An aliquote (0.1 mL) of the organic phase was removed, 






5.3 Experimental Procedures and Analytical Data 
5.3.1 Ruthenium(II)-Oxidase C–H Alkenylation of Benzoic Acids 
5.3.1.1 Experimental Data for the Synthesis of Phthalides 
 
n-Butyl 2-(4-methyl-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47aa): 
a) The representative procedure A was followed using 2-methylbenzoic acid (21a) (136 mg, 1.00 mmol, 
1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol). Purification by column chromatography 
(n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47aa (180 mg, 0.74 mmol, 74%) as a colorless oil.  
b) The representative procedure B was followed using 2-methylbenzoic acid (21a) (136 mg, 1.00 mmol, 
1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47aa (237 mg, 0.90 mmol 90%) as a 
colorless oil. 
c) The representative procedure B was followed using 2-methylbenzoic acid (21a) (680 mg, 5.00 mmol, 
1.0 equiv) and n-butyl acrylate (45a) (960 mg, 7.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47aa (1265 mg, 4.85 mmol 97%) as a 
colorless oil. 
1H-NMR (400 MHz, CDCl3): δ = 7.53 (dd, J = 7.6, 7.6 Hz, 1H), 7.31–7.27 (m, 2H), 5.81 (t, J = 6.8 
Hz, 1H), 4.16 (t, J = 6.7 Hz, 2H), 2.87 (dd, J = 6.5, 2.2 Hz, 2H), 2.69 (s, 3H), 1.67–1.56 (m, 2H), 1.43–
1.32 (m, 2H), 0.93 (t, J = 7.4 Hz, 3H).  
13C-NMR (101 MHz, CDCl3): δ = 170.2 (Cq), 169.6 (Cq), 149.4 (Cq), 140.1 (Cq), 134.1 (CH), 131.3 
(CH), 123.6 (Cq), 119.4 (CH), 76.2 (CH), 65.3 (CH2), 39.9 (CH2), 30.7 (CH2), 19.2 (CH2), 17.5 (CH3), 
13.8 (CH3).  




MS (EI) m/z (relative intensity): 262 (14) [M]+, 206 (74), 160 (82), 147 (100), 132 (25), 119 (33), 
91 (35), 46 (13).  
HR-MS (ESI) m/z calcd for C15H19O4, [M+H]
+ 263.1287, found 263.1276.  
The spectral data are in accordance with those reported in the literature.[41g] 
 
 
n-Butyl 2-(4-phenyl-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47ba): 
a) The representative procedure A was followed using 2-phenylbenzoic acid (21b) (198 mg, 
1.00 mmol, 1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by 
column chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ba (195 mg, 0.60 mmol, 60%) 
as a colorless oil.  
b) The representative procedure B was followed using 2-phenylbenzoic acid (21b) (198 mg, 
1.00 mmol, 1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by 
column chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ba (211 mg, 0.65 mmol, 65%) 
as a colorless oil. 
1H-NMR (300 MHz, CDCl3): δ = 7.61 (dd, J = 7.6, 7.6 Hz, 1H), 7.49–7.42 (m, 2H), 7.42–7.30 (m, 
5H), 5.78 (t, J = 6.5 Hz, 1H), 4.09 (t, J = 6.7 Hz, 2H), 2.85 (d, J = 6.7 Hz, 2H), 1.62–1.45 (m, 2H), 
1.40–1.19 (m, 2H), 0.85 (t, J = 7.3 Hz, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 169.5 (Cq), 168.7 (Cq), 150.2 (Cq), 143.0 (Cq), 136.4 (Cq), 134.1 (CH), 
131.4 (CH), 129.6 (CH), 128.5 (CH), 128.1 (CH), 122.1 (Cq), 120.8 (CH), 75.7 (CH), 65.3 (CH2), 39.9 
(CH2), 30.6 (CH2), 19.2 (CH2), 13.8 (CH3).  




MS (EI) m/z (relative intensity): 324 (28) [M]+, 268 (39), 250 (75), 223 (100), 209 (82), 181 (55), 152 
(84), 76 (8).  
HR-MS (ESI) m/z calcd for C20H21O4, [M+H]
+ 325.1434, found 325.1438.  
The spectral data are in accordance with those reported in the literature.[51] 
 
 
n-Butyl 2-(4-methoxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47ca): 
a) The representative procedure A was followed using 2-methoxybenzoic acid (21c) (152 mg, 
1.00 mmol, 1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by 
column chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ca (141 mg, 0.51 mmol, 51%) 
as a colorless oil.  
b) The representative procedure B was followed using 2-methoxybenzoic acid (21c) (152 mg, 
1.00 mmol, 1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by 
column chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ca (167 mg, 0.60 mmol, 60%) 
as a colorless oil.  
1H-NMR (300 MHz, CDCl3): δ = 7.61 (dd, J = 8.3, 7.6 Hz, 1H), 7.00 (d, J = 7.6 Hz, 1H), 6.95 (d, 
J = 8.3 Hz, 1H), 7.07–6.93 (m, 2H), 5.79 (dd, J = 7.0, 6.2 Hz, 1H), 4.15 (t, J = 6.7 Hz, 2H), 3.99 (s, 
3H), 2.96–2.76 (m, 2H), 1.70–1.50 (m, 2H), 1.44–1.25 (m, 2H), 0.93 (t, J = 7.3 Hz, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 169.5 (Cq), 168.0 (Cq), 158.9 (Cq), 151.8 (Cq), 136.6 (CH), 113.7 
(CH), 113.6 (Cq), 111.3 (CH), 76.1 (CH), 65.3 (CH2), 56.2 (CH3), 39.9 (CH2), 30.7 (CH2), 19.2 (CH2), 
13.8 (CH3).  




MS (EI) m/z (relative intensity): 278 (25) [M]+, 222 (62), 163 (100), 135 (33), 120 (11), 105 (25), 
77 (26), 41 (18).  
HR-MS (ESI) m/z calcd for C15H19O5, [M+H]
+ 279.1228, found 279.1227.  
The spectral data are in accordance with those reported in the literature.[41g] 
 
 
n-Butyl 2-(4-ethoxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47da): 
The representative procedure A was followed using 2-ethoxybenzoic acid (21d) (166 mg, 1.00 mmol, 
1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ca (144 mg, 0.49 mmol, 49%) as a 
colorless oil.  
1H-NMR (500 MHz, CDCl3): δ = 7.57 (dd, J = 8.2, 7.7 Hz, 1H), 6.97 (d, J = 7.7 Hz, 1H), 6.92 (d, J = 
8.2 Hz, 1H), 5.77 (t, J = 6.6 Hz, 1H), 4.24 (q, J = 7.0 Hz, 2H), 4.15 (t, J = 6.7 Hz, 2H), 2.90–2.79 (m, 
2H), 1.66–1.58 (m, 2H), 1.51 (t, J = 7.0 Hz, 3H), 1.40–1.32 (m, 2H), 0.93 (t, J = 7.4 Hz, 3H). 
13C-NMR (126 MHz, CDCl3): δ = 169.6 (Cq), 167.8 (Cq), 158.3 (Cq), 151.7 (Cq), 136.4 (CH), 113.6 
(Cq), 113.4 (CH) 112.2 (CH), 75.9 (CH), 65.3 (CH2), 64.8 (CH2), 39.9 (CH2), 30.7 (CH2), 19.2 (CH2), 
14.6 (CH3),13.8 (CH3). 
IR (ATR): 2960, 2934, 2874, 1761, 1731, 1602, 1471, 1197, 1036, 1008, 691 cm–1. 
MS (EI) m/z (relative intensity): 292 (28) [M]+, 277 (56), 236 (48), 221 (51), 190 (53), 177 (72), 163 
(64), 149 (100), 121 (32), 65 (28). 
HR-MS (ESI) m/z calcd for C16H21O5, [M+H]






n-Butyl 2-(4-iodo-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47ea): 
a) The representative procedure A was followed using 2-iodobenzoic acid (21e) (201 mg, 1.00 mmol, 
1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 1/1 + 1% NEt3) yielded 47ea (231 mg, 0.63 mmol, 63%) as a 
colorless oil.  
b) The representative procedure B was followed using 2-iodobenzoic acid (21e) (201 mg, 1.00 mmol, 
1.0 equiv) and n-butyl acrylate (2a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 1/1 + 1% NEt3) yielded 47ea (201 mg, 0.54 mmol, 54%) as a 
colorless oil.  
1H-NMR (500 MHz, CDCl3): δ = 8.00 (d, J = 7.7 Hz, 1H), 7.48 (d, J = 7.7 Hz, 1H), 7.34 (dd, J = 7.7, 
7.7 Hz, 1H), 5.76 (t, J = 6.9 Hz, 1H), 4.14 (t, J = 6.7 Hz, 2H), 3.08–2.75 (m, 2H), 1.69–1.52 (m, 2H), 
1.44–1.20 (m, 2H), 0.92 (t, J = 7.4 Hz, 3H).  
13C-NMR (126 MHz, CDCl3): δ = 169.3 (Cq), 168.0 (Cq), 151.1 (Cq), 141.1 (CH), 135.1 (CH), 127.2 
(Cq), 122.0 (CH), 92.5 (Cq), 74.9 (CH), 65.4 (CH2), 39.4 (CH2), 30.6 (CH2), 19.2 (CH2), 13.8 (CH3).  
IR (ATR): 2959, 1763, 1727, 1457, 1304, 1173, 1076, 968, 781, 678 cm–1. 
MS (EI) m/z (relative intensity): 374 (22) [M]+, 318 (100), 273 (75), 259 (81), 231 (29), 203 (9), 
104 (10), 76 (19).  
HR-MS (EI) m/z calcd for C14H15IO4, [M]






n-Butyl 2-(4-hydroxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47fa): 
a) The representative procedure A was followed using salicylic acid (21f) (138 mg, 1.00 mmol, 
1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 1/1 + 1% MeOH) yielded 47fa (72 mg, 0.27 mmol, 27%) as a 
colorless oil.  
b) The representative procedure B was followed using salicylic acid (21f) (138 mg, 1.00 mmol, 
1.0 equiv) and n-butyl acrylate (2a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 1/1 + 1% MeOH) yielded 47fa (138 mg, 0.52 mmol, 52%) as a 
colorless oil.  
1H-NMR (300 MHz, CDCl3): δ = 7.76 (s, 1H), 7.52 (dd, J = 8.3, 7.5 Hz, 1H), 6.98–6.87 (m, 2H), 5.86 
(t, J = 6.6 Hz, 1H), 4.13 (t, J = 6.7 Hz, 2H), 2.88 (d, J = 6.6 Hz, 2H), 1.68–1.51 (m, 2H), 1.45–1.22 
(m, 2H), 0.90 (t, J = 7.4 Hz, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 171.4 (Cq), 169.2 (Cq), 156.6 (Cq), 149.1 (Cq), 137.2 (CH), 116.0 
(CH), 113.4 (CH), 111.0 (Cq), 78.3 (CH), 65.2 (CH2), 39.3 (CH2), 30.5 (CH2), 19.1 (CH2), 13.7 (CH3).  
IR (ATR): 2960, 1727, 1615, 1464, 1280, 1158, 997, 801, 689, 436 cm–1. 
MS (EI) m/z (relative intensity): 264 (15) [M]+, 208 (95), 165 (35), 162 (100), 149 (95), 134 (15), 121 
(30), 65 (20).  
HR-MS (EI) m/z calcd for C14H16O5, [M]






n-Butyl 2-(4,6-dimethyl-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47ga): 
a) The representative procedure A was followed using 2,4-dimethylbenzoic acid (21g) (150 mg, 
1.00 mmol, 1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by 
column chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ga (200 mg, 0.72 mmol, 72%) 
as a colorless oil.  
b) The representative procedure B was followed using 2,4-dimethylbenzoic acid (21g) (150 mg, 
1.00 mmol, 1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by 
column chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ga (261 mg, 0.95 mmol, 95%) 
as a colorless oil.  
1H-NMR (300 MHz, CDCl3): δ = 7.10 (s, 1H), 7.05 (s, 1H), 5.76 (t, J = 6.5 Hz, 1H), 4.16 (t, J = 6.7 Hz, 
2H), 2.85 (d, J = 6.5 Hz, 2H), 2.64 (s, 3H), 2.42 (s, 3H), 1.68–1.54 (m, 2H), 1.45–1.30 (m, 2H), 0.93 
(t, J = 7.3 Hz, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 170.2 (Cq), 169.7 (Cq), 150.0 (Cq), 145.3 (Cq), 139.7 (Cq), 132.4 (CH), 
121.1 (Cq), 119.8 (CH), 76.0 (CH), 65.3 (CH2), 40.0 (CH2), 30.7 (CH2), 22.1 (CH3), 19.2 (CH2), 17.4 
(CH3), 13.8 (CH3).  
IR (ATR): 2960, 1754, 1731, 1613, 1310, 1270, 1203, 1170, 1013, 686 cm–1. 
MS (EI) m/z (relative intensity): 276 (20) [M]+, 220 (60), 174 (95), 161 (100), 146 (35), 133 (40), 105 
(25), 77 (15).  
HR-MS (EI) m/z calcd for C16H20O4, [M]
+ 276.1362, found 276.1359. 






n-Butyl 2-(6-bromo-4-methyl-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47ha): 
The representative procedure A was followed using 2-methyl-4-bromobenzoic acid (21h) (150 mg, 
1.00 mmol, 1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by 
column chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ha (243 mg, 0.71 mmol, 71%) 
as a colorless oil.  
1H-NMR (500 MHz, CDCl3): δ = 7.47–7.45 (m, 2H), 5.76 (t, J = 6.5 Hz, 1H), 4.20–4.13 (m, 2H), 
2.95–2.80 (m, 2H), 2.66 (s, 3H), 1.65–1.58 (m, 2H), 1.41–1.33 (m, 2H), 0.93 (t, J = 6.5 Hz, 3H). 
13C-NMR (126 MHz, CDCl3): δ = 169.3 (Cq), 169.2 (Cq), 151.2 (Cq), 141.7 (Cq), 134.5 (Cq), 129.1 
(CH), 121.1 (Cq), 123.0 (CH), 122.7 (Cq), 75.6 (CH), 65.4 (CH2), 39.6 (CH2), 30.7 (CH2), 19.2 (CH2), 
17.3 (CH3), 13.8 (CH3). 
IR (ATR): 2960, 2873, 1757, 1589, 1337, 1197, 1172, 1011, 865, 678 cm–1. 
MS (EI) m/z (relative intensity): 340 (8) [M]+, 286 (86), 284 (84), 240 (92), 225 (100), 210 (20), 197 
(24), 118 (32), 89 (34), 69 (22). 
HR-MS (EI): m/z calcd for C15H17
79BrO4, [M]
+ 340.0310, found: 340.0316. 








n-Butyl 2-(5-methyl-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47ia): 
The representative procedure A was followed using 3-methylbenzoic acid (21i) (136 mg, 1.00 mmol, 
1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ha (124 mg, 0.72 mmol, 47%) as a 
colorless oil.  
1H-NMR (500 MHz, CDCl3): δ = 7.70 (s, 1H), 7.48 (d, J = 7.8 Hz, 1H), 7.37 (d, J = 7.8 Hz, 2H), 5.84 
(t, J = 6.6 Hz, 1H), 4.16 (t, J = 6.7 Hz, 2H), 2.94–2.80 (m, 2H), 2.46 (s, 3H), 1.64–1.58 (m, 2H),      
1.40–1.32 (m, 2H), 0.93 (t, J = 6.5 Hz, 3H). 
13C-NMR (126 MHz, CDCl3): δ = 170.2 (Cq), 169.5 (Cq), 146.3 (Cq), 140.0 (Cq), 135.5 (CH), 126.3 
(Cq), 126.0 (CH), 121.9 (CH), 77.1 (CH), 65.3 (CH2), 39.8 (CH2), 30.7 (CH2), 21.4 (CH3), 19.2 (CH2), 
13.8 (CH3).  
IR (ATR): 2960, 2873, 1763, 1730, 1287, 1153, 1057, 1006, 779, 555 cm–1. 
MS (EI) m/z (relative intensity): 262 (8) [M]+, 206 (75), 163 (38), 160 (96), 147 (100), 119 (44), 91 
(28), 65 (15), 41 (12). 
HR-MS (EI) m/z calcd for C15H18O4, [M]
+ 262.1205, found: 262.1207. 







The representative procedure A was followed using 3-methoxybenzoic acid (21j) (152 mg, 1.00 mmol, 
1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ja (77 mg, 0.28 mmol, 28%) as a white 
solid, 3ja’ (77 mg, 0.13 mmol, 13%) as a colorless oil and 48jaa (133 mg, 0.33 mmol, 33%) as a 
yellow solid.  
n-Butyl 2-(7-methoxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47ja): 
M. p. = 78–80 °C. 
1H-NMR (500 MHz, CDCl3): δ = 7.53–7.47 (m, 2H), 7.11 (dd, J = 7.8, 2.0 Hz, 1H), 5.88 (m, 1H), 4.12 
(t, J = 6.7 Hz, 2H), 3.91 (s, 3H), 3.23–3.27 (m, 1H), 2.97–2.84 (m, 1H), 1.62–1.56 (m, 2H), 1.40–1.31 
(m, 2H), 0.92 (t, J = 7.4 Hz, 3H). 
13C-NMR (126 MHz, CDCl3): δ = 170.0 (Cq), 169.7 (Cq), 154.3 (Cq), 136.4 (Cq), 131.5 (CH), 128.2 
(Cq), 117.5 (CH), 115.2 (CH), 76.4 (CH), 65.2 (CH2), 55.8 (CH3), 39.0 (CH2), 30.7 (CH2), 19.2 (CH2), 
13.8 (CH3). 
IR (ATR): 2946, 1762, 1732, 1610, 1491, 1313, 1173, 1033, 745, 506 cm–1. 
MS (EI) m/z (relative intensity): 278 (8) [M]+, 222 (52), 176 (84), 163 (100), 135 (22), 105 (26), 77 
(22), 43 (28). 
HR-MS (EI) m/z calcd for C15H18O5, [M]
+ 278.1154, found 278.1163. 
n-Butyl 2-(5-methoxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47ja’): 
1H-NMR (500 MHz, CDCl3): δ = 7.38 (d, J = 8.4 Hz, 1H), 7.33 (d, J = 2.2 Hz, 1H), 7.23 (dd, J = 8.4, 
2.4 Hz, 1H), 5.82 (t, J = 6.8 Hz, 1H), 4.16 (t, J = 6.7 Hz, 2H), 3.87 (s, 3H), 2.96–2.76 (m, 2H),            




13C-NMR (500 MHz, CDCl3): δ = 170.0 (Cq), 169.6 (Cq), 161.1 (Cq), 141.4 (Cq), 127.6 (Cq), 123.3 
(CH), 123.2 (CH), 107.8 (Cq), 77.0 (CH), 65.3 (CH2), 56.0 (CH3), 39.9 (CH2), 30.7 (CH2), 19.2 (CH2), 
13.8 (CH3). 
IR (ATR): 2960, 2935, 2873, 1760, 1495, 1322, 1242, 1052, 838, 779 cm–1. 
MS (EI) m/z (relative intensity): 278 (25) [M]+, 222 (51), 176 (100), 163 (186), 135 (52), 77 (17), 43 
(36). 
HR-MS (EI) m/z calcd for C15H18O5, [M]
+ 278.1154, found 278.1156. 
n-Butyl 3-[1-(2-n-butoxy-2-oxoethyl)-5-methoxy-3-oxo-1,3-dihydroisobenzofuran-4-yl]acrylate 
(48jaa): 
M. p. = 78–80 °C. 
1H-NMR (500 MHz, CDCl3): δ = 8.63 (d, J = 16.2 Hz, 1H), 7.76 (d, J = 8.5 Hz, 1H), 7.11 (d, J =8.6 Hz, 
1H), 6.49 (d, J = 16.2 Hz, 1H), 5.84–5.81 (m, 1H), 4.22 (t, J = 6.7 Hz, 2H), 4.11 (t, J = 6.7 Hz, 2H), 
3.94 (s, 3H), 3.31–3.25 (m, 1H), 2.69–2.63 (m, 1H), 1.73–1.66 (m, 2H), 1.61–1.54 (m, 2H), 1.48–1.40 
(m, 2H), 1.38–1.31 (m, 2H), 0.96 (t, J = 7.4 Hz, 3H), 0.91 (t, J = 7.4 Hz, 3H). 
13C-NMR (126 MHz, CDCl3): δ = 169.5 (Cq), 169.0 (Cq), 166.7 (Cq), 155.2 (Cq), 137.3 (CH), 137.0 
(Cq), 129.1 (CH), 127.0 (Cq), 125.4 (Cq), 120.6 (CH), 115.4 (CH), 75.4 (CH), 65.2 (CH2), 64.7 (CH2), 
56.1 (CH), 37.8 (CH2), 30.9 (CH2), 30.7 (CH2), 19.3 (CH2), 19.2 (CH2), 13.9 (CH3),13.8 (CH3). 
IR (ATR): 2957, 2873, 1764, 1722, 1612, 1505, 1280, 1159, 1013, 830, 545, 492 cm–1. 
MS (EI) m/z (relative intensity): 404 (16) [M]+, 330 (100), 302 (67), 274 (44), 246 (70), 229 (82), 187 
(92), 131 (22), 57 (33), 41 (84). 
HR-MS (EI) m/z calcd for C22H28O7, [M]






The representative procedure A was followed using 4-methoxybenzoic acid (21k) (152 mg, 1.00 mmol, 
1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ka (92 mg, 0.33 mmol, 33%) as a 
colorless oil and 48kaa (77 mg, 0.19 mmol, 19%) as a white solid.  
n-Butyl 2-(6-methoxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47ka): 
1H-NMR (500 MHz, CDCl3): δ = 7.81 (d, J = 8.5 Hz, 1H), 6.93 (dd, J = 8.5, 2,2 Hz , 1H), 6.93 (d, 
J = 2.2 Hz, 2H), 5.88 (t, J = 8.5 Hz, 1H), 4.17 (t, J = 6.7 Hz, 2H), 3.89 (s, 3H), 2.97–2.80 (m, 2H), 
1.66–1.59 (m, 2H), 1.42–1.33 (m, 2H), 0.93 (t, J = 7.4 Hz, 3H). 
13C-NMR (126 MHz, CDCl3): δ = 169.7 (Cq), 169.6 (Cq), 165.0 (Cq), 151.2 (Cq), 127.5 (CH), 118.4 
(Cq), 116.9 (CH), 106.4 (CH), 76.4 (CH), 65.3 (CH2), 56.0 (CH3), 39.8 (CH2), 30.7 (CH2), 19.2 (CH2), 
13.8 (CH3). 
IR (ATR): 2960, 2874, 1754, 1731, 1606, 1490, 1173, 1153, 1006, 689 cm–1. 
MS (EI) m/z (relative intensity): 278 (14) [M]+, 222 (53), 176 (91), 163 (100), 135 (37), 77 (15), 43 
(15).  
HR-MS (EI) m/z calcd for C15H18O5, [M]
+ 278.1154, found 278.1147. 
n-Butyl 3-[1-(2-n-butoxy-2-oxoethyl)-5-methoxy-3-oxo-1,3-dihydroisobenzofuran-4-yl]acrylate 
(48kaa): 
M. p. = 89–91 °C. 
1H-NMR (500 MHz, CDCl3): δ = 8.61 (d, J = 16.2 Hz, 1H), 7.23 (d, J = 2.2 Hz, 1H), 6.94 (t, J = 2.1 Hz, 
1H), 6.57 (d, J = 16.2 Hz, 1H), 5.76 (t, J = 6.8 Hz, 1H), 4.23 (t, J = 6.7 Hz, 2H), 4.16 (t, J = 6.7 Hz, 
2H), 3.91 (s, 3H), 2.96–2.81 (m, 2H), 1.74–1.67 (m, 2H), 1.65–1.58 (m, 2H), 1.49–1.42 (m, 2H),     




13C-NMR (126 MHz, CDCl3): δ = 169.5 (Cq), 168.8 (Cq), 166.3 (Cq), 164.6 (Cq), 152.6 (Cq), 137.5 
(CH), 136.6 (Cq), 123.3 (CH), 116.0 (Cq), 113.3 (CH), 107.9 (CH), 75.7 (CH), 65.4 (CH2), 65.0 (CH2), 
56.2 (CH), 39.7 (CH2), 30.9 (CH2), 30.7 (CH2), 19.3 (CH2), 19.2 (CH2), 13.9 (CH3),13.8 (CH3). 
IR (ATR): 2959, 2874, 1735, 1603, 1338, 1260, 1173, 1064, 1011, 682 cm–1. 
MS (EI) m/z (relative intensity): 404 (16) [M]+, 331 (22), 303 (83), 229 (100), 201 (36), 187 (25), 163 
(24), 57 (16), 41 (34). 
HR-MS (EI) m/z calcd for C22H28O7, [M]
+ 404.1835, found 404.1835. 
 
 
a) The representative procedure A was followed using benzoic acid (21l) (122 mg, 1.00 mmol, 
1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47la (106 mg, 0.43 mmol, 43%) and 48laa 
(85 mg, 0.23 mmol, 23%) as colorless oils.  
b) The representative procedure B was followed using benzoic acid (21l) (122 mg, 1.00 mmol, 
1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47la (100 mg, 0.40 mmol, 40%) and 48laa 
(96 mg, 0.26 mmol, 26%) as colorless oils.  
n-Butyl 2-(3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47la): 
1H-NMR (500 MHz, CDCl3): δ = 7.91 (d, J = 7.7 Hz, 1H), 7.68 (ddd, J = 7.5, 7.5, 1,1 Hz , 1H),       
7.58–7.48 (m, 2H), 5.88 (t, J = 6.6 Hz, 1H), 4.16 (t, J = 6.7 Hz, 2H), 2.97–2.84 (m, 2H), 1.65–1.57 (m, 
2H), 1.42–1.32 (m, 2H), 0.93 (t, J = 7.4 Hz, 3H).  
13C-NMR (126 MHz, CDCl3): δ = 170.0 (Cq), 169.5 (Cq), 149.0 (Cq), 134.4 (CH), 129.7 (CH), 126.1 




IR (ATR): 2960, 2934, 2873, 1761, 1466, 1287, 1171, 1059, 1002, 747 cm–1. 
MS (EI) m/z (relative intensity): 248 (8) [M]+, 192 (60), 175 (10), 146 (54), 133 (100), 105 (35), 77 
(29), 41 (18). 
HR-MS (ESI) m/z calcd for C14H16O4, [M+H]
+ 248.1055, found 248.1055. 
The spectral data are in accordance with those reported in the literature.[125] 
n-Butyl 3-[1-(2-n-butoxy-2-oxoethyl)-3-oxo-1,3-dihydroisobenzofuran-4-yl]acrylate (48laa): 
1H-NMR (500 MHz, CDCl3): δ = 8.71 (d, J = 16.2 Hz, 1H), 7.77 (d, J = 7.8 Hz, 1H), 7.66 (t, J = 7.9 Hz, 
1H), 7.48 (d, J = 7.6 Hz, 1H), 6.60 (d, J = 16.2 Hz, 1H), 5.85 (t, J = 6.5 Hz, 1H), 4.24 (t, J = 6.7 Hz, 
2H), 4.15 (t, J = 6.7 Hz, 2H), 2.90–2.79 (m, 2H), 1.72–1.67 (m, 2H), 1.64–1.57 (m, 2H), 1.47–1.32 (m, 
4H), 0.94 (t, J = 7.4 Hz, 3H), 0.92 (t, J = 7.4 Hz, 3H). 
13C-NMR (126 MHz, CDCl3): δ = 169.3 (Cq), 169.0 (Cq), 166.3 (Cq), 149.9 (Cq), 137.4 (CH), 135.2 
(Cq), 134.4 (CH), 126.8 (CH), 123.4 (Cq), 123.3 (CH), 123.1 (CH), 76.2 (CH), 65.4 (CH2), 64.9 (CH2), 
39.6 (CH2), 30.8 (CH2), 30.6 (CH2), 19.3 (CH2), 19.2 (CH2), 13.9 (CH3), 13.8 (CH3). 
IR (ATR): 2959, 2874, 1711, 1640, 1287, 1165, 1078, 1047, 804, 791 cm–1. 
MS (EI) m/z (relative intensity): 374 (14) [M]+, 301 (65), 273 (63), 244 (33), 199 (100), 171 (31), 157 
(30), 57 (21), 41 (32).  
HR-MS (ESI) m/z calcd for C14H16O4, [M+H]
+ 374.1729, found 374.1735. 









n-Butyl 2-(4-bromo-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47ma): 
The representative procedure B was followed using 2-bromobenzoic acid (21m) (201 mg, 1.00 mmol, 
1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 1/1 + 1% MeOH) yielded 47ma (227 mg, 0.70 mmol, 70%) as a 
colorless oil. 
1H-NMR (300 MHz, CDCl3): δ = 7.64 (d, J = 7.6 Hz, 1H), 7.44 (dd, J = 7.6, 7.6 Hz, 1H), 7.38 (d, 
J = 7.6 Hz, 1H), 5.74 (t, J = 6.5 Hz, 1H), 4.09 (t, J = 6.7 Hz, 2H), 2.99–2.69 (m, 2H), 1.61–1.43 (m, 
2H), 1.37–1.23 (m, 2H), 0.86 (t, J = 7.3 Hz, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 169.3 (Cq), 167.3 (Cq), 151.4 (Cq), 135.3 (CH), 134.4 (CH), 124.5 
(Cq), 121.4 (Cq), 121.2 (CH), 75.4 (CH), 65.5 (CH2), 39.6 (CH2), 30.7 (CH2), 19.2 (CH2), 13.8 (CH3).  
IR (ATR): 2957, 1735, 1599, 1456, 1340, 1204, 1079, 1043, 797, 677 cm–1. 
MS (EI) m/z (relative intensity): 326 (5) [79Br-M+], 272 (91), 227 (88), 211 (100), 183 (30), 155 (18), 
104 (10), 75 (30).  
HR-MS (ESI) m/z calcd for C14H16
79BrO4, [M+H]
+ 327.0226, found 327.0228. 
 
n-Butyl 2-(4-tosyloxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47na): 
The representative procedure B was followed using 2-tosyloxybenzoic acid (21n) (292 mg, 1.00 mmol, 




chromatography (n-hexane/EtOAc: 1/1 + 1% MeOH) yielded 47na (206 mg, 0.49 mmol, 49%) as a 
colorless oil.  
1H-NMR (300 MHz, CDCl3): δ = 7.84 (d, J = 8.2 Hz, 1H), 7.84 (d, J = 8.5 Hz, 1H), 7.66 (m, 1H), 7.40 
(d, J = 8.0 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 5.75 (t, J = 6.5 Hz, 1H), 4.10 (t, J = 6.7 Hz, 2H), 2.83 (d, 
J = 6.5 Hz, 2H), 2.41 (s, 3H), 1.65–1.46 (m, 2H), 1.40–1.18 (m, 2H), 0.89 (t, J = 7.5 Hz, 1H).  
13C-NMR (75 MHz, CDCl3): δ = 169.1 (Cq), 165.4 (Cq), 151.2 (Cq), 146.5 (Cq), 145.9 (Cq), 136.0 (CH), 
132.0 (Cq), 129.8 (CH), 128.9 (CH), 123.7 (CH), 120.9 (CH), 118.7 (Cq), 76.0 (CH), 65.2 (CH2), 39.3 
(CH2), 30.5 (CH2), 21.8 (CH3), 19.1 (CH2), 13.7 (CH3).  
IR (ATR): 2960, 1769, 1732, 1475, 1172, 997, 812, 748, 668, 548 cm–1.  
MS (EI) m/z (relative intensity): 418 (5) [M]+, 354 (7), 303 (14), 263 (45), 207 (44), 163 (22), 155 (87), 
91 (100).  
HR-MS (EI) m/z calcd for C21H22O7S, [M]
+ 418.1086, found 418.1071.  
 
 
n-Butyl 2-(4-methylsulonyloxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47oa): 
The representative procedure B was followed using 2-methylsulfonyloxybenzoic acid (21o) (192 mg, 
1.00 mmol, 1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by 
column chromatography (n-hexane/EtOAc: 1/1 + 1% MeOH) yielded 47oa (188 mg, 0.55 mmol, 55%) 
as a colorless oil.  
1H-NMR (300 MHz, CDCl3): δ = 7.74 (dd, J = 7.5, 7.5 Hz, 1H), 7.48–7.47 (m, 1H), 7.45–7.44 (m, 
1H), 5.87 (t, J = 6.4 Hz, 1H), 4.15 (t, J = 6.7 Hz, 2H), 3.41 (s, 3H), 3.03–2.86 (m, 2H), 1.67–1.56 (m, 




13C-NMR (75 MHz, CDCl3): δ = 169.1 (Cq), 166.4 (Cq), 151.4 (Cq), 146.3 (Cq), 136.4 (CH), 124.9 
(CH), 121.2 (CH), 118.8 (Cq), 76.6 (CH), 65.5 (CH2), 39.3 (CH2), 39.2 (CH3), 30.6 (CH2), 19.2 (CH2), 
13.8 (CH3).  
IR (ATR): 2961, 2874, 1764, 1729, 1618, 1476, 1365, 1117, 1003, 787 cm–1.  
MS (EI) m/z (relative intensity): 342 (22) [M]+, 286 (100), 240 (52), 227 (75), 207 (100), 162 (82), 
149 (81), 120 (32).  
HR-MS (ESI) m/z calcd for C15H19O7S, [M+H]
+ 343.0846, found 343.0859. 
 
 
n-Butyl 2-(4-benzoyl-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47pa): 
The representative procedure B was followed using 2-benzoylbenzoic acid (21p) (226 mg, 1.00 mmol, 
1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 1/1 + 1% MeOH) yielded 47pa (287 mg, 0.82 mmol, 82%) as a 
colorless oil.  
1H-NMR (300 MHz, CDCl3): δ = 7.82–7.74 (m, 3H), 7.68–7.52 (m, 3H), 7.49–7.41 (m, 2H), 5.93 (t, 
J = 6.6 Hz, 1H), 4.17 (t, J = 6.7 Hz, 2H), 3.09–2.83 (m, 2H), 1.69–1.55 (m, 2H), 1.47–1.29 (m, 2H), 
0.94 (t, J = 7.4 Hz, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 194.6 (Cq), 169.4 (Cq), 167.6 (Cq), 149.6 (Cq), 139.4 (Cq), 136.6 (Cq), 
134.3 (CH), 134.0 (CH), 130.0 (CH), 128.7 (CH), 128.6 (CH), 123.9 (Cq), 123.7 (CH), 77.0 (CH), 65.4 
(CH2), 39.6 (CH2), 30.7 (CH2), 19.2 (CH2), 13.8 (CH3).  
IR (ATR): 2959, 1763, 1730, 1669, 1282, 1174, 1077, 1005, 711, 696 cm –1.  
MS (EI) m/z (relative intensity): 352 (20) [M]+, 278 (75), 252 (30), 236 (75), 208 (45), 152 (30), 105 




HR-MS (EI) m/z calcd for C21H20O5, [M]
+ 352.1311, found 352.1302.  
 
 
n-Butyl 2-(7-bromo-4-iodo-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47qa): 
The representative procedure B was followed using 2-iodo-5-bromobenzoic acid (21q) (327 mg, 
1.00 mmol, 1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by 
column chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47qa (320 mg, 0.71 mmol, 71%) 
as a colorless oil.  
1H-NMR (300 MHz, CDCl3): δ = 7.88 (dd, J = 8.2, 0.6 Hz, 1H), 7.47 (d, J = 8.2 Hz, 1H), 5.70 (ddd, 
J = 8.0, 3.0, 0.6 Hz, 1H), 4.10 (t, J = 6.7 Hz, 2H), 3.46 (dd, J = 16.7, 3.0 Hz, 1H), 2.81 (dd, J = 16.8, 
8.0 Hz, 1H), 1.63–1.52 (m, 2H), 1.41–1.26 (m, 2H), 0.92 (t, J = 7.3 Hz, 3H).  
13C-NMR (126 MHz, CDCl3): δ = 168.5 (Cq), 166.6 (Cq), 149.2 (Cq), 142.3 (CH), 138.0 (CH), 129.5 
(Cq), 116.5 (Cq), 91.0 (Cq), 75.5 (CH), 65.3 (CH2), 36.7 (CH2), 30.5 (CH2), 19.1 (CH2), 13.8 (CH3).  
IR (ATR): 2958, 2932, 2872, 1769, 1730, 1449, 1338, 1172, 1060, 831 cm–1. 
MS (EI) m/z (relative intensity): 452 (15) [79Br-M+], 396 (100), 350 (85), 337 (75), 309 (15), 154 (10), 
75 (165, 41 (20).  
HR-MS (EI) m/z calcd for C14H14
79BrIO4, [M]








n-Butyl 2-(1-oxo-1,3-dihydronaphtho[1,2-c]furan-3-yl)acetate (47ra):  
The representative procedure B was followed using 1-naphthoic-acid (21r) (172 mg, 1.00 mmol, 
1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ra (177 mg, 0.59 mmol, 59%) as a 
colorless solid.  
M. p. = 78–80 °C.  
1H-NMR (300 MHz, CDCl3): δ = 9.01 (dd, J = 8.2, 1.2 Hz, 1H), 8.15 (d, J = 8.4 Hz, 1H), 7.98 (d, 
J = 8.3 Hz, 1H), 7.75 (ddd, J = 8.2, 6.9, 1.4 Hz, 1H), 7.65 (ddd, J = 8.2, 6.9, 1.4 Hz, 1H), 7.53 (d, 
J = 8.4 Hz, 1H), 5.96 (t, J = 6.6 Hz, 1H), 4.18 (t, J = 6.7 Hz, 2H), 2.96 (d, J = 6.6 Hz, 2H), 1.68–1.56 
(m, 2H), 1.44–1.29 (m, 2H), 0.92 (t, J = 7.4 Hz, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 170.3 (Cq), 169.6 (Cq), 150.6 (Cq), 135.9 (CH), 133.7 (Cq), 129.4 
(CH), 128.6 (CH), 127.7 (CH), 123.7 (CH), 120.4 (Cq), 120.1 (Cq), 118.6 (CH), 76.5 (CH), 65.4 (CH2), 
39.6 (CH2), 30.7 (CH2), 19.2 (CH2), 13.8 (CH3).  
IR (ATR): 3073, 2956, 2932, 2871, 1739, 1400, 1290, 1175, 695, 502 cm–1.  
MS (EI) m/z (relative intensity): 298 (26) [M]+, 242 (75), 199 (26), 196 (100), 183 (62), 155 (42), 
127 (56), 115 (8).  
HR-MS (ESI) m/z calcd for C18H19O4, [M+H]







n-Butyl 2-(5,6-dimethyl-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47sa):  
The representative procedure B was followed using 3,4-dimethylbenzoic-acid (21s) (150 mg, 
1.00 mmol, 1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by 
column chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47sa (219 mg, 0.79 mmol, 79%) 
as a colorless oil.  
1H-NMR (300 MHz, CDCl3): δ = 7.65 (s, 1H), 7.23 (s, 1H), 5.80 (t, J = 6.6 Hz, 1H), 4.16 (t, J = 6.7 Hz, 
2H), 2.97–2.75 (m, 2H), 2.38 (s, 3H), 2.35 (s, 3H), 1.67–1.57 (m, 2H), 1.45–1.30 (m, 2H), 0.93 (t, 
J = 7.3 Hz, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 170.3 (Cq), 169.7 (Cq), 147.1 (Cq), 144.6 (Cq), 138.9 (Cq), 126.2 (CH), 
123.9 (Cq), 122.9 (CH), 76.8 (CH), 65.3 (CH2), 39.9 (CH2), 30.7 (CH2), 21.0 (CH3), 20.1 (CH3), 19.2 
(CH2), 13.8 (CH3).  
IR (ATR): 2960, 2873, 1759, 1731, 1460, 1390, 1340, 1170, 1015, 990 cm–1.  
MS (EI) m/z (relative intensity): 276 (13) [M]+, 220 (51), 177 (44), 174 (100), 161 (84), 133 (34), 
105 (16), 77 (12).  
HR-MS (ESI) m/z calcd for C16H21O4, [M+H]









n-Butyl 2-(5-methoxy-6-hydroxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47ta):  
The representative procedure B was followed using vanillic acid (21t) (168 mg, 1.00 mmol, 1.0 equiv) 
and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by column chromatography 
(n-hexane/EtOAc: 1/1 + 1% MeOH) yielded 47ta (164 mg, 0.56 mmol, 56%) as colorless solid.  
M. p. = 118–120 °C.  
1H-NMR (300 MHz, CDCl3): δ = 7.30 (s, 1H), 6.97 (d, J = 0.8 Hz, 1H), 6.27 (s, 1H), 5.76 (ddd, J = 7.0, 
6.2, 0.8 Hz, 1H), 4.16 (t, J = 6.7 Hz, 2H), 3.98 (s, 3H), 2.94–2.75 (m, 2H), 1.70–1.54 (m, 2H),           
1.45–1.30 (m, 2H), 0.94 (t, J = 7.3 Hz, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 170.3 (Cq), 169.6 (Cq), 152.0 (Cq), 148.2 (Cq), 144.0 (Cq), 117.7 (Cq), 
107.4 (CH), 106.3 (CH), 76.6 (CH), 65.3 (CH2), 56.6 (CH3), 39.8 (CH2), 30.7 (CH2), 19.2 (CH2), 13.8 
(CH3).  
IR (ATR): 3300, 2961, 2927, 2874, 1737, 1707, 1600, 1498, 1062, 1043 cm–1. 
MS (EI) m/z (relative intensity): 294 (16) [M]+, 238 (36), 195 (42), 193 (61), 192 (100), 179 (70), 
164 (10), 151 (27).  
HR-MS (ESI) m/z calcd for C15H19O6, [M+H]








n-Butyl 2-(5-acetyl-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47ua):  
The representative procedure B was followed using 3-acetylbenzoic acid (21u) (180 mg, 1.00 mmol, 
1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 1/1 + 1% MeOH) yielded 47ua (244 mg, 0.84 mmol, 84%) as a 
colorless oil.  
1H-NMR (300 MHz, CDCl3): δ = 8.37 (s, 1H), 8.26 (d, J = 8.1 Hz, 1H), 7.60 (d, J = 8.1 Hz, 1H), 5.88 
(t, J = 6.4 Hz, 1H), 4.09 (t, J = 6.7 Hz, 2H), 2.92 (dd, J = 6.4, 1.9 Hz, 2H), 2.62 (s, 3H), 1.63–1.45 (m, 
2H), 1.39–1.19 (m, 2H), 0.86 (t, J = 7.3 Hz, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 196.3 (Cq), 169.0 (Cq), 169.0 (Cq), 152.9 (Cq), 138.6 (Cq), 133.9 (CH), 
126.8 (Cq), 126.0 (CH), 122.8 (CH), 77.1 (CH), 65.3 (CH2), 39.0 (CH2), 30.5 (CH2), 26.8 (CH3), 19.0 
(CH2), 13.6 (CH3).  
IR (ATR): 2961, 1772, 1734, 1690, 1345, 1397, 1288, 1181, 1075, 605 cm–1. 
MS (EI) m/z (relative intensity): 290 (10) [M]+, 275 (15), 234 (100), 189 (70), 175 (95), 147 (20), 119 
(10), 43 (35).  
HR-MS (EI) m/z calcd for C16H18O5, [M]









n-Butyl-2-(5,6,7-trimethoxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47va):  
The representative procedure B was followed using 3,4,5-trimethoxybenzoic-acid (21v) (212 mg, 
1.00 mmol, 1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by 
column chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47va (326 mg, 0.96 mmol, 96%) 
as a colorless oil.  
1H-NMR (300 MHz, CDCl3): δ = 7.12 (s, 1H), 5.82 (dd, J = 8.6, 3.4 Hz, 1H), 4.12 (t, J = 6.7 Hz, 2H), 
3.99 (s, 3H), 3.93 (s, 3H), 3.91 (s, 3H), 3.20 (dd, J = 16.3, 3.4 Hz, 1H), 2.64 (dd, J = 16.3, 8.6 Hz, 1H), 
1.65–1.54 (m, 2H), 1.45–1.26 (m, 2H), 0.92 (t, J = 7.5 Hz, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 169.9 (Cq), 169.5 (Cq), 156.2 (Cq), 147.6 (Cq), 146.8 (Cq), 133.9 (Cq), 
121.5 (Cq), 102.7 (CH), 75.9 (CH), 65.2 (CH2), 61.3 (CH3), 61.1 (CH3), 56.6 (CH3), 38.6 (CH2), 30.7 
(CH2), 19.2 (CH2), 13.8 (CH3).  
IR (ATR): 2958, 2874, 1765, 1733, 1477, 1420, 1339, 1170, 1104, 765 cm–1. 
MS (EI) m/z (relative intensity): 338 (42) [M]+, 282 (24), 237 (78), 236 (100), 223 (100), 195 (24), 
180 (16), 165 (16).  
HR-MS (ESI) m/z calcd for C17H23O7, [M+H]








The representative procedure B was followed using 4-dimethylaminobenzoic acid (21w) (165 mg, 
1.00 mmol, 1.0 equiv) and n-butyl acrylate (45a) (192 mg, 1.50 mmol, 1.5 equiv). Purification by 
column chromatography (n-hexane/EtOAc: 1/1 + 1% MeOH) yielded 47wa (169 mg, 0.59 mmol, 59%) 
as a colorless oil and 48waa (60 mg, 0.14 mmol, 14%) as a yellow oil. 
n-Butyl-2-(6-dimethylamino-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47wa):  
1H-NMR (300 MHz, CDCl3): δ = 7.69 (d, J = 8.7 Hz, 1H), 6.76 (dd, J = 8.7, 2.3 Hz, 1H), 6.54 (d, 
J = 2.3 Hz, 1H), 5.73 (t, J = 6.2 Hz, 1H), 4.16 (t, J = 6.7 Hz, 2H), 3.08 (s, 6H), 2.94–2.75 (m, 2H), 
1.67–1.52 (m, 2H), 1.41–1.25 (m, 2H), 0.93 (t, J = 7.4 Hz, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 170.5 (Cq), 169.9 (Cq), 154.6 (Cq), 151.9 (Cq), 127.0 (CH), 113.2 
(CH), 112.5 (Cq), 102.6 (CH), 76.3 (CH), 65.2 (CH2), 40.5 (CH3), 40.2 (CH2), 30.7 (CH2), 19.2 (CH2), 
13.8 (CH3).  
IR (ATR): 2958, 1730, 1606, 1517, 1368, 1321, 1167, 1003, 691, 608 cm–1. 
MS (EI) m/z (relative intensity): 291 (100) [M]+, 235 (25), 180 (70), 176 (100), 162 (10), 148 (40), 
119 (15), 77 (10).  
HR-MS (EI) m/z calcd for C16H21NO4, [M]
+ 291.1471, found 291.1479.  
n-Butyl-3-(1-(2-n-butoxy-2-oxoethyl)-6-(dimethylamino)-3-oxo-1,3-dihydroisobenzofuran-4-
yl)acrylate (48waa): 
1H-NMR (300 MHz, CDCl3): δ = 8.54 (d, J = 16.4 Hz, 1H), 6.89 (d, J = 2.2 Hz, 1H), 6.59 (d, 
J = 16.6 Hz, 1H), 6.59–6.51 (m, 1H), 5.68 (dd, J = 6.8, 6.8 Hz, 1H), 4.20 (t, J = 6.7 Hz, 2H), 4.13 (t, 
J = 6.7 Hz, 2H), 3.09 (s, 6H), 2.84 (dd, J = 6.6, 2.6 Hz, 2H), 1.76–1.55 (m, 4H), 1.50–1.25 (m, 4H), 




13C-NMR (75 MHz, CDCl3): δ = 169.8 (Cq), 169.5 (Cq), 166.6 (Cq), 154.2 (Cq), 152.5 (Cq), 139.0 
(CH), 135.6 (Cq), 122.3 (CH), 110.4 (Cq), 110.0 (CH), 104.1 (CH), 75.6 (CH), 65.2 (CH2), 64.7 (CH2), 
40.5 (CH3), 40.1 (CH2), 30.8 (CH2), 30.7 (CH2), 19.3 (CH2), 19.2 (CH2), 13.8 (CH3), 13.8 (CH3). 
IR (ATR): 2957, 1731, 1604, 1518, 1368, 1230, 1168, 1003, 819, 691 cm–1. 
MS (EI) m/z (relative intensity): 417 (100) [M]+, 344 (15), 316 (35), 242 (85), 214 (30), 200 (20), 174 
(10), 115 (5).  
HR-MS (EI) m/z calcd for C23H31NO6, [M]
+ 417.2151, found 417.2150.  
 
 
Methyl-2-(4-methyl-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47ab):  
a) The representative procedure A was followed using 2-methylbenzoic acid (21a) (136 mg, 
1.00 mmol, 1.0 equiv) and methyl acrylate (45b) (129 mg, 1.50 mmol, 1.5 equiv). Purification by 
column chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ab (159 mg, 0.72 mmol, 72%) 
as colorless solid.  
b) The representative procedure B was followed using 2-methylbenzoic acid (21a) (136 mg, 
1.00 mmol, 1.0 equiv) and methyl acrylate (45b) (129 mg, 1.50 mmol, 1.5 equiv). Purification by 
column chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ab (135 mg, 0.61 mmol, 61%) 
as colorless solid.  
M. p. = 89–90 °C. 
1H-NMR (300 MHz, CDCl3): δ = 7.53 (dd, J = 7.6, 7.6 Hz, 1H), 7.32–7.25 (m, 2H), 5.82 (t, J = 6.6 Hz, 
1H), 3.77 (s, 3H), 2.87 (d, J = 6.6 Hz, 2H), 2.69 (s, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 170.1 (Cq), 170.0 (Cq), 149.3 (Cq), 140.1 (Cq), 134.1 (CH), 131.3 




IR (ATR): 2952, 1757, 1732, 1600, 1441, 1400. 1199, 1086, 1007, 687 cm–1. 
MS (EI) m/z (relative intensity): 220 (20) [M]+, 160 (100), 147 (90), 132 (37), 119 (38), 91 (39), 65 (16), 
58 (38).  
HR-MS (ESI) m/z calcd for C12H13O4, [M+H]
+ 221.0808, found 221.0810. 
The spectral data are in accordance with those reported in the literature.[127] 
 
 
Ethyl-2-(4-methyl-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47ac):  
a) The representative procedure A was followed using 2-methylbenzoic acid (21a) (136 mg, 
1.00 mmol, 1.0 equiv) and ethyl acrylate (45c) (150 mg, 1.50 mmol, 1.5 equiv). Purification by 
column chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ac (145 mg, 0.62 mmol, 62%) 
as colorless solid.  
b) The representative procedure B was followed using 2-methylbenzoic acid (21a) (136 mg, 
1.00 mmol, 1.0 equiv) and ethyl acrylate (45c) (150 mg, 1.50 mmol, 1.5 equiv). Purification by 
column chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ac (195 mg, 0.83 mmol, 83%) 
as colorless solid.  
M. p. = 50–52 °C.  
1H-NMR (300 MHz, CDCl3): δ = 7.53 (dd, J = 7.6, 7.6 Hz, 1H), 7.31–7.25 (m, 2H), 5.81 (t, J = 6.6 Hz, 
1H), 4.22 (q, J = 7.1 Hz, 2H), 2.86 (d, J = 6.6 Hz, 2H), 2.69 (s, 3H), 1.27 (t, J = 7.1 Hz, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 170.2 (Cq), 169.5 (Cq), 149.4 (Cq), 140.1 (Cq), 134.1 (CH), 131.3 
(CH), 123.6 (Cq), 119.4 (CH), 76.2 (CH), 61.4 (CH2), 40.0 (CH2), 17.5 (CH3), 14.3 (CH3).  




MS (EI) m/z (relative intensity): 234 (18) [M]+, 160 (100), 147 (87), 132 (32), 119 (31), 91 (31), 65 (13), 
43 (25).  
HR-MS (ESI) m/z calcd for C13H15O4, [M+H]
+ 235.0965, found 235.0967. 
The spectral data are in accordance with those reported in the literature.[41g] 
 
 
Benzyl-2-(4-methyl-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47ad):  
a) The representative procedure A was followed using 2-methylbenzoic acid (21a) (136 mg, 
1.00 mmol, 1.0 equiv) and benzyl acrylate (45d) (243 mg, 1.50 mmol, 1.5 equiv). Purification by 
column chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ad (205 mg, 0.69 mmol, 69%) 
as a 7:1 mixture with 47aa. 
b) The representative procedure B was followed using 2-methylbenzoic acid (21a) (136 mg, 
1.00 mmol, 1.0 equiv) and benzyl acrylate (45d) (243 mg, 1.50 mmol, 1.5 equiv). Purification by 
column chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ad (204 mg, 0.69 mmol, 69%) 
as colorless solid. 
c) The representative procedure B was followed using 2-methylbenzoic acid (21a) (0.63 g, 5.00 mmol, 
1.0 equiv) and benzyl acrylate (45d) (1.22 g, 7.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ad (1.37 g, 4.60 mmol, 92%) as 
colorless solid. 
M. p. = 58–61 °C.  
1H-NMR (300 MHz, CDCl3): δ = 7.49 (dd, J = 7.6, 7.6 Hz, 1H), 7.36 (m, 5H), 7.29–7.25 (m, 1H), 7.20 




13C-NMR (75 MHz, CDCl3): δ = 170.1 (Cq), 169.3 (Cq), 149.3 (Cq), 140.1 (Cq), 135.4 (Cq), 134.1 (CH), 
131.3 (CH), 128.8 (CH), 128.6 (CH), 128.6 (CH), 123.5 (Cq), 119.4 (CH), 76.1 (CH), 67.2 (CH2), 39.9 
(CH2), 17.5 (CH3).  
IR (ATR): 3037, 2944, 1745, 1599, 1478, 1386, 1311, 1291, 1203, 1002 cm–1. 
MS (EI) m/z (relative intensity): 296 (15) [M]+, 205 (54), 162 (71), 147 (55), 119 (40), 91 (100), 77 (11), 
65 (23).  
HR-MS (EI) m/z calcd for C18H16O4, [M]
+ 296.1049, found 296.1054. 
 
 
t-Butyl-2-(4-methyl-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47ae):  
The representative procedure B was followed using 2-methylbenzoic acid (21a) (136 mg, 1.00 mmol, 
1.0 equiv) and tert-butyl acrylate (45e) (192 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ae (178 mg, 0.68 mmol, 68%) as 
colorless solid.  
M. p. = 74–75 °C.  
1H-NMR (300 MHz, CDCl3): δ = 7.52 (dd, J = 7.6, 7.6 Hz, 1H), 7.30–7.26 (m, 2H), 5.76 (t, J = 6.4 Hz, 
1H), 2.81 (d, J = 6.4 Hz, 2H), 2.69 (s, 3H), 1.44 (s, 9H).  
13C-NMR (75 MHz, CDCl3): δ = 170.3 (Cq), 168.7 (Cq), 149.7 (Cq), 140.0 (Cq), 134.0 (CH), 131.1 
(CH), 123.7 (Cq), 119.4 (CH), 82.0 (Cq), 76.5 (CH), 41.0 (CH2), 28.2 (CH3), 17.5 (CH3).  
IR (ATR): 2980, 2929, 1740, 1598, 1478, 1049, 1003, 908, 828, 794 cm–1. 





HR-MS (ESI) m/z calcd for C15H19O4, [M+H]
+ 263.1278, found 263.1279. 
 
 
2-Ethylhexyl-2-(4-methyl-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47af):  
The representative procedure B was followed using 2-methylbenzoic acid (21a) (136 mg, 1.00 mmol, 
1.0 equiv) and 2-ethylhexyl acrylate (45f) (276 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47af (196 mg, 0.61 mmol, 61%) as 
colorless solid.  
M. p. = 42–44 °C.  
1H-NMR (300 MHz, CDCl3): δ = 7.52 (dd, J = 7.6, 7.6 Hz, 1H), 7.33–7.22 (m, 2H), 5.81 (t, J = 6.6 Hz, 
1H), 4.08 (m, 2H), 2.88 (m, 2H), 2.69 (s, 3H), 1.63–1.51 (m, 1H), 1.43–1.22 (m, 8H), 0.93–0.85 (m, 
6H).  
13C-NMR (75 MHz, CDCl3): δ = 170.2 (Cq), 169.7 (Cq), 149.5 (Cq), 140.1 (Cq), 134.1 (CH), 131.3 
(CH), 123.6 (Cq), 119.4 (CH), 76.2 (CH), 67.8 (CH2), 39.9 (CH2), 38.8 (CH), 30.5 (CH2), 29.0 (CH2), 
23.8 (CH2), 23.1 (CH2), 17.5 (CH3), 14.2 (CH3), 11.1 (CH3).  
IR (ATR): 2957, 2928, 2860, 1743, 1601, 1461, 1399, 1202, 1049, 1001 cm–1. 
MS (EI) m/z (relative intensity): 318 (1) [M]+, 206 (100), 161 (52), 147 (90), 119 (18), 91 (20), 71 (12), 
57 (19).  
HR-MS (ESI) m/z calcd for C19H27O4, [M+H]







2-Methoxyethyl-2-(4-methyl-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47ag):  
The representative procedure B was followed using 2-methylbenzoic acid (21a) (136 mg, 1.00 mmol, 
1.0 equiv) and 2-methoxyethyl acrylate (45g) (195 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ag (224 mg, 0.85 mmol, 85%) as a 
colorless oil.  
1H-NMR (300 MHz, CDCl3): δ = 7.53 (dd, J = 7.6, 7.6 Hz, 1H), 7.29 (m, 2H), 5.82 (t, J = 6.6 Hz, 1H), 
4.37–4.27 (m, 2H), 3.66–3.56 (m, 2H), 3.39 (s, 3H), 2.92 (dd, J = 6.6, 1.6 Hz, 2H), 2.69 (s, 3H).  
13C-NMR (126 MHz, CDCl3): δ = 170.2 (Cq), 169.5 (Cq), 149.4 (Cq), 140.1 (Cq), 134.1 (CH), 131.3 
(CH), 123.6 (Cq), 119.5 (CH), 76.1 (CH) 70.4 (CH2), 64.3 (CH2), 59.2 (CH3), 39.9 (CH2), 17.5 (CH3).  
IR (ATR): 2927, 1753, 1733, 1382, 1238, 1127, 1045, 1005, 787, 687 cm–1. 
MS (EI) m/z (relative intensity): 264 (16) [M]+, 160 (76), 147 (100), 132 (21), 119 (23), 91 (27), 58 (19), 
45 (17).  
HR-MS (ESI) m/z calcd for C14H17O5, [M+H]
+ 265.1071, found 265.1071. 
 
 
(Tetrahydrofuran-2-yl)methyl-2-(4-methyl-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47ah):  
The representative procedure B was followed using 2-methylbenzoic acid (21a) (136 mg, 1.00 mmol, 




column chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ah (237 mg, 0.82 mmol, 82%) 
as a colorless oil. 
1H-NMR (300 MHz, CDCl3): δ = 7.53 (dd, J = 7.6, 7.6 Hz, 1H), 7.29 (m, 2H), 5.83 (t, J = 6.7 Hz, 1H), 
4.29–4.21 (m, 1H), 4.18–4.06 (m, 2H), 3.93–3.75 (m, 2H), 2.92 (d, J = 6.7 Hz, 2H), 2.69 (s, 3H),    
2.10–1.85 (m, 3H), 1.68–1.55 (m, 1H).  
13C-NMR (126 MHz, CDCl3): δ = 170.0 (Cq), 169.3 (Cq), 149.2 (Cq), 140.0 (Cq), 134.0 (CH), 131.2 
(CH), 123.5 (Cq), 119.4 (CH), 76.5 (CH), 76.1 (CH), 68.6 (CH2), 67.3 (CH2), 40.0 (CH2), 28.2 (CH2), 
25.9 (CH2), 17.6 (CH3).  
IR (ATR): 2953, 2872, 1753, 1734, 1380, 1167, 1005, 787, 687, 472 cm–1. 
MS (EI) m/z (relative intensity): 290 (4) [M]+, 247 (13), 220 (20), 207 (18), 162 (15), 147 (46), 84 (26), 
71 (100).  
HR-MS (ESI) m/z calcd for C16H19O5, [M+H]
+ 291.1227, found 291.1228. 
 
 
4-(Fluorobenzyl)-2-(4-methyl-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47ai):  
The representative procedure B was followed using 2-methylbenzoic acid (21a) (136 mg, 1.00 mmol, 
1.0 equiv) and 4-fluorobenzyl acrylate (45i) (249 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 1/1 + 5% NEt3) yielded 47ai (277 mg, 0.92 mmol, 92%) as a 
colorless oil.  
1H-NMR (300 MHz, CDCl3): δ = 7.49 (dd, J = 7.6, 7.6 Hz, 1H), 7.38–7.25 (m, 3H), 7.20 (d, J = 7.6 Hz, 
1H), 7.05 (dd, J = 8.8, 8.8 Hz, 2H), 5.81 (t, J = 6.5 Hz, 1H), 5.15 (m, 2H), 2.91 (d, J = 6.5 Hz, 2H), 




13C-NMR (75 MHz, CDCl3): δ = 170.1 (Cq), 169.2 (Cq), 162.9 (d, 
1JC-F = 247.4 Hz, Cq), 149.2 (Cq), 
140.2 (Cq), 134.1 (CH), 131.3 (CH), 131.3 (Cq), 130.6 (d, 
3JC-F = 8.3 Hz, CH), 123.5 (Cq), 119.3 (CH), 
115.7 (d, 2JC-F = 21.5 Hz, CH), 76.0 (CH), 66.4 (CH2), 39.9 (CH2), 17.5 (CH3). 
19F-NMR (282 MHz, CDCl3): δ = -113.18.  
IR (ATR): 2959, 2924, 1602, 1482, 1385, 1289, 1090, 1046, 787, 687 cm–1. 
MS (EI) m/z (relative intensity): 314 (26) [M]+, 205 (52), 162 (68), 147 (53), 119 (42), 109 (100), 
91 (28), 83 (16).  
HR-MS (EI) m/z calcd for C18H15FO4, [M]




yl)acetate (47aj):  
The representative procedure B was followed using 2-methylbenzoic acid (21a) (136 mg, 1.00 mmol, 
1.0 equiv) and R-(-)-menthyl acrylate (45j) (316 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47aj (238 mg, 0.69 mmol, 69%) as 
colorless solid. The product was observed as a 57:43 mixture of two diastereomers.[128]  
M. p. = 81–84 °C.  
1H-NMR (300 MHz, CDCl3): δ = 7.52 (dd, J = 7.6, 7.6 Hz, 1H), 7.31–7.27 (m, 2H), 5.80 (m, 1H), 4.76 
(m, 1H), 2.97–2.78 (m, 2H), 2.69 (s, 3H), 2.06–1.62 (m, 4H), 1.58–1.25 (m, 2H), 1.11–0.83 (m, 9H), 




13C-NMR (75 MHz, CDCl3): δ = 170.2 (Cq), 169.1 (Cq), 149.4 (Cq), 140.0 (Cq), 134.0 (CH), 131.2 
(CH), 119.4 (CH), 100.2 (Cq), 76.3 (CH), 75.5 (CH), 47.1 (CH), 40.9 (CH2), 40.1 (CH2), 34.3 (CH2), 
31.6 (CH), 26.4 (CH), 23.5 (CH2), 22.1 (CH3), 20.9 (CH3), 17.5 (CH3), 16.4 (CH3).  
IR (ATR): 2938, 2864, 1751, 1725, 1601, 1481, 1288, 1199, 1175, 688 cm–1. 
MS (EI) m/z (relative intensity): 344 (1) [M]+, 206 (70), 189 (16), 161 (18), 147 (100), 138 (21), 
123 (14), 95 (33).  
HR-MS (ESI) m/z calcd for C21H29O4, [M+H]
+ 345.2060, found 345.2057. 
 
Pent-4-en-1-yl-2-(4-methyl-3-oxo-1,3-dihydroisobenzofuran-1-yl)acetate (47ak):  
The representative procedure B was followed using 2-methylbenzoic acid (21a) (136 mg, 1.00 mmol, 
1.0 equiv) and pent-4-en-1-yl acrylate (45k) (210 mg, 1.50 mmol, 1.5 equiv). Purification by column 
chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47ak (169 mg, 0.62 mmol, 62%) as a 
colorless oil.  
1H-NMR (300 MHz, CDCl3): δ = 7.53 (dd, J = 7.6, 7.6 Hz, 1H), 7.34–7.22 (m, 2H), 5.87–5.70 (m, 
2H), 5.08–4.96 (m, 2H), 4.17 (t, J = 6.5 Hz, 2H), 2.87 (d, J = 6.5 Hz, 2H), 2.69 (s, 3H) 2.11 (m, 2H), 
1.74 (m, 2H).  
13C-NMR (75 MHz, CDCl3): δ = 170.2 (Cq), 169.5 (Cq), 149.4 (Cq), 140.1 (Cq), 137.4 (CH), 134.1 
(CH), 131.3 (CH), 123.6 (Cq), 119.4 (CH), 115.6 (CH2), 76.2 (CH), 64.8 (CH2), 39.9 (CH2), 30.1 (CH2), 
27.8 (CH2), 17.5 (CH3).  
IR (ATR): 3078, 2927, 1755, 1731, 1601, 1237, 1046, 912, 687, 630 cm–1. 
MS (EI) m/z (relative intensity): 274 (3) [M]+, 207 (40), 189 (11), 160 (24), 147 (100), 119 (19), 91 (26), 
68 (46).  
HR-MS (ESI) m/z calcd for C16H19O4, [M+H]




5.3.1.2 Kinetic and Mechanistic Studies 
O2-Uptake study for the synthesis of phthalide 3aa 
 
2-Methylbenzoic acid (21a) (136 mg, 1.00 mmol, 1.0 equiv), [RuCl2(p-cymene)]2 (30) (30.6 mg, 
0.05 mmol, 5.0 mol %) and KOAc (108 mg, 1.10 mmol, 1.1 equiv) were placed in a pre-dried 25 mL 
Schlenk-flask. The flask was evacuated and refilled with ambient oxygen 3 times. n-Butyl acrylate 
(45a) (192 mg, 1.50 mmol, 1.5 equiv) and HOAc (60.0 mg, 1.00 mmol, 1.0 equiv) in O2 saturated 
GVL (77) (1.0 mL) were added. The Schlenk-tube was connected to a burette with a reservoir filled 
with O2 saturated water. The mixture was stirred at 80 °C and the changes in volume were determined 
as shown in (Figure 16, Table 36). Purification by column chromatography (n-hexane/EtOAc: 4/1 + 
5% NEt3) yielded 47aa (229 mg, 0.87 mmol, 87%) as a colorless oil. 

























Table 36: Data of the oxygen uptake study. 
t [min] V [mL] ∆V [mL] n [mmol] t [min] V [mL] ∆V [mL] n [mmol] 
0 23.2 0.00 0.00 65 14.2 9.0 0.36885 
2 22.6 0.6 0.02459 95 13.5 9.7 0.39754 
5 22.0 1.2 0.04918 108 13.3 9.9 0.40574 
8 21.5 1.7 0.06967 134 13.2 10.0 0.40984 
10 19.9 3.3 0.13525 150 13.0 10.2 0.41803 
16 18.3 4.9 0.20082 180 12.7 10.5 0.43033 
23 17.6 5.6 0.22951 215 12.4 10.8 0.44262 
29 16.2 7.0 0.28689 257 12.0 11.2 0.45902 
35 15.6 7.6 0.31148 308 11.5 11.7 0.47951 
41 15.1 8.1 0.33197 366 11.3 11.9 0.4877 
46 14.8 8.4 0.34426 1344 10.0 13.2 0.54098 






Benzoic acid depending kinetic isotope effect measurment in γ-valerolactone (77) 
 
Two independent reactions of n-butyl acrylate (45a) with 2-methylbenzoic acids 21a and [D1]-21a 
respectively were performed to determine the KIE value by comparison of the initial rates.  
The representative procedure B was followed using 21a (136 mg, 1.00 mmol) or [D1]-21a (137 mg, 
1.00 mmol), acrylate 45a (192 mg, 1.00 mmol), [RuCl2(p-cymene)]2 (30) (30.6 mg, 0.05mmol), 
n-dodecane (100 mg), HOAc (60.0 mg, 1.00 mmol) and KOAc (98.0 mg, 1.00 mmol) in GVL (77) 
(2.0 mL) under an ambient atmosphere of O2. The mixture was stirred at 80 °C, an aliquot (10 μL) was 














 = 0.97 ± 0.06 
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 = 0.33 ± 0.01 
 
Figure 17: Graphical representation of the benzoic acid depending kinetic isotope effect 
measurement in γ-valerolactone (77). 
 
Table 37: Data of the benzoic acid depending kinetic isotope effect measurement in γ-valerolactone 
(77). 
time Product formation with 21a [%] Product formation with [D3]-21a [%] 
10 6.22905 6.08418 
15 7.31185 6.57329 
20 8.81117 8.73404 
25 10.27729 10.34562 
30 11.52389 12.28783 
40 15.02926 14.90412 
50 18.57822 18.60369 







Benzoic acid depending kinetic isotope effect measurment with addidition of HOAc in n-butanol 
 
Two independent reactions of n-butyl acrylate (45a) with 2-methylbenzoic acids 21a and [D1]-21a 
respectively were performed to determine the KIE value by comparison of the initial rates.  
The representative procedure A was followed using 21a (136 mg, 1.00 mmol) or [D1]-21a (137 mg, 
1.00 mmol), acrylate 45a (192 mg, 1.00 mmol), [RuCl2(p-cymene)]2 (30) (30.6 mg, 0.05 mmol), 
n-dodecane (100 mg), HOAc (60.0 mg, 1.00 mmol) and KOAc (98.0 mg, 1.00 mmol) in n-butanol 
(2.0 mL) under an ambient atmosphere of O2. The mixture was stirred at 80 °C, an aliquot (10 μL) was 







































 = 2.59 ± 0.5 
m
D
 = 0.21 ± 0.02 
 
Figure 18: Graphical representation of the benzoic acid depending kinetic isotope effect 
measurement in n-butanol. 
 
Table 38: Data of the benzoic acid depending kinetic isotope effect measurement in n-butanol. 
time Product formation with 21a [%] Product formation with [D3]-21a [%] 
5 3.60468 1.42328 
10 6.36762 1.62497 
15 9.43342 3.74658 
20 12.70033 4.54636 
25 15.33569 5.50538 
30 16.96373 6.43273 
40 21.07747 8.04151 







Acrylate depending kinetic isotope effect measurment in γ-valerolactone (77) 
 
Two indendendent reactions of 2-methylbenzoic acid (21a) with benzyl acrylate (45d) and [D3]-benzyl 
acrylate ([D3]-45d) respectively were performed to determine the KIE value by comparison of the 
initial rates.  
The representative procedure B was followed using 21a (136 mg, 1.00 mmol) and benzyl acrylate 45d 
(192 mg, 1.00 mmol) or [D3]-45d (195 mg, 1.00 mmol), [RuCl2(p-cymene)]2 (30.6 mg, 0.05 mmol), 
n-dodecane (100 mg), HOAc (60.0 mg, 1.00 mmol) and KOAc (98.0 mg, 1.00 mmol) in GVL (77) 
(2.0 mL) under an ambient atmosphere of O2. The mixture was stirred at 80 °C, an aliquot (10 μL) was 






















 = 1.14 ± 0.08
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Figure 19: Graphical representation of the acrylate depending kinetic isotope effect measurement. 
 
Table 39: Data of the acrylate depending kinetic isotope effect measurement in γ-valerolactone (77). 
time Product formation with 45a [%] Product formation with [D3]-45a [%] 
5 4.39572 5.45038 
10 8.07793 8.32636 
15 10.71772 11.25543 
20 14.87325 14.51241 
25 18.79746 17.62722 
30 22.04618 21.79044 
40 29.53813 26.88421 








Labelled Oxygen Study 
 
The representative procedure B was followed using 21a (136 mg, 1.00 mmol) and benzyl acrylate 45d 
(192 mg, 1.00 mmol), [RuCl2(p-cymene)]2 (30) (30.6 mg, 0.05 mmol), HOAc (60.0 mg, 1.00 mmol) 
and KOAc (98.0 mg, 1.00 mmol) in GVL (77) (1.0 mL) under an ambient atmosphere of 16O2 or 
18O2. 
Prior to the work-up POCl3 (153 mg, 1.00 mmol) was added and the mixture was stirred for 15 minutes. 
An aliquot (~10 μl) was removed, diluted by a factor of 103 in MeCN and analyzed via ESI-MS. K2CO3 
(138 mg, 1.00 mmol) and 1-iodobutane (184 mg, 1.00 mmol) were added and the reaction solution 
was stirred at 60 °C for 18 h, before the regular work-up procedure was continued. Purification by 
column chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47aa as a colorless oil (Table 40).  
For analysis, the sample solutions were injected into the ESI source of a micrOTOF-Q II mass 
spectrometer (Bruker Daltonik) via a gastight syringe at a flow rate of 5 μL min−1. The ESI source was 
operated with a stainless-steel capillary and with nitrogen as nebulizer gas (typical backing pressure 
of 0.7 bar) and drying gas (typical flow rate of 5 L min−1). Negative-ion mode ESI mass spectra over 
an m/z range of 50-1000 were recorded with an ESI voltage of +3.5 kV and a drying-gas temperature 
of 200 °C (Figure 20). The mass spectrometer was externally calibrated with a mixture of CF3CO2H 
and phosphazenes in H2O/MeCN. The detected ions were identified on the basis of their exact m/z 
ratios and their isotope patterns. For the calculation of theoretical m/z ratios and the simulation of 








Table 40: Labelled oxygen studies 
Entry 16O2/
18O2 [P*]
- [%] [a] H/Na[P*P]- [%] [c] H/Na[P*2]- [%] [c] Yield [%] [c] 
1 16O2 0 0  Not isolated. 
2 18O2 28 38 10 81 
3 18O2 31 39 12 72 
[a] Percentage of [P16O18OCl2]
- in [PO2Cl2]





- [b] Percentage of H/Na[P16O3
18O2Cl2]
- in H/Na[PO4Cl4]
-. P* = [P16O18OCl2], 
P = [P16O2Cl2]. 
 
 
Figure 20: ESI-MS overview spectrum of entry 1. 
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Figure 21: Expansion of the [PO2Cl2]
- region of the measured ESI-MS spectrum (black) and the 
simulation (blue) of entry 1. Simulated for 100% [PO2Cl2]




Figure 22: Expansion of the H[PO2Cl2]2
- region of the measured ESI-MS spectrum (black) and the 




















































Figure 23:ESI-MS overview spectrum of entry 2. 
 
Figure 24: Expansion of the [PO2Cl2]
- region of the measured ESI-MS spectrum (black) and the 
simulation (blue) of entry 2. Simulated for 72% [PO2Cl2]














































Figure 25: Expnsion of the H[PO2Cl2]2
- region of the measured ESI-MS spectrum (black) and the 

























































Figure 27: Expansion of the [PO2Cl2]
- region of the measured ESI-MS spectrum (black) and the 
simulation (blue) of entry 3. Simulated for 69.5% [PO2Cl2]
- and 30.5% [P16O18OCl2]
-. 
 
Figure 28: Expansion of the H[PO2Cl2]2
- region of the measured ESI-MS spectrum (black) and the 



















































5.3.1.3 Synthesis of Reaction Intermediates 
Synthesis of donor stabilized intermediates 100: 
 
[RuCl2(p-cymene)]2 (30) (100 mg, 0.16 mmol, 1.0 equiv) was placed in a pre-dried 25 mL Schlenk-
tube equipped with a rubber septum. The tube was evacuated and refilled with Ar three times. Solvent 
(either CH2Cl2, MeOH or γ-Valerolactone (77), 5.0 mL) was added together with pyridine (26.0 mg, 
0.32 mmol, 2.0 equiv) and stirred for 2 h. 1-Naphthoic acid sodium salt (21r-K) (155 mg, 0.82 mmol, 
5.0 equiv) and triethylamine (0.4 mL) were added and the mixture was stirred for 36 h at 35 °C. All 
volatiles were removed in vacuo and column chromatography (using a solvent gradient from 
CH2Cl2/MeOH: 40/1 to CH2Cl2/MeOH: 20/1) of the crude reaction mixture yielded 100-Py (68.0 mg, 
0.23 mmol, 71% from CH2Cl2, 49.0 mg, 0.16 mmol, 51% from MeOH, 36.0 mg, 12 mmol, 38% from 
γ-valerolactone (77)). 
 M. p. (decomp.) = 147 °C. 
1H-NMR (400 MHz, CDCl3): δ = 9.46 (d, J = 8.7 Hz, 1H), 8.50 (d, J = 5.4 Hz, 2H), 8.19 (d, J = 8.2 Hz, 
1H), 7.67 (d, J = 8.1 Hz, 2H), 7.40–7.27 (m, 2H), 7.23 (ddd, J = 8.3, 6.9, 1.3 Hz, 1H), 6.92–6.86 (m, 
2H), 5.58 (d, J = 5.1 Hz, 1H), 5.49 (d, J = 5.7 Hz, 1H), 5.27 (d, J = 6.0 Hz, 1H), 4.82 (d, J = 5.7 Hz, 
1H), 2.46–2.28 (m, 1H), 1.67 (s, 3H), 0.94 (d, J = 6.9 Hz, 3H), 0.94 (d, J = 6.9 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ = 181.5 (Cq), 180.0 (Cq), 153.6 (CH), 136.7 (CH), 135.8 (CH), 132.7 
(Cq), 131.5 (Cq), 130.4 (Cq), 130.0 (CH), 127.6 (CH), 126.2 (CH), 124.3 (CH), 123.7 (CH), 123.3 (CH), 
102.2 (Cq), 98.4 (Cq), 88.1 (CH), 87.3 (CH), 85.1 (CH), 80.1 (CH), 30.8 (CH), 22.5 (CH3), 22.3 (CH3), 
18.0 (CH3).  
IR (ATR): 3045, 2963, 2211, 1601, 1267, 819, 728 cm–1;  
HR-MS (ESI) m/z calcd for C26H27NO2Ru, [M+H]




The spectral data are in accordance with those reported in the literature.[41d] 
 
 
[RuCl2(p-cymene)]2 (30) (100 mg, 0.16 mmol, 1.0 equiv) and N,N-dimethylaminopyridine (DMAP) 
(39.0 mg, 0.32 mmol, 2.0 equiv) were placed in a pre-dried 25 mL Schlenk-tube equipped with a 
rubber septum. The tube was evacuated and refilled with Ar three times. CH2Cl2 (5 mL) was added 
and stirred for 2 h. 1-Naphthoic acid sodium salt (21r-K) (155 mg, 0.82 mmol, 5.0 equiv) and 
triethylamine (0.4 mL) were added and the mixture was stirred for 36 h at 35 °C. All volatiles were 
removed in vacuo and column chromatography (using a solvent gradient from CH2Cl2/MeOH: 40/1 to 
CH2Cl2/MeOH: 20/1) of the crude reaction mixture yielded 100-DMAP (122 mg, 0.23 mmol, 72%) 
as a yellow solid.  
M. p. (decomp.) = 154 °C. 
1H-NMR (500 MHz, CDCl3): δ = 9.52 (d, J = 8.6 Hz, 1H), 8.20 (d, J = 8.1 Hz, 1H), 7.87 (d, J = 6.2 Hz, 
2H), 7.68 (t, J = 7.3 Hz, 2H), 7.35 (ddd, J = 8.5, 6.7, 1.5 Hz, 1H), 7.21 (ddd, J = 7.9,6.7, 1.1 Hz, 1H), 
5.91 (d, J = 5.6 Hz, 2H), 5.56 (d, J = 5.5 Hz, 1H), 5.46 (d, J = 5.8 Hz, 1H), 5.22 (d, J =5.8 Hz, 1H), 
4.77 (d, J = 5.3 Hz, 1H), 2.70 (s, 6H), 2.36 (hept, J = 6.1 Hz, 1H), 1.72 (s, 3H), 1.00–0.94 (m,6H). 
13C-NMR (125 MHz, CDCl3): δ = 181.5 (Cq), 181.0 (Cq), 153.4 (Cq), 152.1 (CH), 136.1 (CH), 132.7 
(Cq), 131.4 (Cq), 130.5 (Cq), 129.4 (CH), 127.4 (CH), 125.9 (CH), 123.9 (CH), 123.0 (CH), 106.9 (CH), 
101.5 (Cq), 98.1 (Cq), 87.6 (CH), 87.2 (CH), 84.6 (CH), 79.7 (CH), 38.9 (CH3), 30.9 (CH), 22.7 (CH3), 
22.5 (CH3), 18.3 (CH3). 
IR (ATR): 2959, 1613, 1529, 1421, 1382, 1224, 1190, 1136, 811 cm–1. 
HR-MS (ESI) m/z calcd for C28H31N2O2Ru, [M+H]
+ 529.1431, found 529.1428. 




Synthesis of intermediate 101: 
 
[RuCl2(p-cymene)]2 (30) (61.0 mg, 0.10 mmol, 1.0 equiv), 1-naphtoic acid (21r) (34.0 mg, 0.20 mmol, 
2.0 equiv) and potassium acetate (39.0 mg, 0.40 mmol, 4.0 equiv) were placed in a pre-dried 25 mL 
Schlenk-tube equipped with a rubber septum. The tube was evacuated and refilled with Ar three times. 
Solvent (methanol, γ-valerolactone (77) or PhMe, 5.0 mL) was added together with methyl acrylate 
(45b) (17.0 mg, 0.20 mmol, 2.0 equiv) and the mixture was stirred at 60 °C for 36 h. All volatiles were 
removed in vacuo and column chromatography (using a solvent gradient from CH2Cl2/MeOH: 1/0 to 
CH2Cl2/MeOH: 10/1) of the crude reaction mixture yielded 101 (84.0 mg, 0.17 mmol, 85% in 
methanol, 94.0 mg, 0.19 mmol, 96% in γ-valerolactone (77) and 86.0 mg, 0.18 mmol, 87% in PhMe) 
as a yellow solid. 
The reaction was scaled to 0.3 mmol of [RuCl2(p-cymene)]2 (30) in PhMe yielding 101 (299 mg, 0.60 
mmol, >99%). 
M. p. (decomp.) = 160–164 °C. 
1H-NMR (300 MHz, CDCl3): δ = 8.53 (d, J = 7.9 Hz, 1H), 7.70–7.47 (m, 3H), 7.47 (d, J = 8.9 Hz, 1H), 
7.01 (d, J = 9.7 Hz, 1H), 5.26 (dd, J = 5.8, 1.3 Hz, 1H), 4.81 (dd, J = 6.0, 1.3 Hz, 1H), 4.68 (dd, J = 6.0, 
1.3 Hz, 1H), 4.06 (dd, J = 5.8, 1.3 Hz, 1H), 3.76 (s, 3H), 3.54 (dd, J = 15.0, 6.9 Hz, 1H), 3.40 (dd, 
J = 15.0, 7.8 Hz, 1H), 2.39 (dd, J = 7.8, 6.9 Hz, 1H), 2.30 (hept, J = 6.9 Hz, 1H), 1.24 (s, 3H), 1.20 (d, 
J = 6.9 Hz, 3H), 1.18 (d, J = 6.9 Hz, 3H). 
13C-NMR (126 MHz, CDCl3): δ = 172.2 (Cq), 169.3 (Cq), 135.1 (Cq), 132.4 (CH), 131.3 (Cq), 128.5 
(CH), 128.3 (CH), 127.7 (CH), 126.9 (CH), 123.6 (CH), 110.0 (Cq), 99.3 (Cq), 96.8 (Cq), 85.8 (CH), 
85.2 (CH), 83.9 (CH), 83.8 (Cq), 80.6 (CH), 57.3 (CH), 52.3 (CH), 38.8 (CH2), 30.9 (CH3), 23.1 (CH3), 
23.1 (CH3), 16.6 (CH3). 




HR-MS (ESI) m/z calcd for C25H27O4Ru, [M+H]
+ 493.0954, found: 493.0958. 
 
Synthesis of 101 using isotopically labeled acrylates: 
 
[D2]-101 (92.0 mg, 19.0 mmol, 93%) was synthesized according to the previous procedure using 
[D3]-45b. 
HR-MS (ESI) m/z calcd for C25H25O4RuD2, [M+H]
+ 495.1080, found 495.1082.  
 
[D1]-101 (84.0 mg, 17.0 mmol, 84%) was synthesized according to the previous procedure using 
[D2]-45b. 
HR-MS (ESI) m/z calcd for C25H26O4RuD1, [M+H]
 + 494.1017, found 494.1021. 
1H-NMR analysis of [D2]-101 and [D1]-101 indicate a hydrogen exchange with the reaction medium 






Synthesis of intermediate 101 from donor stabilized intermediate 100-Py 
 
100-Py (10.0 mg, 20.6 μmol, 1.0 equiv) was placed in a pre-dried 25 mL Schlenk-tube equipped with 
a rubber septum. The tube was evacuated and refilled with Ar three times and solvent (methanol or γ-
valerolactone (77), 1.0 mL) and methyl acrylate (45b) (2.00 mg, 22.0 μmol, 1.0 equiv) were added. 
The mixture was stirred at 60 °C for 18 h. Column chromatography (using a solvent gradient from 
CH2Cl2/MeOH: 1/0 to CH2Cl2/MeOH: 10/1) of the crude reaction mixture yielded 1011 (8.90 mg, 
18.5 μmol, 90% in methanol, 9.20 mg, 19.2 μmol, 93% in γ-valerolactone (77)). 
 
Attempted hydrogen exchange at 101 
 
101 (44.0 mg, 0.10 mmol, 1.0 equiv) was placed in a pre-dried 25 mL Schlenk-tube equipped with a 
rubber septum. The tube was evacuated and refilled with Ar three times and d3-MeOD (1.0 mL) and 
d4-acetic acid (2.00 mg, 22.0 μmol, 1.0 equiv) were added. The mixture was stirred at 60 °C for 18 h. 
An aliquot (0.1 mL) was removed and analysis by high resolution ESI-MS did not show incorporation 
of deuterium at 101. The solution was heated to 80°C for 18 h and analyzed by high resolution ESI-MS. 





Product release from 101:  
 
101 (50.0 mg, 0.10 mmol, 1.0 equiv) was placed in a pre-dried 25 mL Schlenk-tube equipped with a 
rubber septum. The tube was evacuated and refilled with O2 three times and MeOH (1.0 mL) and acetic 
acid (60.0 mg, 1.00 μmol, 10.0 equiv) were added. The reaction mixture was stirred at 60 °C for 18 h. 
GC and TLC analysis of the reaction mixture just showed traces of product. 
 
 
101 (50.0 mg, 0.10 mmol, 1.0 equiv) was placed in a pre-dried 25 mL Schlenk-tube equipped with a 
rubber septum. The tube was evacuated and refilled with O2 three times and γ-valerolactone (77) 
(0.5 mL) and acetic acid (30.0 mg, 0.50 μmol, 50.0 equiv) were added. The reaction mixture was 
stirred at 80 °C for 18 h. The mixture was diluted with water (10 mL) and extracted with MTBE/n-
hexane (1/1 mixture, 10 mL). The organic phase was washed with water (4∙10 mL) and dried over 
anhydrous sodium sulfate. The solvent was removed and purification by column chromatography 
(n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 47rb (9.30 mg, 0.03 mmol, 30 %) as colorless solid. 




1H-NMR (300 MHz, CDCl3): δ = 9.02–8.97 (m, 1H), 8.15 (dd, J = 8.4, 0.7, 0.7 Hz, 1H), 7.97 (ddd, 
J = 8.1, 1.3, 0.6, 0.6 Hz, 1H), 7.74 (ddd, J = 8.4, 7.0, 1.4 Hz, 1H), 7.64 (ddd, J = 8.2, 6.9, 1.4 Hz, 1H), 
7.52 (dd, J = 8.4, 0.6 Hz, 1H), 5.96 (ddd, J = 6.9, 6.2, 0.5 Hz, 1H), 3.79 (s, 3H), 2.96 (dd, J = 6.7, 0.9 
Hz, 2H). 
13C-NMR (126 MHz, CDCl3): δ = 169.9 (Cq), 169.7 (Cq), 150.2 (Cq), 135.7 (CH), 133.4 (Cq), 129.1 
(CH), 129.1 (Cq), 128.4 (CH), 127.5 (CH), 123.5 (CH), 120.1 (Cq), 118.3 (CH), 76.3 (CH), 52.3 (CH2), 
39.3 (CH3). 
IR (ATR): 2944, 1730, 1578, 1517, 1435, 1328, 1106, 963, 891, 694 cm–1. 
MS (EI) m/z (relative Intensity): 256 (25) [M]+, 242 (5), 196 (100), 183 (35), 168 (10), 155 (30), 
127 (35), 115 (5).  
HR-MS (ESI) m/z calcd forr C15H13O4, [M+H]
+ 257.0808, found 257.0803. 
 
 
101 (19.0 mg, 0.04 mmol, 1.0 equiv) was placed in a pre-dried 25 mL Schlenk-tube equipped with a 
rubber septum. The tube was evacuated and refilled with O2 three times and n-BuOD (0.5 mL) and 
d4-acetic acid (30.0 mg, 0.50 mmol, 12.0 equiv) were added. The reaction mixture was stirred at 80 °C 
for 18 h. The solvent was removed and purification by column chromatography (n-hexane/EtOAc: 4/1 
+ 5% NEt3) yielded [D0.6]-47rb (8.6 mg, 0.29 mmol, 87%). 
HR-MS (ESI) m/z calcd for C15H11O4DNa, [M+Na]
 + 280.0691, found 280.0692; Intensity: 100%.  
HR-MS (ESI) m/z calcd for C15H12O4Na, [M+Na]








5.3.2 Data for the Ruthenium(II) Decarboxylative Alkenylation of Benzoic Acids 
5.3.2.1 Data of Alkenylated Arenes 
 
n-Butyl-(E)-3-(3-methoxyphenyl)acrylate (97ca):  
The general procedure C was followed using 2-methoxybenzoic acid (21c) (456 mg, 3.00 mmol) and 
n-butyl acrylate (45a) (128 mg, 1.00 mmol). Purification by column chromatography 
(n-hexane/EtOAc: 15/1) yielded 97ca (129 mg, 55%) as a colorless oil.  
1H-NMR (500 MHz, CDCl3): δ = 7.71 (d, J = 15.9 Hz, 1H), 7.36 (dd, J = 8.3 Hz, 7.6 Hz, 1H), 7.18 (d, 
J = 7.6 Hz, 1H), 7.11 (dd, J = 1.7 Hz, 1.6 Hz, 1H), 7.00 (ddd, J = 8.3, 1.7, 1.6 Hz, 1H), 6.49 (d, J = 15.9 
Hz, 1H), 4.28 (t, J = 6.7 Hz, 2H), 3.90 (s, 3H), 1.80–1.72 (m, 2H), 1.56–1.46 (m, 2H), 1.03 (t, J = 7.4 
Hz, 3H).  
13C-NMR (126 MHz, CDCl3): δ = 167.2 (Cq), 160.1 (Cq), 144.6 (CH), 136.0 (Cq), 130.0 (CH), 120.9 
(CH), 118.8 (CH), 116.3 (CH), 113.0 (CH), 64.6 (CH2), 55.5 (CH3), 30.9 (CH2), 19.4 (CH2), 13.9 
(CH3).  
IR (ATR): 2959, 2873, 1707, 1637, 1580, 1292, 1164, 1040, 781, 679 cm–1.  
MS (EI) m/z (relative intensity): 234 (40) [M]+, 178 (100), 161 (90), 133 (25), 118 (20), 103 (10), 90 
(15), 77 (15), 63 (10).  
HR-MS (ESI) m/z calcd for C14H19O3, [M+H]
+ 235.1322, found 235.1329.  






Benzyl-(E)-3-(3-methoxyphenyl)acrylate (97cd):  
a) The general procedure C was followed using 2-methoxybenzoic acid (21c) (456 mg, 3.00 mmol) 
and benzyl acrylate (45d) (162 mg, 1.00 mmol). Purification by column chromatography 
(n-hexane/EtOAc: 15/1) yielded 97cd (161 mg, 0.60 mmol, 60%) as a colorless oil.  
b) The general procedure C scaled up by a factor of 5 was followed using 2-methoxybenzoic acid (21c) 
(2.28 g, 15.0 mmol) and benzyl acrylate (45d) (0.81 g, 5.00 mmol). Purification by column 
chromatography (n-hexane/EtOAc: 15/1) yielded 97cd (1.01 g, 3.75 mmol, 75%) as a colorless oil.  
1H-NMR (300 MHz, CDCl3): δ = 7.70 (d, J = 16.0 Hz, 1H), 7.46–7.27 (m, 6H), 7.12 (ddd, J = 7.6, 1.1, 
0.5 Hz, 1H), 7.04 (dd, J = 2.6, 1.6 Hz, 1H), 6.94 (ddd, J = 8.3, 2.6, 1.1 Hz, 1H), 6.48 (d, J = 16.0 Hz, 
1H), 5.26 (s, 2H), 3.83 (s, 3H).  
13C-NMR (126 MHz, CDCl3): δ = 166.8 (Cq), 160.0 (Cq), 145.2 (CH), 136.2 (Cq), 135.9 (Cq), 130.0 
(CH), 128.7 (CH), 128.4 (CH), 128.4 (CH), 121.0 (CH), 118.3 (CH), 116.4 (CH), 113.0 (CH), 66.5 
(CH2), 55.4 (CH3).  
IR (ATR): 3032, 2956, 2835, 1707, 1636, 1228, 1153, 979, 696, 678 cm–1.  
MS (EI) m/z (relative intensity): 268 (35) [M]+, 221 (45), 177 (30), 161 (60), 134 (20), 91 (100), 77 
(20), 65 (20).  
HR-MS (EI) m/z calcd for C17H16O3, [M]






t-Butyl-(E)-3-(3-methoxyphenyl)acrylate (97ce):  
The general procedure C was followed using 2-methoxybenzoic acid (21c) (456 mg, 3.00 mmol) and 
t-butyl acrylate (45e) (128 mg, 1.00 mmol). Purification by column chromatography 
(n-hexane/EtOAc: 10/1) yielded 97ce (135 mg, 58%) as a colorless oil.  
1H-NMR (400 MHz, CDCl3): δ = 7.45 (d, J = 15.9, Hz, 1H), 7.18 (dd, J = 8.2, 7.7 Hz, 1H), 7.00 (ddd, 
J = 7.7, 1.5, 0.9 Hz, 1H), 6.95–6.90 (m, 1H), 6.81 (ddd, J = 8.2, 2.6, 0.9 Hz, 1H), 7.25 (dd, J = 16.0, 
0.4 Hz, 1H), 3.73 (s, 3H), 1.44 (s, 9H).  
13C-NMR (101 MHz, CDCl3): δ = 166.4 (Cq), 160.0 (Cq), 143.6 (CH), 136.2 (Cq), 129.9 (CH), 120.9 
(CH), 120.6 (CH), 116.0 (CH), 112.9 (CH), 80.7 (Cq), 55.4 (CH3), 28.4 (CH3).  
IR (ATR): 2976, 2935, 1703, 1636, 1580, 1143, 1041, 978, 849, 679 cm–1.  
MS (EI) m/z (relative intensity): 234 (30) [M]+, 178 (100), 161 (40), 147 (15), 133 (10), 118 (10), 77 
(10), 57 (25), 43 (25).  
HR-MS (EI) m/z calcd for C14H18O3, [M]
+ 234.1256, found 234.1245.  









2-Methoxyethyl-(E)-3-(3-methoxyphenyl)acrylate (97cg):  
The general procedure C was followed using 2-methoxybenzoic acid (21c) (456 mg, 3.00 mmol) and 
2-methoxyethyl acrylate (45g) (130 mg, 1.00 mmol). Purification by column chromatography 
(n-hexane/EtOAc: 3/1) yielded 97cg (147 mg, 62%) as a colorless oil.  
1H-NMR (400 MHz, CDCl3): δ = 7.68 (d, J = 16.0 Hz, 1H), 7.29 (dd, J = 8.2, 7.7 Hz, 1H), 7.11 (ddd, 
J = 7.7, 1.5, 0.9 Hz, 1H), 7.05–7.03 (m, 1H), 6.93 (ddd, J = 8.2, 2.6, 1.0 Hz, 1H), 6.48 (d, J = 16.0 Hz, 
1H), 4.42–4.25 (m, 2H), 3.82 (s, 3H), 3.71–3.61 (m, 2H), 3.42 (s, 3H).  
13C-NMR (101 MHz, CDCl3): δ = 167.0 (Cq), 160.1 (Cq), 145.2 (CH), 135.9 (Cq), 130.0 (CH), 121.0 
(CH), 118.3 (CH), 116.5 (CH), 113.0 (CH), 70.7 (CH2), 63.7 (CH2), 59.2 (CH3), 55.4 (CH3).  
IR (ATR): 2944, 2837, 1708, 1637, 1246, 1165, 1038, 850, 782, 679 cm–1.  
MS (EI) m/z (relative intensity): 236 (15) [M]+, 178 (85), 161 (100), 133 (30), 118 (25), 90 (15), 77 
(10), 58 (10), 43 (15).  
HR-MS (EI) m/z calcd for C13H16O4, [M]








(Tetrahydrofuran-2-yl)methyl-(E)-3-(3-methoxyphenyl)acrylate (97ch):  
The general procedure C was followed using 2-methoxybenzoic acid (21c) (456 mg, 3.00 mmol) and 
tetrahydrofurfuryl acrylate (45h) (156 mg, 1.00 mmol). Purification by column chromatography 
(n-hexane/EtOAc: 3/1) yielded 97ch (184 mg, 70%) as a colorless oil.  
1H-NMR (400 MHz, CDCl3): δ = 7.68 (d, J = 15.9 Hz, 1H), 7.29 (dd, J = 8.1, 7.7 Hz, 1H), 7.11 (ddd, 
J = 7.5, 1.5, 0.9 Hz, 1H), 7.05–7.03 (m, 1H), 6.93 (ddd, J = 8.2, 2.6, 0.9 Hz, 1H), 6.48 (d, J = 15.9 Hz, 
1H), 4.31 (dd, J = 11.2, 3.3 Hz, 1H), 4.20 (ddd, J = 7.1, 7.0, 3.2 Hz, 1H), 4.13 (dd, J = 11.1, 7.0 Hz, 
1H), 3.93 (ddd, J = 8.3, 7.0, 6.4 Hz, 1H), 3.87–3.78 (m, 1H), 3.83 (s, 3H), 2.10–1.87 (m, 3H),            
1.72–1.61 (m, 1H).  
13C-NMR (101 MHz, CDCl3): δ = 167.0 (Cq), 160.1 (Cq), 145.2 (CH), 136.0 (Cq), 130.0 (CH), 121.0 
(CH), 118.4 (CH), 116.5 (CH), 113.0 (CH), 76.8 (CH), 68.6 (CH2), 66.8 (CH2), 55.5 (CH3), 28.2 (CH2), 
25.9 (CH2).  
IR (ATR): 2949, 2873, 1637, 1579, 1247, 1162, 1025, 855, 782, 679 cm–1.  
MS (EI) m/z (relative intensity): 262 (5) [M]+, 178 (35), 161 (40), 133 (105), 118 (15), 84 (50), 71 
(100), 58 (10), 43 (35).  
HR-MS (EI) m/z calcd for C15H18O4, [M]






Cholesteryl-(E)-3-(3-methoxyphenyl)acrylate (97cl):  
The general procedure C was followed using 2-methoxybenzoic acid (21c) (228 mg, 1.50 mmol) and 
cholesteryl acrylate (45l) (202 mg, 0.50 mmol). Purification by column chromatography 
(n-hexane/EtOAc: 15/1) yielded 97cl (210 mg, 77%) as a white solid.  
M. p. = 119–120 °C.  
1H-NMR (400 MHz, CDCl3): δ = 7.64 (d, J = 16.0 Hz, 1H), 7.34–7.27 (dd, J = 8.0, 7.9 Hz 1H), 7.11 
(ddd, J = 8.1, 1.5, 0.8 Hz, 1H), 7.04 (dd, J = 2.7, 1.5 Hz, 1H), 6.93 (ddd, J = 8.2, 2.6, 1.0 Hz, 1H), 6.41 
(d, J = 15.9 Hz, 1H), 5.41 (d, J = 3.5 Hz, 1H), 4.75 (ddt, J = 14.3, 7.4, 4.3 Hz, 1H), 3.83 (s, 3H),      
2.54–2.28 (m, 2H), 2.06–0.95 (m, 29H), 0.92 (d, J = 6.5 Hz, 3H), 0.87 (dd, J = 6.6, 1.9 Hz, 6H), 0.69 
(s, 3H).  
13C-NMR (101 MHz, CDCl3): δ = 166.5 (Cq), 160.0 (Cq), 144.5 (CH), 139.8 (Cq), 136.0 (Cq), 130.0 
(CH), 122.9 (CH), 120.9 (CH), 119.1 (CH), 116.2 (CH), 112.9 (CH), 74.3 (CH), 56.8 (CH), 56.3 (CH), 
55.4 (CH3), 50.2 (CH), 42.5 (Cq), 39.9 (CH2), 39.7 (CH2), 38.4 (CH2), 37.2 (CH2), 36.8 (Cq), 36.3 
(CH2), 36.0 (CH), 32.1 (CH2), 32.0 (CH), 28.4 (CH2), 28.2 (CH), 28.0 (CH2), 24.4 (CH2), 24.0 (CH2), 
23.0 (CH3), 22.7 (CH3), 21.2 (CH2), 19.5 (CH3), 18.9 (CH3), 12.0 (CH3).  
IR (ATR): 2931, 2864, 1706, 1637, 1578, 1261, 1168, 1001, 736, 455 cm–1.  
MS (EI) m/z (relative intensity): 546 (0.2) [M]+, 386 (0.2), 368 (100), 353 (20), 260 (25), 247 (20), 
213 (15), 161 (40), 147 (30), 43 (30).  
HR-MS (ESI) m/z calcd for C37H54O3Na, [M+Na]
+ 569.3965, found 569.3938.  





Benzyl-(E)-3-(3-ethoxyphenyl)acrylate (97dd):  
The general procedure C was followed using 2-ethoxybenzoic acid (21d) (499 mg, 3.00 mmol) and 
benzyl acrylate (45d) (162 mg, 1.00 mmol). Purification by column chromatography 
(n-hexane/EtOAc: 10/1) yielded 97dd (194 mg, 69%) as a colorless oil.  
1H-NMR (300 MHz, CDCl3): δ = 7.70 (d, J = 16.0 Hz, 1H), 7.48–7.27 (m, 6H), 7.16 (ddd, J = 7.6, 1.5, 
1.5 Hz, 1H), 7.04 (d, J = 2.1 Hz, 1H), 6.92 (ddd, J = 8.3, 2.6, 1.1 Hz, 1H), 6.47 (d, J = 16.1 Hz, 1H), 
5.26 (s, 2H), 4.05 (q, J = 7.0 Hz, 2H), 1.42 (t, J = 7.0 Hz, 3H).  
13C-NMR (75 MHz, CDCl3): δ = 166.9 (Cq), 159.4 (Cq), 145.3 (CH), 136.2 (Cq), 135.8 (Cq), 130.0 
(CH), 128.7 (CH), 128.4 (CH), 128.4 (CH), 120.8 (CH), 118.2 (CH), 117.0 (CH), 113.6 (CH), 66.5 
(CH2), 63.7 (CH2), 14.9 (CH3).  
IR (ATR): 3034, 2980, 2937, 1708, 1636, 1226, 1154, 979, 696, 678 cm–1.  
MS (EI) m/z (relative intensity): 282 (35) [M]+, 236 (20), 191 (15), 163 (30), 147 (30), 91 (100), 65 
(25), 43 (15).  
HR-MS (ESI) m/z calcd for C18H18O3Na, [M+Na]









Benzyl-(E)-3-(3-phenoxyphenyl)acrylate (3xd):  
The general procedure C was followed using 2-phenoxybenzoic acid (21x) (643 mg, 3.00 mmol) and 
benzyl acrylate (45d) (162 mg, 1.00 mmol). Purification by column chromatography 
(n-hexane/EtOAc: 10/1) yielded 97xd (191 mg, 58%) as a white solid.  
M. p. = 54–57 °C.  
1H-NMR (500 MHz, CDCl3): δ = 7.64 (d, J = 16.0 Hz, 1H), 7.41–7.28 (m, 8H), 7.24–7.20 (m, 1H), 
7.16–7.08 (m, 2H), 7.04–6.96 (m, 3H), 6.40 (d, J = 16.0 Hz, 1H), 5.22 (s, 2H).  
13C-NMR (126 MHz, CDCl3): δ = 166.7 (Cq), 158.1 (Cq), 156.8 (Cq), 144.6 (CH), 136.3 (Cq), 136.1 
(Cq), 130.4 (CH), 130.1 (CH), 128.8 (CH), 128.5 (CH), 128.4 (CH), 123.9 (CH), 123.2 (CH), 120.7 
(CH), 119.3 (CH), 118.8 (CH), 117.7 (CH), 66.6 (CH2).  
IR (ATR): 3033, 2970, 1703, 1637, 1487, 1234, 1153, 980, 784, 692 cm–1.  
MS (EI) m/z (relative intensity): 330 (40) [M]+, 284 (25), 223 (30), 199 (20), 165 (15), 131 (15), 91 
(100), 77 (25), 65 (55), 51 (15).  
HR-MS (ESI) m/z calcd for C22H18O3Na, [M+Na]








Benzyl-(E)-3-(3,4-dimethoxyphenyl)acrylate (97yd):  
The general procedure C was followed using 2,3-dimethoxybenzoic acid (21y) (547 mg, 3.00 mmol) 
and benzyl acrylate (45d) (162 mg, 1.00 mmol). Purification by column chromatography 
(n-hexane/EtOAc: 4/1) yielded 97yd (156 mg, 52%) as a colorless oil.  
1H-NMR (500 MHz, CDCl3): δ = 7.67 (d, J = 15.9 Hz, 1H), 7.45–7.31 (m, 5H), 7.10 (dd, J = 8.3, 
2.1 Hz, 1H), 7.05 (d, J = 2.0 Hz, 1H), 6.86 (d, J = 8.3 Hz, 1H), 6.36 (d, J = 15.9 Hz, 1H), 5.25 (s, 2H), 
3.91 (s, 3H), 3.90 (s, 3H).  
13C-NMR (126 MHz, CDCl3): δ = 167.2 (Cq), 151.3 (Cq), 149.3 (Cq), 145.2 (CH), 136.3 (Cq), 128.7 
(CH), 128.4 (CH), 128.4 (CH), 127.5 (Cq), 122.9 (CH), 115.7 (CH), 111.1 (CH), 109.7 (CH), 66.4 
(CH2), 56.1 (CH3), 56.0 (CH3).  
IR (ATR): 2934, 2838, 1703, 1510, 1254, 1136, 845, 806, 733, 696 cm–1.  
MS (EI) m/z (relative intensity): 298 (100) [M]+, 253 (15), 207 (15), 191 (35), 164 (50), 91 (75), 84 
(25), 77 (20), 65 (15), 43 (35).  
HR-MS (EI) m/z calcd for C18H18O4, [M]









Benzyl-(E)-3-(3,5-dimethoxyphenyl)acrylate (97zd):  
The general procedure C was followed using 2,4-dimethoxybenzoic acid (21z) (547 mg, 3.00 mmol) 
and benzyl acrylate (45d) (162 mg, 1.00 mmol). Purification by column chromatography 
(n-hexane/EtOAc: 10/1) yielded 97zd (212 mg, 71%) as a white solid.  
M. p. = 51-53 °C.  
1H-NMR (300 MHz, CDCl3): δ = 7.65 (d, J = 16.0 Hz, 1H), 7.47–7.30 (m, 5H), 6.66 (d, J = 2.3 Hz, 
2H), 6.50 (t, J = 2.3 Hz, 1H), 6.46 (d, J = 16.0 Hz, 1H), 5.25 (s, 2H), 3.81 (s, 6H).  
13C-NMR (126 MHz, CDCl3): δ = 166.6 (Cq), 161.0 (Cq), 145.2 (CH), 136.3 (Cq), 136.1 (Cq), 128.7 
(CH), 128.3 (CH), 128.3 (CH), 118.5 (CH), 106.1 (CH), 102.8 (CH), 66.5 (CH2), 55.6 (CH3).  
IR (ATR): 2838, 1709, 1637, 1589, 1455, 1277, 1043, 1004, 860, 696 cm–1.  
MS (EI) m/z (relative intensity): 298 (80) [M]+, 253 (40), 207 (60), 191 (50), 164 (45), 148 (30), 91 
(100), 77 (20), 65 (20), 43 (15).  
HR-MS (EI) m/z calcd for C18H18O4, [M]









Benzyl-(E)-3-(3,6-dimethoxyphenyl)acrylate (97aad):  
The general procedure C was followed using 2,5-dimethoxybenzoic acid (21aa) (547 mg, 3.00 mmol) 
and benzyl acrylate (45d) (162 mg, 1.00 mmol). Purification by column chromatography 
(n-hexane/EtOAc: 10/1) yielded 97aad (240 mg, 81%) as a colorless oil.  
1H-NMR (400 MHz, CDCl3): δ = 8.02 (d, J = 16.2 Hz, 1H), 7.48–7.30 (m, 5H), 7.04 (d, J = 3.0 Hz, 
1H), 6.91 (dd, J = 8.9, 3.0 Hz, 1H), 6.85 (d, J = 8.9 Hz, 1H), 6.56 (d, J = 16.2 Hz, 1H), 5.26 (s, 2H), 
3.84 (s, 3H), 3.78 (s, 3H).  
13C-NMR (101 MHz, CDCl3): δ = 167.3 (Cq), 153.7 (Cq), 153.1 (Cq), 140.6 (CH), 136.4 (Cq), 128.7 
(CH), 128.4 (CH), 128.3 (CH), 124.1 (Cq), 118.7 (CH), 117.4 (CH), 113.5 (CH), 112.6 (CH), 66.4 
(CH2), 56.2 (CH3), 55.9 (CH3).  
IR (ATR): 2949, 2834, 1709, 1630, 1494, 1217, 1152, 860, 803, 695 cm–1.  
MS (EI) m/z (relative intensity): 298 (80) [M]+, 237 (10), 207 (25), 191 (15), 176 (20), 148 (15), 91 
(100), 77 (20), 65 (15), 51 (10).  
HR-MS (EI) m/z calcd for C18H18O4, [M]








Cholesteryl-(E)-3-(3,6-dimethoxyphenyl)acrylate (97aal):  
The general procedure C was followed using 2,5-dimethoxybenzoic acid (21aa) (273 mg, 1.50 mmol) 
and cholesteryl acrylate (45l) (202 mg, 0.50 mmol). Purification by column chromatography 
(n-hexane/EtOAc: 10/1) yielded 97aal (280 mg, 97%) as a viscous oil.  
1H-NMR (300 MHz, CDCl3): δ = 7.93 (dd, J = 16.1, 0.5 Hz, 1H), 7.02 (d, J = 2.9 Hz, 1H), 6.88 (dd, 
J = 9.0, 2.9 Hz, 1H), 6.82 (d, J = 9.0 Hz, 1H), 6.46 (d, J = 16.1 Hz, 1H), 5.40–5.35 (d, J = 5.1 Hz, 1H), 
4.85–4.61 (m, 1H), 3.82 (s, 3H), 3.77 (s, 3H), 2.41–2.36 (d, J = 8.0 Hz, 2H), 2.09–0.97 (m, 29H), 0.90 
(d, J = 6.5 Hz, 3H), 0.85 (dd, J = 6.6, 1.4 Hz, 6H), 0.67 (s, 3H).  
13C-NMR (101 MHz, CDCl3): δ = 166.9 (Cq), 153.6 (Cq), 153.0 (Cq), 139.9 (Cq), 139.7 (CH), 124.2 
(Cq), 122.8 (CH), 119.6 (CH), 117.2 (CH), 113.4 (CH), 112.6 (CH), 74.1 (CH), 56.9 (CH), 56.3 (CH), 
56.2 (CH3), 55.9 (CH3), 50.2 (CH), 42.5 (Cq), 39.9 (CH2), 39.7 (CH2), 38.4 (CH2), 37.2 (CH2), 36.8 
(Cq), 36.4 (CH2), 36.0 (CH), 32.1 (CH2), 32.1 (CH), 28.4 (CH2), 28.2 (CH), 28.1 (CH2), 24.5 (CH2), 
24.0 (CH2), 23.0 (CH3), 22.7 (CH3), 21.2 (CH2), 19.5 (CH3), 18.9 (CH3), 12.0 (CH3).  
IR (ATR): 2935, 2867, 1706, 1630, 1495, 1254, 1219, 1163, 1027, 800 cm–1.  
MS (EI) m/z (relative intensity): 577 (0.6) [M]+, 368 (30), 353 (10), 208 (100), 191 (15), 147 (10), 105 
(10), 81 (10), 55 (10), 43 (20). 
HR-MS (ESI) m/z calcd for C38H56O4Na, [M+Na]






Benzyl-(E)-3-(3,5,6-trimethoxyphenyl)acrylate (97abd):  
The general procedure C was followed using 2,4,5-trimethoxybenzoic acid (21ab) (637 mg, 
3.00 mmol) and benzyl acrylate (45d) (162 mg, 1.00 mmol). Purification by column chromatography 
(n-hexane/EtOAc: 4/1 + 5% NEt3) yielded 97abd (247 mg, 75%) as a colorless oil.  
1H-NMR (400 MHz, CDCl3): δ = 8.03 (dd, J = 16.1, 0.6 Hz, 1H), 7.49–7.30 (m, 5H), 6.59 (d, 
J = 2.8 Hz, 1H), 6.54 (d, J = 2.8 Hz, 1H), 6.51 (d, J = 16.1 Hz, 1H), 5.26 (s, 2H), 3.85 (s, 3H), 3.80 (s, 
3H), 3.79 (s, 3H).  
13C-NMR (101 MHz, CDCl3): δ = 167.0 (Cq), 156.2 (Cq), 154.0 (Cq), 143.2 (Cq), 140.1 (CH), 136.3 
(Cq), 128.7 (CH), 128.4 (CH), 128.4 (CH), 128.4 (Cq), 119.3 (CH), 102.9 (CH), 101.0 (CH), 66.4 
(CH2), 61.8 (CH3), 56.0 (CH3), 55.7 (CH3).  
IR (ATR): 2940, 2837, 1710, 1632, 1585, 1279, 1152, 1054, 738, 696 cm–1.  
MS (EI) m/z (relative intensity): 328 (55) [M]+, 237 (30), 206 (25), 178 (10), 135 (10), 91 (100), 77 
(5), 65 (10), 43 (5).  
HR-MS (EI) m/z calcd for C19H20O5, [M]










Benzyl-(E)-3-(2-chloro-5-methoxyphenyl)acrylate (97acd):  
The general procedure C was followed using 5-chloro-2-methoxybenzoic acid (21ac) (279 mg, 
1.50 mmol) and benzyl acrylate (45d) (81 mg, 0.50 mmol) at 100 °C. Purification by column 
chromatography (n-hexane/EtOAc: 15/1) yielded 97acd (122 mg, 81%) as a colorless oil.  
1H-NMR (500 MHz, CDCl3): δ = 8.10 (d, J = 16.0 Hz, 1H), 7.45–7.33 (m, 5H), 7.31 (d, J = 8.8 Hz, 
1H), 7.10 (d, J = 3.0 Hz, 1H), 6.87 (dd, J = 8.8, 3.0 Hz, 1H), 6.46 (d, J = 16.0 Hz, 1H), 5.27 (s, 2H), 
3.81 (s, 3H).  
13C-NMR (126 MHz, CDCl3): δ = 166.4 (Cq), 158.5 (Cq), 141.2 (CH), 136.0 (Cq), 133.3 (Cq), 131.0 
(CH), 128.8 (CH), 128.4 (CH), 128.4 (CH), 126.8 (Cq), 120.7 (CH), 117.7 (CH), 112.2 (CH), 66.7 
(CH2), 55.7 (CH3).  
IR (ATR): 2940, 2836, 1711, 1467, 1288, 1266, 1227, 1159, 695, 451 cm–1.  
MS (EI) m/z (relative intensity): 302 (10) [M]+, 267 (20), 195 (15), 161 (10), 132 (10), 91 (100), 84 
(15), 77 (10), 65 (10), 43 (35).  
HR-MS (EI) m/z calcd for C17H15ClO3, [M]









Benzyl-(E)-3-(2-bromo-5-methoxyphenyl)acrylate (97add):  
The general procedure C was followed using 5-bromo-2-methoxybenzoic acid (21ad) (346 mg, 
1.50 mmol) and benzyl acrylate (45d) (81 mg, 0.50 mmol) at 100 °C. Purification by column 
chromatography (n-hexane/EtOAc: 15/1) yielded 97add (138 mg, 83%) as a colorless oil.  
1H-NMR (500 MHz, CDCl3): δ = 8.04 (d, J = 15.9 Hz, 1H), 7.47 (d, J = 8.8 Hz, 1H), 7.44–7.30 (m, 
5H), 7.08 (d, J = 3.1 Hz, 1H), 6.79 (dd, J = 8.8, 3.1 Hz, 1H), 6.40 (d, J = 15.8 Hz, 1H), 5.25 (s, 2H), 
3.79 (s, 3H).  
13C-NMR (126 MHz, CDCl3): δ = 166.3 (Cq), 159.1 (Cq), 143.8 (CH), 136.1 (Cq), 135.2 (Cq), 134.2 
(CH), 128.8 (CH), 128.5 (CH), 128.4 (CH), 120.9 (CH), 118.0 (CH), 116.2 (Cq), 112.6 (CH), 66.7 
(CH2), 55.7 (CH3).  
IR (ATR): 3031, 2937, 2836, 1710, 1463, 1287, 1225, 1159, 601, 448 cm–1.  
MS (EI) m/z (relative intensity): 348 (10) [M(81Br)+], 346 (10) [M(79Br)+], 267 (20), 239 (5), 221 (10), 
160 (15), 132 (10), 117 (5), 91 (100).  
HR-MS (ESI) m/z calcd for C17H15
79BrO3Na, [M+Na]










Benzyl-(E)-3-(2-bromo-5-methoxyphenyl)acrylate (97aed):  
The general procedure A was followed using 2-methoxy-3-naphtoic acid (21ae) (477 mg, 1.50 mmol) 
and benzyl acrylate (45d) (81 mg, 0.50 mmol). Purification by column chromatography 
(n-hexane/EtOAc: 15/1) yielded 97aed (83 mg, 52%) as a yellow solid.  
M. p. = 60-63 °C.  
1H-NMR (300 MHz, CDCl3): δ = 8.52 (dd, J = 15.7, 0.6 Hz, 1H), 8.09 (d, J = 8.2 Hz, 1H), 7.84–7.73 
(m, 1H), 7.55–7.30 (m, 8H), 7.21 (d, J = 2.7 Hz, 1H), 6.57 (d, J = 15.7 Hz, 1H), 5.32 (s, 2H), 3.94 (s, 
3H).  
13C-NMR (126 MHz, CDCl3): δ = 166.5 (Cq), 156.9 (Cq), 141.8 (CH), 136.1 (Cq), 135.2 (Cq), 133.4 
(Cq), 128.7 (CH), 128.4 (CH), 128.3 (CH), 127.6 (CH), 127.2 (Cq), 126.8 (CH), 124.6 (CH), 123.4 
(CH), 121.1 (CH), 117.4 (CH), 108.8 (CH), 66.6 (CH2), 55.6 (CH3).  
IR (ATR): 2940, 2829, 1708, 1628, 1304, 1167, 855, 730, 695, 431 cm–1.  
MS (EI) m/z (relative intensity): 318 (100) [M]+, 273 (10), 227 (45), 183 (55), 168 (40), 139 (40), 91 
(100), 77 (15), 65 (15), 58 (10), 43 (25).  
HR-MS (EI) m/z calcd for C21H18O3, [M]




5.3.2.2 Additional Studies for the Decarboxylative Alkenylation of Benzoic Acids 
Kinetic Isotope Effect Measurement: 
 
Two parallel reactions of benzyl acrylate (45d) with 2-methoxybenzoic acid (21c) or [D1]-21c were 
performed to determine the KIE value by comparison of the initial rates for the formation of 97cd. The 
kinetic data was determined by 1H-NMR spectroscopy of the crude reation mixtures using ethyl 
benzene as an internal standard. 
2-Methoxybenzoic acid (21c) (228 mg, 1.50 mmol) or [D1]-21c (230 mg, 1.50 mmol), 
[Ru(O2CMes)2(p-cymene)] (99) (28.1 mg, 0.05 mmol, 10.0 mol %) and V2O5 (91.0 mg, 0.50 mmol, 
1.0 equiv) were placed in a pre-dried Schlenk-tube. The tubes were evacuated and refilled with Argon 
three times. PhMe (3.0 mL), benzyl acrylate (45d) (81.1 mg, 0.50 mmol) and ethyl benzene (53.1 mg, 
0.5 mmol) were added. The reaction mixtures were heated to 120 °C and aliquots (~0.05 mL) were 
removed every 5 min. The aliquots were filtered over a short pad of silica (eluent: CDCl3) and analyzed 
by 1H-NMR spectroscopy. The product formation was determined by the comparison of the intensities 
of the methoxy-group signal of 97cd and the aliphatic CH3-group of ethyl benzene in the 
1H-NMR 
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Figure 29: Graphical representation of the kinetic isotope effect measurement for the 
decarboxylative alkenylation. 
 
Table 41: Data for the kinetic isotope effect measurement for the decarboxylative alkenylation. 
Time [min] Product formation with 21a [%] Product formation with [D1]-21a [%] 
5 0.9 0.2 
10 3.0 0.3 
15 6.5 1.5 
20 8.6 3.0 
25 10.6 3.8 
30 12.0 4.0 
35 13.3 5.3 









2,5-Dimethoxybenzoic acid (21α) (405 mg, 2.25 mmol) and [Ru(O2CMes)2(p-cymene)] (99) (42 mg, 
0.075 mmol, 10 mol %) were placed in a pre-dried 10 mL Schlenk-tube and connected over a three-
way-cock to a burette with a reservoir filled with CO2-saturated water. The flask was evacuated and 
refilled with Argon three times, while the three-way-cock was closed. PhMe (3.0 mL) was added and 
the reaction mixture was heated to 100 °C, while the three-way-cock connects the flask and the burrette. 
After the gas equilibrium was reached, the three-way-cock was shortly opened to the atmosphere to 
remove unneeded gas volume and tare the water level of the burette. Then benzyl acrylate (45d) 
(122 mg, 0.75 mmol, 1.0 equiv) was added to the reaction mixture and the changes in the volume were 
recorded (Figure 30, Table 42). After 18 h the reaction was stopped by removal of the solvent in vacuo. 































Table 42: CO2-Evolution study for the decarboxylative alkenylation. 
Time [min] Volume[mL] Time [min] Volume [mL] 
1 0.0 43 5.7 
2 0.3 52 6.2 
3 0.7 58 6.6 
4 1.2 71 7.1 
6 1.8 77 7.3 
8 2.2 92 7.9 
11 2.5 100 8.1 
14 3.0 112 8.5 
16 3.4 128 8.9 
19 3.7 152 9.4 
23 4.2 167 9.7 
26 4.3 183 10.1 
30 4.9 226 11.1 
33 5.1 257 11.2 






5.3.2.3 Studies for the Decarboxylative Alkylation of Benzoic Acids 
Kinetic Isotope Effect Measurement: 
 
Two parallel reactions of N-benzyl maleimide (103a) with 2-fluorobenzoic acid (21af) or [D1]-21af 
were performed to determine the KIE value by comparison of the initial rates for the formation of 
104afa. The kinetic data was determined by 19F-NMR spectroscopy of the crude reation mixtures using 
2-fluoronaphtalene as an internal standard. The 19F-NMR spectroscopic data was further confirmed 
GC measurement. 
2-Fluorobenzoic acid (21ζ) (70 mg, 0.50 mmol) or [D1]-21af (71 mg, 0.50 mmol), N-benzyl 
maleimide (103a) (45 mg, 0.25 mmol), 2-fluoronaphthalene (73 mg, 0.50 mmol) and 
[Ru(O2CMes)2(p-cymene)] (99) (14.1 mg, 0.03 mmol, 10.0 mol %) were placed in a pre-dried 
Schlenk-tube. The reaction tubes were evacuated and backfilled with Ar three times. Toluene-d8 
(2.0 mL) was added, the reaction mixtures were heated to 110 °C and aliquots (~0.05 mL) were 
removed periodically. The aliquots were filtered over a short pad of silica (eluent: CDCl3) and analyzed 
by 19F-NMR spectroscopy. The product formation was determined, as shown in Figure 31, Table 43, 
by the comparison of the intensities of the product signal of 104afa and the 2-flouronaphtalene signal 
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Figure 31: Graphical representation of the kinetic isotope effect measurement by 19F-NMR. 
 
Table 43: Data for the kinetic isotope effect measurement by 19F-NMR. 
t / min Product formation with 21af [%] Product formation with [D1]- 21af [%] 
10 1.87 - 
15 2.24 1.34 
20 2.68 1.63 
26 3.02 2.03 
35 3.61 2.45 
45 4.16 3.06 







CO2-Evolution Study:  
 
2-Fluorobenzoic acid (21af) (280 mg, 2.0 mmol, 2.0 equiv), N-benzyl maleimide (103a) (187 mg, 
1.0 mmol, 1.0 equiv) and [Ru(O2CMes)2(p-cymene)] (99) (56 mg, 0.1 mmol, 10 mol %) were placed 
in a pre-dried 10 mL Schlenk-tube and connected over a three-way-cock to a burette with a reservoir 
filled with CO2-saturated water. The flask was evacuated and backfilled with Ar three times. The three-
way-cock was adjusted to connect the reaction flask and the burrette, the reaction flask was heated to 
110 °C and PhMe (4.0 mL, CO2 saturated, 105 °C) was added. The three-way-cock was opened shortly 
to the atmosphere to remove unneeded gas volume and tare the water level and the changes in the 
volume were recorded (Figure 32, Table 44). After 24 h the reaction mixture was poured into saturated 
NaHCO3 solution and extracted with CH2Cl2 (3∙20 mL). The combined organic layers were washed 
with brine (20 mL) and dried over anhydrous NaSO4. Purification by column chromatography on silica 
gel (n-hexane/EtOAc: 4/1) yielded 104afa (223 mg, 79%) as a colorless oil. 



























Table 44: Data for the CO2-evolution study for the decarboxylatove alkylation. 
t / min V / mL t / min V / mL 
0 0.0 73 6.4 
2.5 1.1 80 6.9 
5 1.6 83 7.0 
7.5 2.0 110 8.4 
10 2.3 122 8.7 
12.5 2.5 155 10 
15 2.8 175 10.7 
17.5 2.9 190 11.1 
20 3.1 217 11.9 
25 3.3 240 12.4 
29 3.5 267 13.2 
34 3.8 302 14.1 
41 4.4 326 14.6 
46 4.6 360 15.0 
50 4.9 469 16.3 
57 5.4 504 16.6 








Decarboxylative Alkylation with Labeled Benzoic Acids: 
 
2-Fluoro-deuterobenzoic acid (21af-D) (70 mg, 0.50 mmol, 2.0 equiv), N-benzyl maleimide (45a) 
(45 mg, 0.25 mmol, 1.0 equiv) and [Ru(O2CMes)2(p-cymene)] (99) (14.0 mg, 0.025 mmol, 10 mol %) 
were placed in a pre-dried pressure tube equipped with a rubber septum. The tube was evacuated and 
filled with N2 or Ar three times, and then PhMe (1.0 mL) was added. The rubber septum was replaced 
by the pressure tube screw cap and the reaction mixture was stirred in a preheated oil bath at 110 °C 
for 24 h. At ambient temperature, all volatiles were removed in vacuo and saturated aq. NaHCO3 
solution (55 mL) was added. The resulting mixture was extracted with CH2Cl2 (3∙45 mL). The 
combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Column 
chromatography on silica gel (n-hexane/EtOAc: 4/1) and further purification by GPC yielded 
[Dn]-104afa (44mg, 62%) as a colorless oil. The deuterium incorporation was determined by 
1H-NMR 
spectroscopy, showing 45% deuterium in D1-position, 38% in the D2-position and 28%/7% in D3/D3‘-
position.  
HR-MS (ESI): m/z calcd for C17H14FNO2 [M+H]
+ 284.1081, found 284.1080. Intensity: 60%. 
m/z calcd for C17H13FNO2D1 [M+H]
+ 285.1144, found 285.1140. Intensity: 100%. 
m/z calcd for C17H12FNO2D2 [M+H]
+ 286.1207, found 285.1196. Intensity: 72%. 
m/z calcd for C17H11FNO2D3 [M+H]







2-Fluoro-6-deuterobenzoic acid ([D1]-21af) (70 mg, 0.50 mmol, 2.0 equiv), N-benzyl maleimide (45a) 
(45 mg, 0.25 mmol), and [Ru(O2CMes)2(p-cymene)] (99) (14.0 mg, 0.025 mmol, 10 mol %) were 
placed in a pre-dried pressure tube equipped with a rubber septum. The tube was evacuated and filled 
with N2 or Ar three times and then PhMe (1.0 mL) was added. The rubber septum was replaced by the 
pressure tube screw cap and the reaction mixture was stirred in a preheated oil bath at 110 °C for 24 h. 
At ambient temperature, all volatiles were removed in vacuo and saturated aq. NaHCO3 solution (55 
mL) was added. The resulting mixture was extracted with CH2Cl2 (3 × 45 mL). The combined organic 
layers were dried over Na2SO4, filtered and concentrated in vacuo. Column chromatography on silica 




colorless oil. The deuterium incorporation was determined by 1H -NMR spectroscopy, giving 35% 
deuterium in D1-Position, 30% in the D2-position and 20% in D3-position. 
HR-MS (ESI): m/z calcd for C17H14FNO2 [M+H]
+ 284.1081, found 284.1077. Intensity: 71% 
m/z calcd for C17H13FNO2D1 [M+H]
+ 285.1144, found 285.1135. Intensity: 100%. 
m/z calcd for C17H12FNO2D2 [M+H]
+ 286.1207, found 285.1170. Intensity: 57%. 
m/z calcd for C17H11FNO2D3 [M+H]






5.3.3 Data for the Ruthenium(II)-Catalyzed Deuteration of Acrylic Esters 
5.3.3.1 Data of Deuterium Labeled Compounds 
 
[D3]-Methyl acrylate ([D3]-45b):  
a) The general procedure E was followed using methyl acrylate (45b) (86.1 mg, 1.00 mmol). After the 
reaction was finished, EtOAc (36.0 mg, 0.41 mmol) was added as the internal standard.  
NMR conversion vs. internal standard: >95%. 
Degree of Deuteration: D1 = 95%; D2 = 95%; D3 = 95%. 
1H-NMR (500 MHz, C6D6): δ = 6.37–6.35 (m, 0.05H), 6.11–6.08 (m, 0.05H), 5.81–5.77 (m, 0.05H), 
3.73 (s, 3H).  
2H-NMR (77 MHz, C6D6): δ = 6.41 (s, 1D), 6.14 (s, 1D), 5.84 (s, 1D).
  
13C-NMR (126 MHz, C6D6): δ = 166.8 (Cq), 130.16 (p, J = 24.6 Hz, CD2), 127.83 (t, J = 25.3 Hz, CD), 
51.7 (CH3). 
[D3]-45b was not detectable via ESI-MS. 
b) [RuCl2(p-cymene)]2 (30) (67.6 mg, 0.11 mmol, 0.2 mol %), m-CF3-benzoic acid (104.9 mg, 
0.55 mmol, 1.0 mol %) and potassium m-CF3-benzoate (125.9 mg, 0.55 mmol, 1.0 mol %) were 
placed in a pre-dried 25 mL Schlenk-tube equipped with a rubber septum. The tube was evacuated and 
refilled with Ar three times. Methyl acrylate (45b) (4.75 g, 55.0 mmol, 1.0 equiv) was added and the 
mixture was stirred for 5 min, before D2O (4.5 mL, 248.0 mmol, 4.5 equiv) was added and the mixture 
was heated to 80°C for 18 h. At ambient temperature a second Schlenk-tube was connected, cooled 
with liquid N2 and passive vacuum (100–300 mbar) was applied until deuterated methyl acrylate was 
condensed to the second flask (4.31 g, 48.4 mmol, 88%). 





[D3]-Ethyl acrylate ([D3]-45c):  
The general procedure E was followed using ethyl acrylate (45c) (100 mg, 1.00 mmol) After the 
reaction was finished, CH2Cl2 (19.7 mg, 0.23 mmol) was added as the internal standard. 
NMR conversion vs. internal standard: >95%. 
Degree of Deuteration: D1 = 96%; D2 = 96%; D3 = 96%. 
1H-NMR (500 MHz, C6D6): δ = 6.30–6.24 (m, 0.04H), 5.99–5.94 (m, 0.04H), 5.26–5.22 (m, 0.04H), 
3.96 (q, J = 7.1 Hz, 1H), 0.93 (t, J = 7.2 Hz, 1H).  
2H-NMR (77 MHz, C6D6): δ = 6.27 (s, 1D), 5.95 (s, 1D), 5.23 (s, 1D).  
13C-NMR (126 MHz, C6D6): δ = 165.7 (Cq), 129.27 (p, J = 24.8 Hz, CD2), 128.43 (t, J = 25.1 Hz, CD), 
60.2 (CH2), 14.1 (CH3). 
[D3]-2c was not detectable via ESI-MS. 
 
 
[D3]-Benzyl acrylate ([D3]-45d):  
The general procedure D was followed using benzyl acrylate (45d) (162 mg, 1.00 mmol). After the 
reaction was finished, C6F5H (16.8 mg, 0.10 mmol) was added as the internal standard. 
NMR conversion vs. internal standard: 90%. 




1H NMR (500 MHz, Chloroform-d): δ = 7.43 – 7.30 (m, 5H), 6.50 – 6.35 (m, 0.04 H), 6.23 – 6.15 (m, 
0.04 H), 5.88 – 5.82 (m, 0.04 H), 5.22 (s, 2H).  
2H NMR (77 MHz, Chloroform-d): δ = 6.50 (s, 1D), 6.22 (s, 1D), 5.89 (s, 1D).  
13C NMR (126 MHz, Chloroform-d): δ = 166.1 (Cq), 135.9(Cq), 130.5 (p, J = 24.6 Hz, CD2), 128.6 
(CH), 128.3 (CH), 128.3 (CH), 127.9 (t, J = 24.5 Hz, CD), 66.4 (CH2). 
HR-MS (ESI) m/z calcd for C10H7O2D3Na, [M+Na]
 + 188.0761, found 188.0765; Intensity: 100% 
HR-MS (ESI) m/z calcd for C10H8O2D2Na, [M+Na]
+ 187.0699, found 187.0703; Intensity: 10%.[129] 
 
 
[D3]-2-Methoxyethyl acrylate ([D3]-45g):  
The general procedure D was followed using 2-methoxyethyl acrylate (45g) (130 mg, 1.00 mmol). 
After the reaction was finished, C6F5H (22.8 mg, 0.14 mmol) was added as the internal standard. 
NMR conversion vs. internal standard: 75%. 
Degree of Deuteration: D1 = 95%; D2 = 95%; D3 = 95%. 
1H-NMR (500 MHz, CDCl3): δ = 6.47–6.34 (m, 0.05H), 6.18–6.09 (m, 0.05H), 5.87–5.75 (m, 0.05H), 
4.38–4.22 (m, 2H), 3.69–3.56 (m, 2H), 3.38 (s, 3H).  
2H-NMR (77 MHz, CDCl3): δ = 6.44 (s, 1D), 6.18 (s, 1D), 5.85 (s, 1D).
  
13C-NMR (126 MHz, CDCl3) δ = 166.3 (Cq), 130.5 (p, J = 24.6 Hz, CD2), 127.8 (t, J = 25.3 Hz, CD), 
70.5 (CH2), 63.7 (CH2), 59.1 (CH3). 
HR-MS (ESI) m/z calcd for C6H7O3D3Na, [M+Na]
 + 156.0710, found 156.0709; Intensity: 100%. 
HR-MS (ESI) m/z calcd for C6H8O3D2Na, [M+Na]





[D3]-Tetrahydrofurfuryl acrylate ([D3]-45h):  
The general procedure D was followed using tetrahydrofurfuryl acrylate (45h) (156 mg, 1.00 mmol). 
After the reaction was finished, C6F5H (17.0 mg, 0.10 mmol) was added as the internal standard. 
NMR conversion vs. internal standard: 91%. 
Degree of Deuteration: D1 = 95%; D2 = 95%; D3 = 94%. 
1H-NMR (500 MHz, CDCl3): δ = 6.41–6.37 (m, 0.05H), 6.15–6.10 (m, 0.06H), 5.83–5.78 (m, 0.05H), 
4.22 (dd, J = 11.3, 3.5 Hz, 1H), 4.15 (qd, J = 7.0, 3.5 Hz, 1H), 4.07 (dd, J = 11.3, 6.8 Hz, 1H), 3.88 
(dt, J = 8.3, 6.7 Hz, 1H), 3.79 (ddd, J = 8.3, 7.3, 6.1 Hz, 1H), 2.00 (dddd, J = 12.1, 8.4, 7.0, 5.3 Hz, 
1H), 1.94–1.83 (m, 2H), 1.61 (ddt, J = 12.1, 8.4, 7.1 Hz, 1H).  
2H-NMR (77 MHz, CDCl3): δ = 6.44 (s, 1D), 6.18 (s, 1D), 5.85 (s, 1D).  
13C-NMR (126 MHz, CDCl3): δ = 166.3 (Cq), 130.5 (p, J = 24.6 Hz, CD2), 127.8 (t, J = 25.2 Hz, CD), 
76.6 (CH), 68.6 (CH2), 66.6 (CH2), 28.1 (CH2), 25.8 (CH2). 
HR-MS (ESI) m/z calcd for C8H9O3D3Na, [M+Na]
 + 182.0867, found 182.0869; Intensity: 100%. 
HR-MS (ESI) m/z calcd for C8H10O3D2Na, [M+Na]









[D3]-(-)-Menthyl acrylate ([D3]- 45j):  
The general procedure D was followed using (-)-menthyl acrylate (45a) (201 mg, 1.00 mmol). After 
the reaction was finished, C6F5H (20.3 mg, 0.12 mmol) was added as the internal standard. 
NMR conversion vs. internal standard: >95%. 
Degree of Deuteration: D1 = 98%; D2 = 98%; D3 = 98%. 
1H-NMR (500 MHz, CDCl3): δ = 6.36–6.34 (m, 0.02H), 6.11–6.06 (m, 0.02H), 5.80–5.76 (m, 0.02H), 
4.76 (td, J = 10.9, 4.5 Hz, 1H), 2.05–1.99 (m, 1H), 1.87 (pd, J = 7.0, 2.7 Hz, 1H), 1.72–1.64 (m, 2H), 
1.56–1.45 (m, 1H), 1.41 (ddt, J = 12.4, 10.8, 3.3 Hz, 1H), 1.04 (dtd, J = 36.7, 12.6, 10.4 Hz, 3H), 0.89 
(t, J = 7.0 Hz, 6H), 0.76 (d, J = 7.0 Hz, 3H).  
2H-NMR (77 MHz, CDCl3): δ = 6.30 (s, 1D), 6.06 (s, 1D), 5.73 (s, 1D). 
13C-NMR (126 MHz, CDCl3): δ = 166.0 (Cq), 129.7 (p, J = 24.4 Hz, CD2), 128.70 (t, J = 25.1 Hz, CD), 
74.4 (CH), 47.2 (CH), 41.0 (CH2), 34.4 (CH2), 31.5 (CH), 26.5 (CH), 23.7 (CH2), 22.2 (CH3), 20.9 
(CH3), 16.6 (CH3). 
HR-MS (ESI) m/z calcd for C13H19O2D3Na, [M+Na]
 + 236.1700, found 236.1700; Intensity: 100%. 
HR-MS (ESI) m/z calcd for C13H20O2D2Na, [M+Na]








[D3]-Pent-4-enyl acrylate ([D3]-45k):  
The general procedure E was followed using pent-4-enyl acrylate (45k) (193 mg, 1.00 mmol). After 
the reaction was finished, CH2Cl2 (21.1 mg, 0.25 mmol) was added as the internal standard. 
NMR conversion vs. internal standard: >95%. 
Degree of Deuteration: D1 = 96%; D2 = 96%; D3 = 96%. 
1H-NMR (500 MHz, C6D6): δ = 6.29–6.25 (m, 0.04H), 5.98–5.95 (m, 0.04H), 5.66–5.54 (m, 1H), 5.28–
5.20 (m, 0.04H), 5.00–4.83 (m, 2H), 3.99 (t, J = 6.7 Hz, 2H), 1.87 (tdt, J = 7.9, 6.7, 1.4 Hz, 2H), 1.46 
(ddt, J = 8.4, 7.5, 6.7 Hz, 2H). 
2H-NMR (77 MHz, C6D6): δ = 6.26 (s, 1D), 5.95 (s, 1D, partly overlayered by C6D6 spinning side-
band), 5.25 (s, 1D). 
13C-NMR (126 MHz, C6D6): δ = 165.8 (Cq), 137.7 (CH), 129.4 (p, J = 24.5 Hz, CD2), 128.1 (t, J = 24.4 
Hz, CD, overlapped by C6D6 signal), 115.3 (CH2), 63.9 (CH2), 30.3 (CH2), 28.1 (CH2). 
HR-MS (ESI) m/z calcd for C8H9O2D4Na, [M+Na]
 + 167.0981, found 167.0963; Intensity: 20%. 
HR-MS (ESI) m/z calcd for C8H9O2D3Na, [M+Na]
 + 166.0918, found 166.0913; Intensity: 100%. 
HR-MS (ESI) m/z calcd for C8H10O2D2Na, [M+Na]






[D3]-Cholesteryl acrylate ([D3]-45l):  
The general procedure E was followed using cholesteryl acrylate (45l) (440 mg, 1.00 mmol). After the 
reaction was finished, CH2Cl2 (19.9 mg, 0.24 mmol) was added as the internal standard. 
NMR conversion vs. internal standard: >95%. 
Degree of Deuteration: D1 = 99%; D2 = 99%; D3 = 98%. 
1H-NMR (500 MHz, C6D6): δ = 7.08–6.97 (m, 0.01H), 6.36–6.30 (m, 0.02H), 6.09–6.00 (m, 0.01H), 
5.36–5.29 (m, 1H), 4.86 (tt, J = 11.4, 4.9 Hz, 1H), 2.46 (ddd, J = 13.2, 5.1, 2.3 Hz, 1H), 2.38 (ddt, 
J = 13.4, 10.1, 2.3 Hz, 1H), 1.99 (dt, J = 12.5, 3.5 Hz, 1H), 1.93–1.78 (m, 3H), 1.69–0.85 (m, 23H), 
0.99 (d, J = 6.7 Hz, 3H), 0.93 (d, J = 1.7 Hz, 3H), 0.91 (d, J = 1.7 Hz, 6H), 0.65 (s, 3H).  
2H-NMR (77 MHz, C6D6): δ = 6.95 (s, 1D, partly overlayered by C6D6 spinning side-band), 6.32 (s, 
1D), 6.02 (s, 1D).  
13C-NMR (126 MHz, C6D6): δ =  165.2 (Cq), 139.8 (Cq), 129.01 (t, J = 24.6 Hz, CD), 128.41–127.70 
(m, CD2, overlapped by C6D6 signal), 123.0 (CH), 74.2 (CH), 57.0 (CH), 56.6 (CH), 50.4 (CH), 42.6 
(Cq), 40.2 (CH2), 40.0 (CH2), 38.7 (CH2), 37.3 (CH2), 36.9 (Cq), 36.7 (CH2), 36.3 (CH), 32.3 (CH2), 
32.2 (CH), 28.7 (CH2), 28.5 (CH), 28.3 (CH2), 24.7 (CH2), 24.5 (CH2), 23.1 (CH3), 22.9 (CH3), 21.4 
(CH2), 19.5 (CH3), 19.1 (CH3), 12.2 (CH3). 
HR-MS (ESI) m/z calcd for C30H45O2D3Na, [M+Na]
 + 466.3765, found 466.3718; Intensity: 100%. 
HR-MS (ESI) m/z calcd for C30H46O2D2Na, [M+Na]






[D3]-2,2,2-Trifluoroethyl acrylate ([D3]-45m):  
The general procedure D was followed using 2,2,2-trifluoroethyl acrylate (45m) (154 mg, 1.00 mmol). 
After the reaction was finished, CH2Cl2 (27.1 mg, 0.32 mmol) was added as the internal standard. 
NMR conversion vs. internal standard: >95%. 
Degree of Deuteration: D1 = 96%; D2 = 96%; D3 = 94%. 
1H-NMR (500 MHz, CDCl3): δ = 6.52–6.49 (m, 0.04H), 6.19–6.16 (m, 0.06H), 5.97–5.95 (m, 0.04H), 
4.54 (q, J = 8.4 Hz, 2H). 
2H-NMR (77 MHz, CDCl3): δ = 6.55 (s, 1D), 6.22 (s, 1D), 6.01 (s, 1D). 
13C-NMR (126 MHz, CDCl3): δ = 164.3 (Cq), 132.5 (p, J = 24.6 Hz, CD2), 126.2 (t, J = 25.4 Hz, CD2), 
122.94 (q, J = 277.2 Hz, CF3), 60.35 (q, J = 36.9 Hz, CH2). 
19F-NMR (376 MHz, CDCl3): δ = -73.86 (t, J = 8.2 Hz). 
[D3]-2m was not detectable via ESI-MS. 
 
 
[D3]-(-)-Bornyl acrylate ([D3]-45n):  
The general procedure D was followed using (-)-bornyl acrylate (45n) (193 mg, 1.00 mmol). After the 




NMR conversion vs. internal standard: >95%. 
Degree of Deuteration: D1 = 97%; D2 = 97%; D3 = 97%. 
1H-NMR (500 MHz, CDCl3): δ = 6.38–6.33 (m, 0.03H), 6.14–6.10 (m, 0.03H), 5.79–5.76 (m, 0.03H), 
4.95 (ddd, J = 9.9, 3.5, 2.2 Hz, 1H), 2.37 (dddd, J = 13.5, 9.9, 4.8, 3.3 Hz, 1H), 1.97 (ddd, J = 12.6, 
9.4, 4.5 Hz, 1H), 1.75 (ttd, J = 12.2, 4.6, 3.0 Hz, 1H), 1.68 (t, J = 4.5 Hz, 1H), 1.36–1.19 (m, 2H), 1.00 
(dd, J = 13.7, 3.6 Hz, 1H), 0.91 (s, 3H), 0.87 (s, 3H), 0.84 (s, 3H).  
2H-NMR (77 MHz, CDCl3): δ = 6.40 (s, 1D), 6.16 (s, 1D), 5.83 (s, 1D). 
13C-NMR (126 MHz, CDCl3): δ = 166.7 (Cq), 129.5 (p, J = 24.5 Hz), 128.7 (t, J = 25.3 Hz), 80.1 (CH), 
49.0 (Cq), 47.9 (Cq), 45.0 (CH), 36.9 (CH2), 28.1 (CH2), 27.3 (CH2), 19.8 (CH3), 19.0 (CH3), 13.6 
(CH3). 
HR-MS (ESI) m/z calcd for C13H17O2D3Na, [M+Na]
+ 234.1544, found 234.1546; Intensity: 100%. 
HR-MS (ESI) m/z calcd for C13H18O2D2Na, [M+Na]
+ 233.1481, found 233.1482; Intensity: 10%.[129] 
 
 
[D3]-2-Trifluorophenyl acrylate ([D3]-45o):  
The general procedure D was followed using 2-trifluoromethylphenyl acrylate (45o). After the reaction 
was finished, C6F5H (22.1 mg, 0.13 mmol) was added as the internal standard. 
NMR conversion vs. internal standard: >95%. 
Degree of Deuteration: D1 = 95%; D2 = 95%; D3 = 84% 
1H-NMR (500 MHz, CDCl3): δ = 7.69 (dd, J = 7.8, 2.0 Hz, 1H), 7.59 (ddd, J = 7.8, 7.8, 1.8 Hz, 1H), 
7.35 (ddd, J = 8.7, 7.2, 1.0 Hz, 1H), 7.30 (d, J = 8.1 Hz, 1H), 6.68–6.61 (m, 0.05H), 6.38–6.30 (m, 




2H-NMR (77 MHz, CDCl3): δ = 6.66 (s, 1D), 6.35 (s, 1D), 6.09 (s, 1D). 
13C-NMR (126 MHz, CDCl3): δ = 163.8 (Cq), 148.0 (q, J = 2.1 Hz, Cq), 133.0 (CH), 132.9 (p, 
J = 25.1 Hz, CD2), 126.9 (q, J = 4.9 Hz, CH), 126.5 (t, J = 25.5 Hz, CD), 125.9 (CH), 124.2 (CH), 
122.9 (q, J = 277.7 Hz, CF3), 122.9 (q, J = 31.7 Hz, Cq).
  
19F-NMR (283 MHz, CDCl3): δ = -61.90. 
HR-MS (ESI) m/z calcd for C10H4O2D3F3Na, [M+Na]
+ 242.0479, found 242.0480; Intensity: 100%. 
HR-MS (ESI) m/z calcd for C10H5O2D2F3Na, [M+Na]
+ 241.0416, found 241.0409; Intensity: 25%.[129] 
 
 
[D3]-4-Chlorophenyl acrylate ([D3]-45p):  
The general procedure D was followed using 4-chlorophenyl acrylate (45p) (182 mg, 1.00 mmol). 
After the reaction was finished, EtOAc (22.1 mg, 0.25 mmol) was added as the internal standard. 
NMR conversion vs. internal standard: 80%. 
Degree of Deuteration: D1 = 96%; D2 = 96%; D3 = 96% 
1H-NMR (500 MHz, CDCl3): δ = 7.37–7.33 (m, 2H), 7.11–7.04 (m, 2H), 6.61–6.56 (m, 0.04H),      
6.31–6.27 (m, 0.04H), 6.03–5.99 (m, 0.04H).  
2H-NMR (77 MHz, CDCl3): δ = 6.63 (s, 1D), 6.34 (s, 1D), 6.06 (s, 1D).
  
13C-NMR (126 MHz, CDCl3): δ = 164.5 (Cq), 149.1 (Cq), 132.47 (p, J = 24.7 Hz), 129.6 (CH), 127.22 
(t, J = 25.5 Hz), 123.0 (CH), 116.7 (Cq). 
HR-MS (ESI) m/z calcd for C9H4O2D3ClNa, [M+Na]
+ 208.0215, found 208.0218; Intensity: 100%. 
HR-MS (ESI) m/z calcd for C9H5O2D2ClNa, [M+Na]






[D3]-4-Bromophenyl acrylate ([D3]-45q):  
The general procedure D was followed using 4-bromophenyl acrylate (45q) (226 mg, 1.00 mmol). 
After the reaction was finished, EtOAc (20.7 mg, 0.24 mmol) was added as the internal standard. 
NMR conversion vs. internal standard: >95%. 
Degree of Deuteration: D1 = 95%; D2 = 95%; D3 = 95% 
1H-NMR (500 MHz, CDCl3): δ = 7.52–7.47 (m, 2H), 7.06–7.00 (m, 2H), 6.61–6.55 (m, 0.05H),     
6.34–6.26 (m, 0.05H), 6.04–5.96 (m, 0.05H).  
2H-NMR (77 MHz, CDCl3): δ = 6.63 (s, 1D), 6.34 (s, 1D), 6.06 (s, 1D).
  
13C-NMR (126 MHz, CDCl3): δ = 164.2 (Cq), 149.5 (Cq), 132.4 (Cq), 132.3 (p, J = 24.5 Hz, CD2), 
127.0 (t, J = 25.1 Hz), 123.3 (CH), 118.9 (CH). 
HR-MS (ESI) m/z calcd for C9H4O2D3
79BrNa, [M+Na]+ 251.9710, found 251.9707; Intensity: 100%. 
HR-MS (ESI) m/z calcd for C9H5O2D2
79BrNa, [M+Na]+ 250.9647, found 250.9662; Intensity: 15%.[129] 
 
 
[D3]-4-Iodophenyl acrylate ([D3]-45r):  
The general procedure D was followed using 4-iodophenyl acrylate (45r) (273 mg, 1.00 mmol). After 




NMR conversion vs. internal standard: 85%. 
Degree of Deuteration: D1 = 92%; D2 = 92%; D3 = 92% 
1H-NMR (500 MHz, CDCl3): δ = 7.75–7.66 (m, 2H), 6.94–6.88 (m, 2H), 6.60–6.57 (m, 0.08H),     
6.32–6.27 (m, 0.08H), 6.03–5.99 (m, 0.08H).  
2H-NMR (77 MHz, CDCl3): δ = 6.63 (s, 1D), 6.33 (s, 1D), 6.06 (s, 1D).
  
13C-NMR (126 MHz, CDCl3): δ = 164.3 (Cq), 150.5 (Cq), 138.6 (CH), 132.5 (p, J = 24.7 Hz), 127.2 (t, 
J = 25.6 Hz), 123.9 (CH), 90.0 (Cq). 
HR-MS (ESI) m/z calcd for C9H4O2D3INa, [M+Na]
+ 299.9571, found 299.9570; Intensity: 100.  
HR-MS (ESI) m/z calcd for C9H5O2D2INa, [M+Na]
+ 298.9508, found 298.9486; Intensity: 15%.[129] 
 
 
[D3]-4-Methoxyphenyl acrylate ([D3]-45s):  
The general procedure D was followed using 4-methoxyphenyl acrylate (45s) (178 mg, 1.00 mmol). 
After the reaction was finished, EtOAc (20.9 mg, 0.24 mmol) was added as the internal standard. 
NMR conversion vs. internal standard: >95%. 
Degree of Deuteration: D1 = 97%; D2 = 97%; D3 = 97% 
1H-NMR (500 MHz, CDCl3): δ = 7.05 (d, J = 9.2 Hz, 2H), 6.90 (d, J = 9.2 Hz, 2H), 6.59–6.53 (m, 
0.03H), 6.32–6.28 (m, 0.03H), 6.01–5.95 (m, 0.03H), 3.80 (s, 3H).  
2H-NMR (77 MHz, CDCl3): δ = 6.61 (s, 1D), 6.34 (s, 1D), 6.02 (s, 1D).  
13C-NMR (126 MHz, CDCl3): δ = 165.1 (Cq), 157.4 (Cq), 144.1 (Cq), 131.8 (p, J = 24.7 Hz, CD2), 




HR-MS (ESI) m/z calcd for C10H7O3D3Na, [M+Na]
+ 204.0710, found 204.0713; Intensity: 100%. 
HR-MS (ESI) m/z calcd for C10H8O3D2Na, [M+Na]
+ 203.0648, found 203.0648; Intensity: 10%.[129] 
 
 
[D3]-3,4-Dimethoxyphenyl acrylate ([D3]-45t):  
The general procedure D was followed using 3,4-dimethoxyphenyl acrylate (45t) (208 mg, 1.00 mmol). 
After the reaction was finished, EtOAc (17.8 mg, 0.20 mmol) was added as the internal standard. 
NMR conversion vs. internal standard: >95%. 
Degree of Deuteration: D1 = 94%; D2 = 94%; D3 = 94% 
1H-NMR (500 MHz, CDCl3): δ = 6.84–6.80 (m, 1H), 6.68–6.64 (m, 2H), 6.55–6.53 (m, 0.06H),      
6.29–6.24 (m, 0.06H), 5.98–5.93 (m, 0.06H), 3.84 (s, 3H), 3.83 (s, 3H).  
2H-NMR (77 MHz, CDCl3): δ = 6.57 (s, 1D), 6.29 (s, 1D), 5.98 (s, 1D). 
13C-NMR (126 MHz, CDCl3): δ = 164.9 (Cq), 149.4 (Cq), 146.9 (Cq), 144.2 (Cq), 131.8 (p, J = 24.6 Hz, 
CD2), 127.4 (t, J = 24.9 Hz, CD), 112.8 (CH), 111.2 (CH), 105.7 (CH), 56.2 (CH3), 56.0 (CH3). 
HR-MS (ESI) m/z calcd for C11H9O4D3Na, [M+Na]
+ 234.0816, found 234.0819; Intensity: 100%. 
HR-MS (ESI) m/z calcd for C11H10O4D2Na, [M+Na]







[D3]-4-Acetylphenyl acrylate ([D3]-45u):  
The general procedure E was followed using 4-acetylphenyl acrylate (45u) (190 mg, 1.00 mmol). 
After the reaction was finished, EtOAc (16.0 mg, 0.18 mmol) was added as the internal standard. 
NMR conversion vs. internal standard: >95%. 
Degree of Deuteration: D1 = 96%; D2 = 96%; D3 = 70%; acetyl group: 17%. 
1H-NMR (500 MHz, C6D6): δ = 7.73–7.66 (m, 2H), 6.99–6.93 (m, 2H), 6.38–6.31 (m, 0.04H),        
6.08–6.00 (m, 0.30 H), 5.46–5.41 (m, 0.04H), 2.14–2.07 (s and t, 2.48H).  
2H-NMR (77 MHz, C6D6): δ = 6.32 (s, 1D), 6.02 (s, 1D), 5.43 (s, 1D), 2.08 (t, J = 2.3 Hz).
  
13C-NMR (126 MHz, C6D6): δ = 196.1 (Cq), 163.4 (Cq), 154.5 (Cq), 135.0 (Cq), 132.18 (p, J = 25.3 Hz, 
CD2), 130.1 (CH), 127.21 (t, J = 25.8 Hz, CD), 121.9 (CH), 26.2 (CH3). 
HR-MS (ESI) m/z calcd for C11H6O3D4Na, [M+Na]
+ 217.0773, found 217.0768; Intensity: 35%. 
HR-MS (ESI) m/z calcd for C11H7O3D3Na, [M+Na]
+ 216.0710, found 216.0711; Intensity: 100%. 
HR-MS (ESI) m/z calcd for C11H8O3D2Na, [M+Na]









[D3]-4-Cyanophenyl acrylate ([D3]-45v):  
The general procedure E was followed using 4-cyanophenyl acrylate (45v) (173 mg, 1.00 mmol). After 
the reaction was finished, EtOAc (25.0 mg, 0.28 mmol) was added as the internal standard. 
NMR conversion vs. internal standard: 89%. 
Degree of Deuteration: D1 = 85%; D2 = 85%; D3 = 52% 
1H-NMR (500 MHz, C6D6): δ = 6.94–6.90 (m, 2H), 6.65–6.61 (m, 2H), 6.33–6.23 (m, 0.15H),         
5.97–5.87 (m, 0.48H), 5.40–5.33 (m, 0.15H).  
2H-NMR (77 MHz, C6D6): δ = 6.26 (s, 1D), 5.91 (s, 1D), 5.34 (s, 1D).  
13C-NMR (126 MHz, C6D6): δ = 163.3 (Cq), 160.9 (Cq), 153.8 (Cq), 134.2 (Cq), 133.5 (CH),         
133.23–132.16 (m, CD2), 127.25–126.96 (m, CD), 122.6 (CH). 
HR-MS (ESI) m/z calcd for C10H4NO2D3Na, [M+Na]
+ 199.0557, found 199.0552; Intensity: 100%. 
HR-MS (ESI) m/z calcd for C10H5NO2D2Na, [M+Na]
+ 198.0495, found 198.0495; Intensity: 90%. 
HR-MS (ESI) m/z calcd for C10H6NO2D1Na, [M+Na]
+ 197.0432, found 197.0433; Intensity: 20%.[129] 
 
 
[D3]-4-Nitrophenyl acrylate ([D3]-45w):  
The general procedure E was followed using 4-nitrophenyl acrylate (45w) (193 mg, 1.00 mmol). After 




NMR conversion vs. internal standard: >95%. 
Degree of Deuteration: D1 = 95%; D2 = 95%; D3 = 36%. 
1H-NMR (500 MHz, C6D6): δ = 7.78–7.69 (m, 2H), 6.68–6.62 (m, 2H), 6.33–6.23 (m, 0.05H),         
5.97–5.89 (m, 0.64H), 5.41–5.34 (m, 0.05H).  
2H-NMR (77 MHz, C6D6): δ = 6.28 (s at 6.30 and s at 6.27, 1D), 5.92 (s, 1D), 5.37 (s, 1D).  
13C-NMR (126 MHz, C6D6): δ = 163.2 (Cq), 155.2 (Cq), 145.5 (Cq), 132.8 (p, J = 24.6 Hz, CD2), 127.0 
(s, CH/CD) & 126.7 (t, J = 25.0 Hz, CH/CD), 125.1 (CH), 122.3 (CH). 
HR-MS (ESI) m/z calcd for C9H4O4D3Na, [M+Na]
+ 219.0456, found 219.0442; Intensity: 70%. 
HR-MS (ESI) m/z calcd for C9H5O4D2Na, [M+Na]





5.3.3.2 Kinetic Study for the Deuterium Labelling Reaction 
 
[RuCl2(p-cymene)]2 (30) (6.1 mg, 0.01 mmol, 1.0 mol %), m-CF3-benzoic acid (9.5 mg, 0.05 mmol, 
5.0 mol %), potassium m-CF3-benzoate (11.5 mg, 0.05 mmol, 5.0 mol %) and 1,3,5-trichlorobenzene 
(36.2 mg, 0.2 mmol, 0.2 equiv) as the internal standard, were placed in a pre-dried 25 mL Schlenk-
tube. The tube was evacuated and refilled with Ar three times. Ethyl acrylate (45b) (100.1 mg, 
1.00 mmol, 1.0 equiv) and d3-MeOD (1.0 mL, 24.7 mmol, 24.7 equiv) were added and the mixture 
was stirred for 10 minutes, before 0.6 ml were transferred into an argon filled NMR tube. The kinetic 
of the deuterium incorporation was determined by periodical 1H-NMR measurement at a Bruker 
Avance 300 with temperature unit at 60°C (Figure 33, Table 45). 
NMR conversion vs. internal standard: >95%. 




































Figure 33: Data of the in-operando NMR study of the deuteration of ethyl acrylate. 
 
Table 45: Data of the in-operando NMR study of the deuteration of ethyl acrylate. 
Time [min] D1 [%D] D2 [%D] D3 [%D] 
0 0 0 0 
100 5 5 4 
200 26 26 17 
300 51 51 35 
400 64 64 47 
500 75 75 57 
600 80 80 64 













Figure 35: 1H-NMR-Spectrum after 400 minutes of the in-operando NMR study of the deuteration 





Figure 36: 1H-NMR-Spectrum after 700 minutes of the in-operando NMR study of the deuteration 





5.3.3.3 Synthesis of 107 
 
[RuCl2(p-cymene)]2 (30) (306 mg, 0.5 mmol, 1.0 equiv), m-CF3-benzoic acid (380 mg, 2.0 mmol, 
4.0 equiv) and K2CO3 (138 mg, 1.0 mmol, 2.0 equiv) were suspended in PhMe (30 mL) and stirred for 
16 h. All volatiles were removed in vacuo and the residue was solved in CH2Cl2 (20 mL). Filtration 
over Celite, followed by evaporation of the solvent delivered 107 as an orange oil (617 mg, 1.0 
mol, >99%). 
X-ray suitable single crystalys were obtained by overlayering a concentrated solution of 107 in CH2Cl2 
solution in n-hexane and storing it at -30 °C. 
1H-NMR (300 MHz, CDCl3): δ = 8.08 (s, 2H), 8.02 (d, J = 8.0 Hz, 2H), 7.63 (d, J = 7.6 Hz, 2H), 7.40 
(dd, J = 8.0, 7.6 Hz, 2H), 6.02 (d, J = 6.1 Hz, 2H), 5.80 (d, J = 6.2 Hz, 2H), 2.37 (s, 3H), 1.43 (d, 
J = 7.0 Hz, 6H). 
13C-NMR (126 MHz, CDCl3): δ = 177.6 (Cq), 134.4 (Cq), 132.3 (CH), 130.5 (q, 
2JC-F = 32.7 Hz, Cq), 
128.5 (CH), 128.1 (CH), 126.2 (CH), 126.1 (Cq), 123.9 (q, 
1JC-F = 272.5 Hz, Cq), 98.7 (CH), 79.3 (Cq), 
78.0 (CH), 31.7 (CH), 22.7 (CH3), 18.8 (CH3). 
19F-NMR (282 MHz, CDCl3): δ = -62.87. 
IR (ATR): 2281, 1617, 1576, 1320, 1278, 1122, 1069, 789, 696, 496 cm–1.  
MS (EI) m/z (relative Intensity): 614 (1) [M]+, 595 (1), 551 (1), 460 (1), 424 (55), 381 (40), 173 (100), 
145 (85).  




5.3.3.4 Synthesis of Deuterium Labeled Compounds 
 
[D3]-Methyl 2-(4-methyl-3-oxo-1,3-dihydroisobenzofuran-1-yl-1-d)acetate ([D3]-47ab):  
2-Methyl-6-deuterobenzoic acid-D ([D1]-21a-D) (138 mg, 1.00 mmol, 2.0 equiv), [RuCl2(p-cymene)]2 
(30) (15 mg, 0.03 mmol, 5.0 mol %) and KOAc (49 mg, 0.50 mmol, 1.0 equiv) were placed in a pre-
dried 25 mL Schlenk-tube. The tube was evacuated and refilled with O2 3 times. Methyl acrylate-d3 
[D3]-45b (45 g, 0.50 mmol, 1.0 equiv, 93% D) and CD3OD (1.0 mL, 55 mmol, 55.0 equiv) were added 
and the mixture was heated to 80 °C for 18 h. The crude reaction mixture was absorbed on silica and 
purified by column chromatography (n-hexane/EtOAc: 4/1 + 5% NEt3) to yield [D3]-47ab as a white 
solid (88 mg, 40 mmol, 79%). 
Degree of Deuteration: D1 = 93%; D2 = 93%; D3 = 93%. D2 and D3 are overlapping in the 1H-NMR 
spectra, their deuteration value is given as the average. 
1H-NMR (500 MHz, CDCl3): δ = 7.52 (t, J = 7.6 Hz, 1H), 7.29–7.24 (m, 2H), 5.83–5.74 (m, 0.07H), 
3.74 (s, 3H), 2.90–2.75 (m, 0.14H), 2.67 (d, J = 0.8 Hz, 3H).  
2H-NMR (77 MHz, CDCl3): δ = 5.79 (s, 1D), 2.84 (s, 2D).
  
13C-NMR (126 MHz, CDCl3): δ = 170.1 (Cq), 169.9 (Cq), 149.2 (Cq), 140.0 (Cq), 134.1 (CH), 131.3 
(CH), 123.4 (Cq), 119.4 (CH), 75.7 (t, J = 24.0 Hz, CD), 52.3 (CH3), 39.0 (p, J = 19.9 Hz, CD2), 17.4 
(CH3). 
HR-MS (ESI) m/z calcd for C12H9O4D3Na, [M+Na]
+ 246.0816, found 246.0814; Intensity: 100%. 
HR-MS (ESI) m/z calcd for C12H10O4D2Na, [M+Na]






[D3]-Methyl (E)-3-(3-methoxyphenyl-2-d)acrylate ([D3]-97cb):  
2-Methoxy-6-deuterobenzoic acid-D ([D1]-21c-D) (231 mg, 1.50 mmol, 3.0 equiv), 
[Ru(CO2Mes)2(p-cymene)] (99) (28 mg, 0.05 mmol, 10 mol %) and V2O5 (91 mg, 0.50 mmol, 1.0 
equiv) were placed in a pre-dried 25 mL pressure tube equipped with a rubber septum. The tube was 
evacuated and refilled with Argon three times. Methyl acrylate-d3 [D3]-45b (45 g, 0.50 mmol, 
1.0 equiv, 93% D) and PhMe (1.0 mL) were added. The pressure tube was sealed and the mixture was 
heated to 120°C for 18 h. The crude reaction mixture was absorbed on silica and purified by column 
chromatography (n-hexane/EtOAc: 20/1) to yield [D3]-97cb as a colorless oil (72 mg, 36 mmol, 54%). 
Degree of Deuteration: D1 = 82%; D2 = 89%; D3 = 89%. 
1H-NMR (500 MHz, CDCl3): δ = 7.68–7.60 (m, 0.11H), 7.30 (t, J = 7.9 Hz, 1H), 7.12 (dd, J = 7.6, 
1.1 Hz, 1H), 7.04 (t, J = 2.1 Hz, 0.18H), 6.94 (dd, J = 8.3, 1.0 Hz, 1H), 6.47–6.35 (m, 0.11H), 3.83 (s, 
3H), 3.81 (s, 3H).  
2H-NMR (77 MHz, CDCl3): δ = 7.71 (s, 1D), 7.09 (s, 1D), 6.46 (s, 1D).
  
13C-NMR (126 MHz, CDCl3): δ = 167.5 (Cq), 160.0 (Cq), 144.5 (t, J = 24.3 Hz, CD), 135.7 (Cq), 
130.0 (CH), 120.9 (CH), 117.8 (t, J = 25.3 Hz, CD), 116.3 (CH), 112.76 (t, J = 24.1 Hz, CD), 
55.5 (CH3), 51.9 (CH3). 
HR-MS (ESI) m/z calcd for C11H10O3D3, [M+H]
+ 196.1048, found 196.1050; Intensity: 100%.  
HR-MS (ESI) m/z calcd for C11H11O3D2, [M+H]






1,2,2-[D3]-Methyl-5,8-dioxaspiro[3.4]octane-1-carboxylate ([D3]-109):  
A KOtBu solution in t-butanol was freshly prepared, by dissolving potassium (2.5 g, 63 mmol, 3.1 
equiv) was in t-BuOH (70 mL). At 100 °C 2-bromomethyl-1,3-dioxolan (108) (6.3 g, 38 mmol, 
1.9 equiv) was added and the mixture was stirred at 85 °C for 2 h. All volatiles were transferred by 
distillation and then by condensation with passiv high vaccum and heating to 100°C of the reaction 
flask and cooling the receiving flask to -196 °C. [D3]-Methyl acrylate (1.8 g, 20 mmol, 1.0 equiv, 
93% D) and MEHQ (100 mg) were added and the mixture was stirred at 90 °C for 72 h. The solvent 
was distilled off and the residue was purified by column chromatography (n-hexane/EtOAc 20/1 
10/1) to yield compound [D3]-109 as a colorless oil (2.25 g, 12.8 mmol, 64%). 
[D3]-109 shows minor impurities. The purity is estimated to be >90%. 
Degree of Deuteration: D1 = 67%; D2/3 = 93%. 
1H-NMR (400 MHz, CDCl3): δ = 4.06–3.94 (m, 2H), 3.92–3.86 (m, 2H), 3.71 (s, 3H), 3.42–3.35 (m, 
0.33H), 2.39 (tt, J = 2.6, 1.1 Hz, 2H), 2.11–2.07 (m, 0.07H), 1.86–1.78 (m, 0.07H).  
2H-NMR (61 MHz, CDCl3): δ = 3.40 (s, 1D), 2.10 (s, 1D), 1.83 (s, 1D).
  
13C-NMR (126 MHz, CDCl3): δ = 171.4 (Cq), 109.1 & 109.0 (Cq), 65.0 (CH2), 64.7 (CH2), 52.5 (s, 
CH/CD), 52.19 (t, J = 21.5 Hz, CH/CD), 51.9 (CH3), 33.7 (CH2), 13.38 (p, J = 21.4 Hz, CD2). 
HR-MS (ESI) m/z calcd for C8H9O2D3Na, [M+Na]
+ 198.0816, found 198.0817; Intensity: 100%. 
HR-MS (ESI) m/z calcd for C8H10O2D2Na, [M+Na]
+ 197.0753, found 197.0754; Intensity: 60%. 
HR-MS (ESI) m/z calcd for C8H11O2DNa, [M+Na]






1,2,2-[D3]-(5,8-dioxaspiro[3.4]octan-1-yl-1,2,2-d3)methanol ([D3]-110):  
LiAlH4 was suspended in Et2O and [D3]-109 (2.5 g, 63 mmol, 3.1 equiv) in Et2O (10 mL) was slowly 
added at 0 °C over a period of 20 minutes. After the mixture was stirred at 30 °C for 3 h, H2O (10 mL) 
was added and the white precipitate extracted with Et2O (5∙50 mL). The combined organic phases were 
washed with H2O (50 mL) dried over MgSO4 and filtered through a short plug of silica (3 cm). 
Removal of the solvent yielded [D3]-110 as a colorless oil (1.12 g, 8.7 mmol, 79%). 
[D3]-110 shows minor impurities. The purity is estimated to be >90%. 
Degree of Deuteration: D1 = 67%; D2/3 = 90%. 
1H-NMR (500 MHz, CDCl3): δ = 3.96–3.85 (m, 4H), 3.80–3.64 (m, 2H), 2.81–2.66 (m, 0.33H), 2.29–
2.19 (m, 2H), 1.79–1.72 (m, 0.10H), 1.58–1.52 (m, 0.10H).  
2H-NMR (77 MHz, CDCl3): δ = 2.74 (s, 1D), 1.76 (s, 1D), 1.57 (s, 1D).  
13C-NMR (126 MHz, CDCl3): δ = 110.1 & 110.1 (Cq), 64.5 (CH2), 64.0 (CH2), 62.1 (d, J = 8.7 Hz, 
CH2OH), 48.5 (CH/CD), 48.1 (t, J = 21.2 , CH/CD), 33.5 (CH), 13.3 (p, J = 21.6, 21.1, 20.7 Hz, CD2). 
HR-MS (ESI) m/z calcd for C7H9O3D3Na, [M+Na]
+ 170.0867, found 170.0868; Intensity: 100%.  
HR-MS (ESI) m/z calcd for C8H10O2D2Na, [M+Na]
+ 169.0804, found 169.0805; Intensity: 70%.  
HR-MS (ESI) m/z calcd for C8H11O2D Na, [M+Na]






5.3.4 Synthesis of Deuterated Benzoic Acids  
  
2-Methyl-6-deuterobenzoic acid ([D1]-21a):  
2-Methyl-benzoic acid (21a) (1.36 g, 10.0 mmol, 1.0 equiv), [RuCl2(p-cymene)]2 (30) (122 mg, 
0.20 mmol, 2.0 mol %) and K2CO3 (55 mg, 0.40 mmol, 0.2 equiv) were placed in a pre-dried Schlenk-
tube. The tube was evacuated and refilled with Ar three times. D2O (4.0 mL, 220 mmol, 22.0 equiv) 
was added and the reaction mixture was stirred at 100 °C for 18 h. The solvent was removed under 
reduced pressure and additional D2O (2.0 mL, 110 mmol, 11.0 equiv) was added. The reaction mixture 
was stirred at 100 °C for 16 h. At ambient temperature, the mixture was extracted with EtOAc 
(2∙50 mL). The combined organic phases were washed with aqueous NaOH (2.0 M, 50 mL) and then 
both phases were acidified to pH = 1 with aqueous HCl (conc.). The organic phase was separated, 
dried over anhydrous Na2SO4 and the solvent was removed under reduced pressure. Purification by 
column chromatography (Et2O) and Kugelrohr-distillation yielded [D1]-21a (1.01 g, 7.4 mmol, 74%) 
as a white solid.  
Degree of Deuteration: >98%. 
1H NMR (300 MHz, CDCl3): δ = 12.46 (s, 1H), 7.47 (dd, J = 7.5, 7.5 Hz, 1H), 7.34–7.27 (m, 2H), 2.68 
(s, 3H). 
13C NMR (75 MHz, CDCl3): δ = 173.5 (Cq), 141.5 (Cq), 133.1 (CH), 132.1 (CH), 131.5 (t, J = 24.6 Hz, 
CD), 128.4 (Cq), 125.9 (CH), 22.3 (CH3). 
IR (ATR): 2645, 1672, 1451, 1267, 1109, 699, 651, 565, 480, 401 cm–1.  
MS (EI) m/z (relative intensity): 137 (90) [M]+, 129 (10), 119 (100), 105 (5), 92 (100), 78 (10), 66 (30), 
63 (20).  
HR-MS (ESI) m/z calcd for C8H6O3D, [M-H]





2-Methyl-6-deuterobenzoic acid-D ([D2]-21a):  
2-Methyl-benzoic acid (21a) (0.68 g, 5.00 mmol, 1.0 equiv), [RuCl2(p-cymene)]2 (30) (31 mg, 
0.05 mmol, 1.0 mol %) and K2CO3 (14 mg, 0.10 mmol, 2.0 mol %) were placed in a pre-dried 
Schlenk-tube. The tube was evacuated and refilled with Ar three times. D2O (1.0 mL, 55 mmol, 
11.0 equiv) and PhMe (1.0 mL) were added and the reaction mixture was stirred at 80 °C for 24 h. The 
solvent was removed under reduced pressure and additional D2O (1.0 mL, 55 mmol, 11.0 equiv) and 
PhMe (1.0 mL) were added. The reaction mixture was stirred at 80 °C for 24 h. All volatiles were 
removed and the residue was purified by column chromatography (n-hexane/Et2O: 1/1) and Kugelrohr-
distillation to yield [D2]-21a (643 mg, 4.17 mmol, 83%) as a white solid.
 
Degree of Deuteration: >98%. 
1H NMR (300 MHz, CDCl3): δ = 7.44 (dd, J = 7.5, 7.5 Hz, 1H), 7.29 (m, 2H), 2.67 (s, 3H). 
13C NMR (75 MHz, CDCl3): δ = 173.0 (Cq), 141.5 (Cq), 133.1 (CH), 132.1 (CH), 131.4 (m, CD), 128.4 
(Cq), 125.9 (CH), 22.2 (CH3). 
IR (ATR): 2639, 1672, 1268, 921, 819, 803, 698, 650, 527, 401 cm–1.  
MS (EI) m/z (relative intensity): 137 (80) [M]+, 124 (5), 119 (95), 106 (5), 92 (100), 78 (10), 66 (25), 
63 (15).  
HR-MS (ESI) m/z calcd for C8H6O2D, [M-D]







2-Methoxy-6-deuterobenzoic acid ([D1]-21c):  
2-Methoxybenzoic acid (21c) (2.50 g, 16.0 mmol, 1.0 equiv), [RuCl2(p-cymene)]2 (30) (200 mg, 
0.30 mmol, 2.0 mol %) and KOAc (160 mg, 1.60 mmol, 0.1 equiv) were placed in a pre-dried Schlenk-
tube. The tube was evacuated and refilled with argon three times. D2O (3.0 mL, 165 mmol, 10.3 equiv) 
was added and the reaction mixture was stirred at 80 °C for 16 h. The solvent was removed under 
reduced pressure and additional D2O (3.0 mL, 165 mmol, 10.3 equiv) was added. The reaction mixture 
was stirred at 80 °C for 16 h. At ambient temperature, the mixture was extracted with EtOAc (2∙50 mL). 
The combined organic phases were washed with aqueous NaOH (2.0 M, 50 mL) and then both phases 
were acidified to pH = 1 with aqueous HCl (conc.). The organic phase was separated, dried over 
anhydrous Na2SO4 and the solvent was removed under reduced pressure. Purification by column 
chromatography (Et2O) and Kugelrohr-distillation yielded [D1]-21c (2.39 g, 15.6 mmol, 95%) as a 
white solid.  
Degree of Deuteration: >98%. 
1H NMR (300 MHz, CDCl3): δ = 10.84 (s, 1H), 7.57 (dd, J = 8.3, 7.4 Hz, 1H), 7.13 (d, J = 7.4 Hz, 
1H), 7.06 (dd, J = 8.3, 1.1 Hz, 1H), 4.07 (s, 3H).  
13C NMR (126 MHz, CDCl3): δ = 165.5 (Cq), 158.1 (Cq), 135.1 (CH), 133.5 (t, J = 25.0 Hz, CD), 122.1 
(CH), 117.6 (Cq), 111.8 (CH), 56.8 (CH3).  
IR (ATR): 2843, 1662, 1642, 1253, 1117, 1011, 914, 823, 785, 702 cm–1.  
MS (EI) m/z (relative intensity): 153 (60) [M]+, 136 (45), 124 (70), 106 (100), 93 (33), 78 (60), 64 (25), 
51 (20), 43 (50).  
HR-MS (EI) m/z calcd for C8H7O3D, [M]






2-Methoxy-6-deuterobenzoic acid-D ([D2]-21c):  
2-Methoxybenzoic acid (21c) (0.76 g, 5.00 mmol, 1.0 equiv), [RuCl2(p-cymene)]2 (30) (31 mg, 
0.05 mmol, 1.0 mol %) and K2CO3 (14 mg, 0.10 mmol, 2.0 mol %) were placed in a pre-dried 
Schlenk-tube. The tube was evacuated and refilled with argon three times. D2O (1.0 mL, 55 mmol, 
11.0 equiv) and PhMe (1.0 mL) were added and the reaction mixture was stirred at 80 °C for 24 h. The 
solvent was removed under reduced pressure and additional D2O (1.0 mL, 55 mmol, 11.0 equiv) and 
PhMe (1.0 mL) were added. The reaction mixture was stirred at 80 °C for 24 h. All Volatiles were 
removed and the residue was purified by column chromatography (n-hexane/Et2O: 1/1) and Kugelrohr-
distillation to yield [D2]- 21c (643 mg, 4.17 mmol, 83%) as a white solid. 
Degree of Deuteration: >98%. 
1H NMR (300 MHz, CDCl3): δ = 7.58 (dd, J = 8.4, 7.4 Hz, 1H), 7.15 (dd, J = 7.4, 1.1 Hz, 1H), 7.07 
(dd, J = 8.4, 1.3 Hz, 1H), 4.08 (s, 3H). 
13C NMR (75 MHz, CDCl3): δ = 166.0 (Cq), 158.2 (Cq), 135.1 (CH), 133.1 (t, J = 25.0 Hz, CD), 121.7 
(CH), 117.4 (Cq), 111.8 (CH), 56.6 (CH3). 
IR (ATR): 2950, 2634, 1662, 1462, 1117, 822, 702, 649, 424, 402 cm–1.  
MS (EI) m/z (relative intensity): 154 (20) [M]+, 153 (65), 136 (55), 124 (70), 106 (100), 93 (40), 78 
(60), 64 (25), 51 (20), 43 (50).  
HR-MS (ESI) m/z calcd for C8H6O3D, [M-D]







2-Fluoro-6-deuterobenzoic acid ([D1]-21af): 
2-Fluorobenzoic acid (21af) (2.0 g, 14.2 mmol, 1.0 equiv), [RuCl2(p-cymene)]2 (30) (174 mg, 0.3 
mmol, 2.0 mol %) and K2CO3 (96 g, 0.7 mmol, 5.0 mol %) was supended in D2O (3.0 mL, 165 mmol, 
11.9 equiv) and stirred for 18 h at 90 °C. D2O was evaporated first in vacuo, then by azeotropic 
distillation with PhMe (2∙5mL). D2O (1.5 mL, 83 mmol, 6.0 equiv) was added and the suspension was 
stirred for another 5 h at 90 °C. At ambient temperature the mixture was poured into Et2O (120 mL) 
and was extracted with aq. NaOH (2 M, 30 mL). The inorganic phase was acidified to pH 1-2 using 
HCl (6 M, 150 mL) and extracted with Et2O (2∙30 mL). The combined organic layers were dried over 
anhydrous Na2SO4. Evaporation of the solvent, Kugelrohr-distillation (2 times) and recrystallisation 
from PhMe gave [D1]-21af (1.1 g, 55%) as white crystals.  
Degree of Deuteration: >98%. 
M. p. = 124–126 °C.  
1H-NMR (300 MHz, CDCl3): δ = 11.88 (s, 1H), 7.59 (ddd, J = 8.3, 7.4, 4.8 Hz, 1H), 7.28–7.14 (m, 
2H).  
13C-NMR (75 MHz, CDCl3): δ = 170.2 (Cq), 162.8 (d, 
1JC-F = 262.3 Hz, Cq), 135.8 (d, 
3JC-F = 9.5 Hz, 
CH), 132.6 (t, J = 25.3 Hz, CD), 124.1 (d, 4JC-F = 4.0 Hz, CH), 117.6 (d, 
3JCF = 8.8 Hz, Cq), 117.3 (d, 
2JC-F = 22.0 Hz, CH). 
19F{1H}-NMR (282 MHz, CDCl3): δ = −108.17.  
IR (ATR): 2652, 1682, 1606, 1458, 1282, 1245, 823, 695, 643, 402 cm–1.  
MS (EI) m/z (relative intensity): 141 (75), 124 (100), 113 (5), 96 (50), 91 (10), 85 (5), 76 (25), 69 (10), 
58 (20), 51 (10).  
HR-MS (ESI) m/z calcd for C7H5O3FD [M+H]





2-Fluoro-benzoic acid-D (21af-D): 
2-Fluorobenzoic acid (21af) (2.0 g, 14.2 mmol, 1.0 equiv) was supended in D2O (2.0 mL, 110 mmol, 
7.9 equiv.) and stirred for 18 h at 90 °C. D2O was evaporated first in vacuo, then by azeotropic 
distillation with PhMe (2 x 5 mL). D2O (1.0 mL, 55 mmol, 3.9 equiv) was added and the suspension 
was stirred for another 5 h at 90 °C. Evaporation of D2O and recrystallisation from PhMe gave 21af-D 
(1.9 g, 95%) as white crystals.  
Degree of Deuteration: >98%. 
M. p. =122-124 °C.  
1H NMR (300 MHz, CDCl3): δ = 12.10 (s, 0.01H), 8.06 (ddd, J = 7.5, 7.5, 1.9 Hz, 1H), 7.60 (ddd, J = 
8.3, 7.4, 1.9 Hz, 1H), 7.33–7.12 (m, 2H).  
13C-NMR (75 MHz, CDCl3): δ = 169.9 (Cq), 162.8 (d, 
1JC-F = 262.3 Hz, Cq), 135.8 (d, 
3JC-F = 9.2 Hz, 
CH), 132.9 (CH), 124.2 (d, 4JC-F = 3.7 Hz, CH), 117.7 (d, 
3JC-F = 8.8 Hz, C
q), 117.3 (d, 2JC-F = 22.4 Hz, 
CH).  
19F{1H}-NMR (282 MHz, CDCl3): δ = −108.08.  
IR (ATR): 2653, 2227, 1682, 1613, 1455, 1360, 1045, 748, 421 cm-1.  
MS (EI) m/z (relative intensity): 140 (80), 123 (100), 112 (5), 95 (55), 75 (35), 69 (10), 63 (5), 50 (15), 
45 (10), 43 (5).  
HR-MS (ESI) m/z calcd for C7H4O3F [M-D]






5.4 Data for X-Ray Diffraction Measurements 
Crystal data for the x-ray structure of 47ad 
Identification code mo_0240_CG_0m 
Empirical formula C18H16O4 
Formula weight 296.31 
Temperature/K 100.0 
Crystal system monoclinic 












Crystal size/mm3 0.447 × 0.308 × 0.028 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection/° 4.788 to 63.098 
Index ranges -11 ≤ h ≤ 14, -15 ≤ k ≤ 15, -41 ≤ l ≤ 41 
Reflections collected 40426 
Independent reflections 9781 [Rint = 0.0347, Rsigma = 0.0351] 
Data/restraints/parameters 9781/0/399 
Goodness-of-fit on F2 1.038 
Final R indexes [I>=2σ (I)] R1 = 0.0450, wR2 = 0.1036 
Final R indexes [all data] R1 = 0.0638, wR2 = 0.1126 
Largest diff. peak/hole / e Å-3 0.35/-0.25 
Identification code mo_0240_CG_0m 






Crystal data for the x-ray structure of 100 
Identification code final  
Empirical formula C57 H69.20 Cl2 N4 O7.60 Ru2  
Formula weight 1205.00  
Temperature 100(2) K  
Wavelength 0.71073 Å  
Crystal system Monoclinic  
Space group Cc  
Unit cell dimensions a = 18.844(2) Å = 90°.
 b = 15.919(2) Å = 97.84(2)°.
 c = 18.261(3) Å  = 90°.
Volume 5426.7(13) Å3  
Z 4  
Density (calculated) 1.475 Mg/m3  
Absorption coefficient 0.712 mm-1  
F(000) 2488  
Crystal size 0.200 x 0.200 x 0.100 mm3  
Theta range for data collection 1.681 to 26.365°.  
Index ranges -23<=h<=23, -19<=k<=19, -22<=l<=22  
Reflections collected 65303  
Independent reflections 11082 [R(int) = 0.0436]  
Completeness to theta = 19.546° 100.0%  
Absorption correction Semi-empirical from equivalents  
Max. and min. transmission 0.4296 and 0.3924  
Refinement method Full-matrix least-squares on F2  
Data / restraints / parameters 11082 / 110 / 724  
Goodness-of-fit on F2 1.050  
Final R indices [I>2sigma(I)] R1 = 0.0249, wR2 = 0.0556  
R indices (all data) R1 = 0.0267, wR2 = 0.0567  
Extinction coefficient -0.021(7)  






Crystal data for the x-ray structure of 101 
Identification code final  
Empirical formula C25 H26 O4 Ru  
Formula weight 491.53  
Temperature 100(2) K  
Wavelength 0.56086 Å  
Crystal system Monoclinic  
Space group P21/c  
Unit cell dimensions a = 8.793(2) Å a= 90°. 
 b = 15.639(2) Å b= 95.500(3)°. 
 c = 15.581(3) Å g = 90°. 
Volume 2132.7(7) Å3  
Z 4  
Density (calculated) 1.531 Mg/m3  
Absorption coefficient 0.412 mm-1  
F(000) 1008  
Crystal size 0.200 x 0.200 x 0.100 mm3  
Theta range for data collection 1.836 to 19.546°.  
Index ranges -10<=h<=10, -18<=k<=18, -18<=l<=18 
Reflections collected 49643  
Independent reflections 3797 [R(int) = 0.0688]  
Completeness to theta = 19.546° 99.9%  
Absorption correction Semi-empirical from equivalents  
Max. and min. transmission 0.4247 and 0.3804  
Refinement method Full-matrix least-squares on F2  
Data / restraints / parameters 3797 / 0 / 275  
Goodness-of-fit on F2 1.020  
Final R indices [I>2sigma(I)] R1 = 0.0272, wR2 = 0.0578  
R indices (all data) R1 = 0.0405, wR2 = 0.0626  
Extinction coefficient n/a  






Crystal data for the x-ray structure of 107 
Identification code mo_0072_CG_0m_4 
Empirical formula C26H22F6O4Ru 
Formula weight 613.50 
Temperature/K 99.99 
Crystal system triclinic 












Crystal size/mm3 0.292 × 0.101 × 0.073 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection/° 4.924 to 57.998 
Index ranges -13 ≤ h ≤ 13, -13 ≤ k ≤ 14, 0 ≤ l ≤ 17 
Reflections collected 6582 
Independent reflections 6582 [Rint = ?, Rsigma = 0.0304] 
Data/restraints/parameters 6582/0/338 
Goodness-of-fit on F2 1.075 
Final R indexes [I>=2σ (I)] R1 = 0.0500, wR2 = 0.1119 
Final R indexes [all data] R1 = 0.0604, wR2 = 0.1187 
Largest diff. peak/hole / e Å-3 3.81/-1.26 
Identification code mo_0072_CG_0m_4 
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